Items where Author or Editor is "Hallek, Michael" - Kölner UniversitätsPublikationsServer

Group by: Item Type | Date | No Grouping

Number of items: 463.

Journal Article

Abruzzo, Lynne, Herling, Carmen, Coombes, Kevin, Benner, Axel, Bloehdorn, Johannes, Barron, Lynn L., Abrams, Zachary, Majewski, Tadeusz, Bondaruk, Jolanta, Bahlo, Jasmin, Fischer, Kirsten, Hallek, Michael, Stilgenbauer, Stephan, Czerniak, Bogdan, Oakes, Christopher, Ferrajoli, Alessandra and Keating, Michael (2020). Gene expression signatures predict time-to-progression after front-line chemoimmunotherapy for CLL. Leuk. Lymphoma, 61. S. 7 - 9. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Agathangelidis, Andreas ORCID: 0000-0002-8467-7945, Chatzidimitriou, Anastasia, Gemenetzi, Katerina, Giudicelli, Veronique, Karypidou, Maria, Plevova, Karla ORCID: 0000-0002-6148-8877, Davis, Zadie, Yan, Xiao-Jie, Jeromin, Sabine, Schneider, Christof, Pedersen, Lone Bredo, Tschumper, Renee C., Sutton, Lesley-Ann, Baliakas, Panagiotis, Scarfo, Lydia, van Gastel, Ellen J., Armand, Marine, Tausch, Eugen, Biderman, Bella, Baer, Constance, Bagnara, Davide, Navarro, Alba, de Septenville, Anne Langlois, Guido, Valentina, Mitterbauer-Hohendanner, Gerlinde, Dimovski, Aleksandar, Brieghel, Christian ORCID: 0000-0002-1816-8106, Lawless, Sarah, Meggendorfer, Manja, Brazdilova, Kamila, Ritgen, Matthias, Facco, Monica, Tresoldi, Cristina, Visentin, Andrea ORCID: 0000-0003-0271-7200, Patriarca, Andrea ORCID: 0000-0003-4415-2906, Catherwood, Mark, Bonello, Lisa, Sudarikov, Andrey ORCID: 0000-0001-9463-9187, Vanura, Katrina, Roumelioti, Maria, Francova, Hana Skuhrova, Moysiadis, Theodoros ORCID: 0000-0003-1673-196X, Veronese, Silvio, Giannopoulos, Krzysztof, Mansouri, Larry, Karan-Djurasevic, Teodora, Sandaltzopoulos, Raphael, Bodor, Csaba, Fais, Franco ORCID: 0000-0002-6643-7083, Kater, Arnon, Panovska, Irina, Rossi, Davide, Alshemmari, Salem ORCID: 0000-0002-5597-5839, Panagiotidis, Panagiotis, Costeas, Paul, Espinet, Blanca ORCID: 0000-0002-4294-8145, Antic, Darko, Foroni, Letizia, Montillo, Marco, Trentin, Livio, Stavroyianni, Niki, Gaidano, Gianluca ORCID: 0000-0002-4681-0151, di Celle, Paola Francia, Niemann, Carsten ORCID: 0000-0001-9880-5242, Campo, Elias, Anagnostopoulos, Achilles, Pott, Christiane, Fischer, Kirsten, Hallek, Michael, Oscier, David, Stilgenbauer, Stephan, Haferlach, Claudia, Jelinek, Diane, Chiorazzi, Nicholas, Pospisilova, Sarka, Lefranc, Marie-Paule, Kossida, Sofia, Langerak, Anton W., Belessi, Chrysoula, Davi, Frederic, Rosenquist, Richard, Ghia, Paolo and Stamatopoulos, Kostas ORCID: 0000-0001-8529-640X (2021). Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL. Blood, 137 (10). S. 1365 - 1377. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Agathangelidis, Andreas, Hadzidimitriou, Anastasia, Minga, Eva, Sutton, Lesley-Ann, Polychronidou, Eleftheria, Shanafelt, Tait D., Davis, Zadie, Yan, Xiao-Jie, Plevova, Karla, Boudjoghra, Myriam, Navarro, Alba, Rossi, Davide, Pedersen, Lone Bredo, Bikos, Vasilis, Baliakas, Panagiotis, Scarfo, Lydia, Mattsson, Mattias, Xochelli, Aliki, di Celle, Paola Francia, Giannopoulos, Krzysztof, Vanura, Katrina, Evers, Ludo, Veronese, Silvio, Facco, Monica ORCID: 0000-0003-0100-5789, Moschonas, Panagiotis, Bystry, Vojtech, Karan-Djurasevic, Teodora, Roumelioti, Maria, Pavlovic, Sonja, Mansouri, Larry, Chu, Charles, Stalika, Evangelia, Giudicelli, Veronique, Panagiotidis, Panagiotis, Sudarikov, Andrey ORCID: 0000-0001-9463-9187, Anagnostopoulos, Achilles, Trentin, Livio, Catherwood, Mark, Montillo, Marco, Stavroyianni, Niki, Gaidano, Gianluca, Campo, Elias ORCID: 0000-0001-9850-9793, Niemann, Carsten Utoft, Langerak, Anton W., Pospisilova, Sarka, Lefranc, Marie-Paule, Jaeger, Ulrich, Kater, Arnon, Pott, Christiane, Chiorazzi, Nicholas, Oscier, David, Jelinek, Diane F., Stilgenbauer, Stephan, Hallek, Michael, Tzovaras, Dimitrios, Darzentas, Nikos, Belessi, Chrysoula, Davi, Frederic, Rosenquist, Richard, Ghia, Paolo and Stamatopoulos, Kostas (2016). Reappraising Immunoglobulin Repertoire Restrictions in Chronic Lymphocytic Leukemia: Focus on Major Stereotyped Subsets and Closely Related Satellites. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Agius, Rudi, Brieghel, Christian ORCID: 0000-0002-1816-8106, Andersen, Michael A., Pearson, Alexander T., Ledergerber, Bruno, Cozzi-Lepri, Alessandro, Louzoun, Yoram, Andersen, Christen L., Bergstedt, Jacob ORCID: 0000-0002-9279-6936, von Stemann, Jakob H., Jorgensen, Mette, Tang, Man-Hung Eric ORCID: 0000-0002-3483-0219, Fontes, Magnus, Bahlo, Jasmin, Herling, Carmen D., Hallek, Michael, Lundgren, Jens, MacPherson, Cameron Ross, Larsen, Jan ORCID: 0000-0003-1880-1810 and Niemann, Carsten U. (2020). Machine learning can identify newly diagnosed patients with CLL at high risk of infection. Nat. Commun., 11 (1). LONDON: NATURE PUBLISHING GROUP. ISSN 2041-1723

Al-Sawaf, Othman, Bahlo, Jasmin, Robrecht, Sandra, Fischer, Kirsten, Herling, Carmen D., Hoechstetter, Manuela, Fink, Anna-Maria, von Tresckow, Julia, Langerbeins, Petra, Cramer, Paula, Stilgenbauer, Stephan, Wendtner, Clemens M., Eichhorst, Barbara, Hallek, Michael and Goede, Valentin (2018). Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia. Br. J. Haematol., 183 (5). S. 727 - 736. HOBOKEN: WILEY. ISSN 1365-2141

Al-Sawaf, Othman, Bazeos, Alexandra, Robrecht, Sandra, Bahlo, Jasmin, Gower, Craig, Fink, Anna-Maria, Tresckow, Julia, Cramer, Paula, Langerbeins, Petra, Kutsch, Nadine, Humphrey, Kathryn, Fingerle-Rowson, Guenter, Stilgenbauer, Stephan, Wendtner, Clemens-Martin, Fischer, Kirsten, Eichhorst, Barbara, Hallek, Michael and Goede, Valentin (2019). Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL). Am. J. Hematol., 94 (9). S. 1002 - 1007. HOBOKEN: WILEY. ISSN 1096-8652

Al-Sawaf, Othman, Cramer, Paula, Goede, Valentin, Hallek, Michael and Pflug, Natali (2017). Bendamustine and its role in the treatment of unfit patients with chronic lymphocytic leukaemia: a perspective review. Ther. Adv. Hematol., 8 (6). S. 197 - 206. LONDON: SAGE PUBLICATIONS LTD. ISSN 2040-6215

Al-Sawaf, Othman, Eichhorst, Barbara and Hallek, Michael (2020). Chronic lymphocytic leukemia. Onkologe, 26 (5). S. 465 - 477. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0415

Al-Sawaf, Othman, Eichhorst, Barbara and Hallek, Michael (2020). Chronic lymphocytic leukemia. Internist, 61 (3). S. 277 - 288. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289

Al-Sawaf, Othman, Fischer, Kirsten, Eichhorst, Barbara and Hallek, Michael (2016). Targeted Therapy of CLL. Oncol. Res. Treat., 39 (12). S. 768 - 777. BASEL: KARGER. ISSN 2296-5262

Al-Sawaf, Othman, Fischer, Kirsten, Engelke, Anja, Pflug, Natali, Hallek, Michael and Goede, Valentin (2017). Obinutuzumab in chronic lymphocytic leukemia: design, development and place in therapy. Drug Des. Dev. Ther., 11. S. 295 - 305. ALBANY: DOVE MEDICAL PRESS LTD. ISSN 1177-8881

Al-Sawaf, Othman, Fischer, Kirsten, Herling, Carmen D., Ritgen, Matthias, Boettcher, Sebastian, Bahlo, Jasmin, Elter, Thomas, Stilgenbauer, Stephan, Eichhorst, Barbara F., Busch, Raymonde, Elberskirch, Ute, Abenhardt, Wolfgang, Kneba, Michael, Hallek, Michael and Wendtner, Clemens-Martin (2017). Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial. Eur. J. Haematol., 98 (3). S. 254 - 263. HOBOKEN: WILEY. ISSN 1600-0609

Al-Sawaf, Othman ORCID: 0000-0001-9895-0570, Gentile, Brittany ORCID: 0000-0002-6302-5593, Devine, Jacob, Zhang, Can, Sail, Kavita, Tandon, Maneesh, Fink, Anna-Maria, Kutsch, Nadine, Wendtner, Clemens-Martin, Eichhorst, Barbara, Hallek, Michael and Fischer, Kirsten (2021). Health-related quality of life with fixed-duration venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: Results from the randomized, phase 3 CLL14 trial. Am. J. Hematol., 96 (9). S. 1112 - 1120. HOBOKEN: WILEY. ISSN 1096-8652

Al-Sawaf, Othman, Lilienweiss, Esther, Bahlo, Jasmin, Robrecht, Sandra, Fink, Anna-Maria, Patz, Michaela, Tandon, Maneesh, Jiang, Yanwen, Schary, William, Ritgen, Matthias, Tausch, Eugen, Stilgenbauer, Stephan, Eichhorst, Barbara, Fischer, Kirsten, Hallek, Michael and Kreuzer, Karl-Anton (2020). High efficacy of venetoclax plus obinutuzumab in patients with complex karyotype and chronic lymphocytic leukemia. Blood, 135 (11). S. 866 - 871. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Al-Sawaf, Othman, Robrecht, Sandra, Bahlo, Jasmin, Fink, Anna Maria, Cramer, Paula, Maurer, Christian, Bergmann, Manuela A., Dreyling, Martin H., Lange, Elisabeth, Kneba, Michael, Stilgenbauer, Stephan, Dohner, Hartmut, Kiehl, Michael G., Jager, Ulrich, Wendtner, Clemens-Martin, Fischer, Kirsten, Hallek, Michael, Eichhorst, Barbara F. and Hopfinger, Georg (2016). Impact of Gender on Outcome after Chemoimmunotherapy with Fludarabine, Cyclophosphamide and Rituximab (FCR) or Bendamustine Plus Rituximab (BR) in Patients with Chronic Lymphocytic Leukemia (CLL): A Meta-Analysis of Three Phase II/III Studies of the German CLL Study Group (GCLLSG). Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Al-Sawaf, Othman, Robrecht, Sandra, Bahlo, Jasmin, Fink, Anna-Maria, Cramer, Paula, Maurer, Christian, Bergmann, Manuela, Dreyling, Martin, Lange, Elisabeth, Kneba, Michael, Stilgenbauer, Stephan, Jaeger, Ulrich, Wendtner, Clemens, Fischer, Kirsten, Goede, Valentin, Hallek, Michael, Eichhorst, Barbara, Hopfinger, Georg, Doehner, Hartmut and Kiehl, Michael (2017). Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis of the German CLL Study Group (GCLLSG). Leuk. Lymphoma, 58. S. 62 - 64. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Al-Sawaf, Othman, Robrecht, Sandra, Bahlo, Jasmin, Fink, Anna-Maria, Cramer, Paula, von Tresckow, Julia, Lange, Elisabeth, Kiehl, Michael, Dreyling, Martin, Rittgen, Matthias, Duerig, Jan, Fischer, Kirsten, Stilgenbauer, Stephan, Wendtner, Clemens, Goede, Valentin, Hallek, Michael and Eichhorst, Barbara (2020). Richter transformation in CLL: a meta-analysis of GCLLSG trials. Leuk. Lymphoma, 61. S. 98 - 101. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Al-Sawaf, Othman, Zhang, Can, Lu, Tong, Liao, Michael Z., Panchal, Anesh, Robrecht, Sandra, Ching, Travers ORCID: 0000-0002-5577-3516, Tandon, Maneesh, Fink, Anna-Maria, Tausch, Eugen, Schneider, Christof, Ritgen, Matthias, Boettcher, Sebastian, Kreuzer, Karl-Anton, Chyla, Brenda, Miles, Dale, Wendtner, Clemens-Martin, Eichhorst, Barbara, Stilgenbauer, Stephan, Jiang, Yanwen, Hallek, Michael and Fischer, Kirsten (2021). Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 Study. J. Clin. Oncol., 39 (36). S. 4049 - 4062. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755

Al-Sawaf, Othman, Zhang, Can, Tandon, Maneesh, Sinha, Arijit, Fink, Anna-Maria, Robrecht, Sandra, Samoylova, Olga, Liberati, Anna M., Pinilla-Ibarz, Javier, Opat, Stephen, Sivcheva, Liliya, Le Du, Katell, Fogliatto, Laura M., Niemann, Carsten U., Weinkove, Robert, Robinson, Sue, Kipps, Thomas J., Tausch, Eugen, Schary, William, Ritgen, Matthias, Wendtner, Clemens-Martin, Kreuzer, Karl-Anton, Eichhorst, Barbara, Stilgenbauer, Stephan, Hallek, Michael and Fischer, Kirsten (2020). Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol., 21 (9). S. 1188 - 1201. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Arndt, Volker ORCID: 0000-0001-9320-8684, Doege, Daniela, Froehling, Stefan, Albers, Peter ORCID: 0000-0002-1747-9615, Alguel, Hana, Bargou, Ralf, Bokemeyer, Carsten, Bornhaeuser, Martin, Brandts, Christian H. ORCID: 0000-0003-1732-2535, Brossart, Peter, Brucker, Sara Yvonne, Bruemmendorf, Tim H., Doehner, Hartmut, Gattermann, Norbert, Hallek, Michael, Heinemann, Volker, Keilholz, Ulrich, Kindler, Thomas, von Levetzow, Cornelia, Lordick, Florian, Neumann, Ulf Peter, Peters, Christoph, Schadendorf, Dirk, Stilgenbauer, Stephan, Zander, Thomas, Zips, Daniel ORCID: 0000-0001-5779-9675, Braun, Delia, Seufferlein, Thomas, Nettekoven, Gerd and Baumann, Michael ORCID: 0000-0002-9340-974X (2023). Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic. J. Cancer Res. Clin. Oncol., 149 (2). S. 913 - 920. NEW YORK: SPRINGER. ISSN 1432-1335

Arshad, Usman, Taubert, Max, Seeger-Nukpezah, Tamina, Ullah, Sami, Spindeldreier, Kirsten C., Jaehde, Ulrich, Hallek, Michael, Fuhr, Uwe, Vehreschild, Jorg Janne and Jakob, Carolin (2021). Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients. BMC Cancer, 21 (1). LONDON: BMC. ISSN 1471-2407

Augustin, Max, Hallek, Michael ORCID: 0000-0002-7425-4455 and Nitschmann, Sirka (2022). Antiviral therapy in patients with COVID-19. Innere Med., 63 (8). S. 900 - 903. Berlin: SPRINGER MEDIZIN. ISSN 2731-7099

Augustin, Max ORCID: 0000-0002-2300-9337, Schommers, Philipp ORCID: 0000-0003-3375-6800, Stecher, Melanie, Dewald, Felix, Gieselmann, Lutz, Gruell, Henning, Horn, Carola, Vanshylla, Kanika ORCID: 0000-0003-4552-9170, Di Cristanziano, Veronica, Osebold, Luise, Roventa, Maria, Riaz, Toqeer, Tschernoster, Nikolai, Altmueller, Janine, Rose, Leonard, Salomon, Susanne, Priesner, Vanessa, Luers, Jan Christoffer, Albus, Christian, Rosenkranz, Stephan, Gathof, Birgit, Faetkenheuer, Gerd, Hallek, Michael, Klein, Florian, Suarez, Isabelle and Lehmann, Clara (2021). Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg. Health-Eur., 6. AMSTERDAM: ELSEVIER. ISSN 2666-7762

Augustin, Max, Schommers, Philipp ORCID: 0000-0003-3375-6800, Suarez, Isabelle, Koehler, Philipp ORCID: 0000-0002-7386-7495, Gruell, Henning, Klein, Florian, Maurer, Christian, Langerbeins, Petra, Priesner, Vanessa, Schmidt-Hellerau, Kirsten, Malin, Jakob J. ORCID: 0000-0002-2989-0436, Stecher, Melanie, Jung, Norma, Wiesmueller, Gerhard, Meissner, Arne, Zweigner, Janine, Langebartels, Georg, Kolibay, Felix, Suarez, Victor, Burst, Volker, Valentin, Philippe, Schedler, Dirk, Cornely, Oliver A., Hallek, Michael, Faetkenheuer, Gerd, Rybniker, Jan and Lehmann, Clara (2020). Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020. Eurosurveillance, 25 (21). S. 6 - 13. STOCKHOLM: EUR CENTRE DIS PREVENTION & CONTROL. ISSN 1560-7917

Augustin, Max ORCID: 0000-0002-2300-9337, Schommers, Philipp Frederik ORCID: 0000-0003-3375-6800, Stecher, Melanie, Dewald, Felix, Gieselmann, Lutz ORCID: 0000-0003-3699-3318, Grüll, Henning ORCID: 0000-0002-0725-7138, Horn, Carola, Vanshylla, Kanika ORCID: 0000-0003-4552-9170, Cristanziano, Veronica Di ORCID: 0000-0003-1604-8386, Osebold, Luise, Roventa, Maria, Riaz, Toqeer, Tschernoster, Nikolai ORCID: 0000-0002-6058-9342, Altmueller, Janine ORCID: 0000-0003-4372-1521, Rose, Leonard, Salomon, Susanne ORCID: 0000-0002-5143-2351, Priesner, Vanessa, Luers, Jan Christoffer, Albus, Christian ORCID: 0000-0002-4033-887X, Rosenkranz, Stephan, Gathof, Birgit, Fätkenheuer, Gerd ORCID: 0000-0002-5054-1871, Hallek, Michael ORCID: 0000-0002-7425-4455, Klein, Florian ORCID: 0000-0003-1376-1792, Suarez, Isabelle ORCID: 0000-0002-9863-9675 and Lehmann, Clara ORCID: 0000-0002-7042-1578 (2021). Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. The Lancet Regional Health - Europe, 6. p. 100122. Elsevier. ISSN 2666-7762

Augustin, Max ORCID: 0000-0002-2300-9337, Schommers, Philipp Frederik ORCID: 0000-0003-3375-6800, Suarez, Isabelle ORCID: 0000-0002-9863-9675, Koehler, Philipp ORCID: 0000-0002-7386-7495, Gruell, Henning ORCID: 0000-0002-0725-7138, Klein, Florian ORCID: 0000-0003-1376-1792, Maurer, Christian ORCID: 0000-0003-4388-5163, Langerbeins, Petra, Priesner, Vanessa, Schmidt-Hellerau, Kirsten, Malin, Jakob J. ORCID: 0000-0002-2989-0436, Stecher, Melanie, Jung, Norma ORCID: 0000-0002-5740-0772, Wiesmüller, Gerhard, Meissner, Arne ORCID: 0000-0002-8506-1624, Zweigner, Janine, Langebartels, Georg ORCID: 0000-0002-2448-2433, Kolibay, Felix ORCID: 0000-0003-0051-256X, Suárez, Victor ORCID: 0000-0003-4781-6480, Burst, Volker ORCID: 0000-0002-0256-6628, Valentin, Philippe, Schedler, Dirk, Cornely, Oliver A. ORCID: 0000-0001-9599-3137, Hallek, Michael ORCID: 0000-0002-7425-4455, Fätkenheuer, Gerd ORCID: 0000-0002-5054-1871, Rybniker, Jan ORCID: 0000-0001-8351-2690 and Lehmann, Clara ORCID: 0000-0002-7042-1578 (2020). Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020. Eurosurveillance, 25 (21). European Centre for Disease Prevention and Control. ISSN 1560-7917

Awan, Farrukh ORCID: 0000-0003-1813-9812, Jaeger, Ulrich, Rifkin, Robert, Thirman, Michael J., Byrd, John C., Hallek, Michael, Stromatt, Scott and Pagel, John M. (2012). Phase 1b Study of TRU-016, an Anti-CD37 SMIP (TM) Protein, in Combination with Bendamustine Vs Bendamustine Alone in Relapsed Chronic Lymphocytic Leukemia. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Bachurski, Daniel ORCID: 0000-0001-9168-9680, Schuldner, Maximiliane, Nguyen, Phuong-Hien, Malz, Alexandra, Reiners, Katrin S., Grenzi, Patricia C., Babatz, Felix, Schauss, Astrid C., Hansen, Hinrich P., Hallek, Michael and von Strandmann, Elke Pogge (2019). Extracellular vesicle measurements with nanoparticle tracking analysis - An accuracy and repeatability comparison between NanoSight NS300 and ZetaView. J. Extracell. Vesicles, 8 (1). ABINGDON: TAYLOR & FRANCIS LTD. ISSN 2001-3078

Bahlo, Jasmin, Pflug, Natali, Elter, Thomas, Bauer, Kathrin, Eichhorst, Barbara, Bergmann, Manuela, Busch, Raymonde, Doehner, Hartmut, Stilgenbauer, Stephan, Wendtner, Clemens-Martin, Fischer, Kirsten and Hallek, Michael (2011). Proposal of A Prognostic Score for Previously Untreated Patients with Chronic Lymphocytic Leukemia Based on An Overall Survival Analysis of Three German CLL Study Group Phase III Trials. Blood, 118 (21). S. 1219 - 1221. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Baltin, Christoph, Kron, Florian, Urbanski, Alexander, Zander, Thomas, Kron, Anna, Berlth, Felix ORCID: 0000-0002-3780-0728, Kleinert, Robert, Hallek, Michael, Hoelscher, Arnulf Heinrich and Chon, Seung-Hun ORCID: 0000-0002-8923-6428 (2019). The economic burden of endoscopic treatment for anastomotic leaks following oncological Ivor Lewis esophagectomy. PLoS One, 14 (8). SAN FRANCISCO: PUBLIC LIBRARY SCIENCE. ISSN 1932-6203

Bamidis, Anna D., Koehler, Philipp ORCID: 0000-0002-7386-7495, di Cristanziano, Veronica, Rasche, Kurt, Demirel, Baris, Bacher, Petra ORCID: 0000-0003-4264-6451, Hallek, Michael, Kochanek, Matthias, Klein, Florian, Hofmann, Silke C., Wesselmann, Ulrich and Kofler, David M. (2021). First manifestation of adult-onset Still's disease after COVID-19. Lancet Rheumatol., 3 (5). S. E319 - 4. AMSTERDAM: ELSEVIER. ISSN 2665-9913

Barbarino, Verena, Henschke, Sinika, Blakemore, Stuart James ORCID: 0000-0003-2892-1162, Izquierdo, Elena ORCID: 0000-0002-3355-2798, Michalik, Michael, Nickel, Nadine, Moellenkotte, Indra, Vorholt, Daniela, Mueller, Linda, Brinker, Reinhild, Fedorchenko, Oleg, Mikhael, Nelly, Seeger-Nukpezah, Tamina, Hallek, Michael and Pallasch, Christian P. ORCID: 0000-0001-5675-6905 (2020). Macrophage-Mediated Antibody Dependent Effector Function in Aggressive B-Cell Lymphoma Treatment is Enhanced by Ibrutinib via Inhibition of JAK2. Cancers, 12 (8). BASEL: MDPI. ISSN 2072-6694

Barthel, Romy, Fedorchenko, Oleg, Velmans, Tanja, Rosen, Natascha, Reinart, Nina, Florin, Alexandra, Herling, Marco, Hallek, Michael and Fingerle-Rowson, Guenter ORCID: 0000-0002-6621-7590 (2020). CD74 is dispensable for development of chronic lymphocytic leukemia inE mu-TCL1 transgenic mice. Leuk. Lymphoma, 61 (12). S. 2799 - 2811. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Baumann, Freerk T., Reike, Alexandra, Hallek, Michael, Wiskemann, Joachim and Reimer, Vanessa (2018). Does Exercise Have a Preventive Effect on Secondary Lymphedema in Breast Cancer Patients Following Local Treatment? - A Systematic Review. Breast Care, 13 (5). S. 380 - 386. BASEL: KARGER. ISSN 1661-3805

Baumann, Freerk T., Reimer, Nadine ORCID: 0000-0002-3729-5266, Gockeln, Theresa, Reike, Alexandra, Hallek, Michael, Ricci, Christian, Zopf, Eva M., Schmid, Daniela, Taaffe, Dennis, Newton, Robert U., Galvao, Daniel A. and Leitzmann, Michael . Supervised pelvic floor muscle exercise is more effective than unsupervised pelvic floor muscle exercise at improving urinary incontinence in prostate cancer patients following radical prostatectomy - a systematic review and meta-analysis. Disabil. Rehabil.. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1464-5165

Baumann, Freerk Theeagnus, Hallek, Michael, Meyer, Janika, Galvao, Daniel Abido, Bloch, Wilhelm and Elter, Thomas (2015). Evidence and recommendations for oncologic clinical exercise - a personalized treatment concept for cancer patients. Dtsch. Med. Wochenschr., 140 (19). S. 1457 - 1463. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Beckmann, Laura, Berg, Valeska, Dickhut, Clarissa, Bloehdorn, Johannes, Bahlo, Jasmin, Robrecht, Sandra, Huelsemann, Malte, Loroch, Stefan, Merkel, Olaf, Fischer, Kirsten, Wendtner, Clemens-Martin, Stilgenbauer, Stephan, Sickmann, Albert ORCID: 0000-0002-2388-5265, Hallek, Michael, Zahedi, Rene and Frenzel, Lukas P. (2018). Integrated Proteomic and Phosphoproteomic Analysis Reveal Novel Targets and Suggest Rationale for Ibrutinib Efficacy in UM-CLL. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Beckmann, Laura ORCID: 0000-0001-5207-8991, Berg, Valeska, Dickhut, Clarissa, Sun, Clare ORCID: 0000-0001-8498-4729, Merkel, Olaf, Bloehdorn, Johannes ORCID: 0000-0003-1433-9702, Robrecht, Sandra, Seifert, Marc, Guerreiro, Alexandra da Palma, Claasen, Julia, Loroch, Stefan, Oliverio, Matteo, Underbayev, Chingiz, Vaughn, Lauren, Thomalla, Daniel, Huelsemann, Malte F., Tausch, Eugen, Fischer, Kirsten, Fink, Anna Maria ORCID: 0000-0002-7669-7890, Eichhorst, Barbara, Sickmann, Albert ORCID: 0000-0002-2388-5265, Wendtner, Clemens M., Stilgenbauer, Stephan, Hallek, Michael, Wiestner, Adrian, Zahedi, Rene P. and Frenzel, Lukas P. (2021). MARCKS affects cell motility and response to BTK inhibitors in CLL. Blood, 138 (7). S. 544 - 557. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Belelstein, Anna, Nickel, Nadine, Alvalrez, Elena Izquiero, Vorholt, Daniela, Schawan, Samruddhi, Moellenkoette, Indra, Hallek, Michael and Pallasch, Christian P. (2020). Modulation of Antibody-Dependent Phagocytosis by Macrophages under Metabolic Regulation in the Tumor Microenvironment. Oncol. Res. Treat., 43. S. 40 - 41. BASEL: KARGER. ISSN 2296-5262

Berg, Valeska, Baatout, Dunja, Wendtner, Clemens, Hallek, Michael and Frenzel, Lukas P. (2016). APT1-Mediated Cross-Talk Between Palmitoylation and Phosphorylation Events of the BCR Pathway Sensitizes CLL Cells Towards BCR-Associated Kinase Inhibitors. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Berg, Valeska, Rusch, Marion, Vartak, Nachiket, Juengst, Christian, Schauss, Astrid, Waldmann, Herbert ORCID: 0000-0002-9606-7247, Hedberg, Christian, Pallasch, Christian P., Bastiaens, Philippe, Hallek, Michael, Wendtner, Clemens-Martin and Frenzel, Lukas P. (2014). Mirs-138 and-424 Control Palmitoylation-Dependent CD95-Mediated Cell Death By Targeting Acyl Protein Thioesterases 1 and 2 in Chronic Lymphocytic Leukemia. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Bloehdorn, Johannes ORCID: 0000-0003-1433-9702, Braun, Andrejs ORCID: 0000-0003-0925-5598, Taylor-Weiner, Amaro, Jebaraj, Billy Michael Chelliah, Robrecht, Sandra, Krzykalla, Julia, Pan, Heng, Giza, Adam, Akylzhanova, Gulnara, Holzmann, Karlheinz, Scheffold, Annika, Johnston, Harvey E., Yeh, Ru-Fang, Klymenko, Tetyana, Tausch, Eugen, Eichhorst, Barbara, Bullinger, Lars ORCID: 0000-0002-5890-5510, Fischer, Kirsten, Weisser, Martin, Robak, Tadeusz ORCID: 0000-0002-3411-6357, Schneider, Christof, Gribben, John, Dahal, Lekh N., Carter, Mathew J., Elemento, Olivier, Landau, Dan A., Neuberg, Donna S., Cragg, Mark S., Benner, Axel, Hallek, Michael, Wu, Catherine J., Doehner, Hartmut, Stilgenbauer, Stephan and Mertens, Daniel (2021). Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia. Nat. Commun., 12 (1). BERLIN: NATURE PORTFOLIO. ISSN 2041-1723

Bloehdorn, Johannes ORCID: 0000-0003-1433-9702, Krzykalla, Julia, Holzmann, Karlheinz, Gerhardinger, Andreas, Jebaraj, Billy Michael Chelliah, Bahlo, Jasmin, Humphrey, Kathryn, Tausch, Eugen, Robrecht, Sandra, Mertens, Daniel ORCID: 0000-0003-0227-7188, Schneider, Christof, Fischer, Kirsten, Hallek, Michael ORCID: 0000-0002-7425-4455, Doehner, Hartmut, Benner, Axel and Stilgenbauer, Stephan (2022). Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients. Haematologica, 107 (3). S. 615 - 625. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Bloehdorn, Johannes, Krzykalla, Julia, Jebaraj, Billy Michael Chelliah, Holzmann, Karlheinz, Bahlo, Jasmin, Robrecht, Sandra, Humphrey, Kathryn, Wenger, Michael, Tausch, Eugen, Schneider, Christof, Bullinger, Lars, Fischer, Kirsten, Hallek, Michael, Mertens, Daniel, Benner, Axel, Doehner, Hartmut and Stilgenbauer, Stephan (2018). MYC Pathway Activation Is Frequently Observed in Treatment-Naive CLL and Defines a Subgroup with Particular Benefit from the Addition of Rituximab to Chemotherapy. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Bloehdorn, Johannes, Sill, Martin, Buehler, Andreas, Mack, Silja, Winter, Doris, Bullinger, Lars, Rouhi, Arefeh, Kuchenbauer, Florian, Mertens, Daniel, Benner, Axel, Hallek, Michael, Doehner, Hartmut and Stilgenbauer, Stephan (2012). Microrna Expression in Fludarabine-Refractory CLL Implicates Independent Mechanisms of Resistance and Is Associated with Response and Progression Free Survival After Alemtuzumab Treatment: Results From the CLL2H Trial. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Boeitcher, Sebastian, Ritgen, Matthias, Fischer, Kirsten, Stilgenbauer, Stephan, Busch, Raymonde, Fingerle-Rowson, Gunter R., Fink, Anna-Maria, Buehler, Andreas, Winkler, Dirk, Wenger, Michael K., Mendila, Myriam, Wendtner, Clemens, Eichhorst, Barbara, Doehner, Hartmut, Hallek, Michael and Kneba, Michael (2011). Minimal Residual Disease (MRD) Re-Growth Kinetics Are An Independent Predictor for Progression Free Survival (PFS) in Chronic Lymphocytic Leukemia (CLL) and Are Related to Biologically Defined CLL-Subgroups-Results From the CLL8 Trial of the German CLL Study Group (GCLLSG). Blood, 118 (21). S. 775 - 776. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Bokemeyer, Carsten, Busse, Reinhard, Engel, Jutta, Gebauer, Alexander, Hallek, Michael, Heinemann, Volker, Lueftner, Diana and Woermann, Bernhard (2018). The older Cancer Patient - Challenges in the Hospital and in Medical Practice. Oncol. Res. Treat., 41. S. 2 - 27. BASEL: KARGER. ISSN 2296-5262

Bokemeyer, Carsten, Hallek, Michael, Lueftner, Diana and Weissinger, Florian (2018). Foreword. Oncol. Res. Treat., 41. S. 1 - 2. BASEL: KARGER. ISSN 2296-5262

Bokemeyer, Carsten, Hallek, Michael, Lueftner, Diana and Weissinger, Florian (2016). Foreword. Oncol. Res. Treat., 39. S. 2 - 3. BASEL: KARGER. ISSN 2296-5262

Bonifacius, Agnes, Tischer-Zimmermann, Sabine, Santamorena, Maria Michela, Mausberg, Philip, Schenk, Josephine, Koch, Stephanie, Barnstorf-Brandes, Johanna, Goedecke, Nina, Martens, Jorg, Goudeva, Lilia, Verboom, Murielle, Wittig, Jana, Maecker-Kolhoff, Britta, Baurmann, Herrad, Clark, Caren, Brauns, Olaf, Simon, Martina, Lang, Peter, Cornely, Oliver A. ORCID: 0000-0001-9599-3137, Hallek, Michael ORCID: 0000-0002-7425-4455, Blasczyk, Rainer, Seiferling, Dominic, Koehler, Philipp and Eiz-Vesper, Britta (2022). Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy. Front. Bioeng. Biotechnol., 10. LAUSANNE: FRONTIERS MEDIA SA. ISSN 2296-4185

Borchmann, Peter, Moccia, Alden, Greil, Richard, Hertzberg, Mark, Schaub, Valdete, Huettmann, Andreas, Keil, Felix, Dierlamm, Judith, Haenel, Mathias, Novak, Urban, Meissner, Julia, Zimmermann, Andreas, Mathas, Stephan, Zijlstra, Josee M., Fossa, Alexander, Viardot, Andreas, Hertenstein, Bernd, Martin, Sonja, Giri, Pratyush, Kamper, Peter, Molin, Daniel, Kreissl, Stefanie, Fuchs, Michael, Schneider, Gundolf, Rosenwald, Andreas, Klapper, Wolfram, Eich, Hans, Baues, Christian, Hallek, Michael, Dietlein, Markus, Kobe, Carsten, Diehl, Volker and Engert, Andreas (2022). Treatment Related Morbidity in Patients with Classical Hodgkin Lymphoma: Results of the Ongoing, Randomized Phase III HD21 Trial By the German Hodgkin Study Group. Blood, 140. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Borchmann, Sven, Selenz, Carolin, Lohmann, Mia, Ludwig, Hanna, Gassa, Asmae, Braegelmann, Johannes, Lohneis, Philipp, Meder, Lydia, Mattlener, Julia, Breid, Sara, Nill, Marieke, Fassunke, Jana, Wisdom, Amy J., Compes, Anik, Gathof, Birgit, Alakus, Hakan, Kirsch, David, Hekmat, Khosro, Buettner, Reinhard, Reinhardt, H. Christian, Hallek, Michael ORCID: 0000-0002-7425-4455 and Ullrich, Roland T. (2022). Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumors. J. Immunother. Cancer, 10 (10). LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426

Borrega, Jorge Garcia, Boell, Boris, Kochanek, Matthias, Naendrup, Jan-Hendrik, Simon, Florian, Sieg, Noelle, Hallek, Michael, Borchmann, Peter, Holtick, Udo, Shimabukuro-Vornhagen, Alexander, Eichenauer, Dennis A. and Heger, Jan-Michel ORCID: 0000-0001-9463-8504 (2023). Characteristics and outcomes of patients undergoing high-dose chemotherapy and autologous stem cell transplantation admitted to the intensive care unit: a single-center retrospective analysis. Ann. Hematol., 102 (1). S. 191 - 198. NEW YORK: SPRINGER. ISSN 1432-0584

Bosch, Francesc ORCID: 0000-0001-9241-2886 and Hallek, Michael (2018). Venetoclax after idelalisib: relevant progress for CLL. Blood, 131 (15). S. 1632 - 1636. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Braun, Till, Glass, Markus ORCID: 0000-0003-2718-8907, Wahnschaffe, Linus, Otte, Moritz, Mayer, Petra, Franitza, Marek, Altmuller, Janine ORCID: 0000-0003-4372-1521, Hallek, Michael ORCID: 0000-0002-7425-4455, Huttelmaier, Stefan, Schrader, Alexandra and Herling, Marco (2022). Micro-RNA networks in T-cell prolymphocytic leukemia reflect T-cell activation and shape DNA damage response and survival pathways. Haematologica, 107 (1). S. 187 - 201. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Braun, Till, Stachelscheid, Johanna ORCID: 0000-0001-7419-8900, Bley, Nadine, Oberbeck, Sebastian, Otte, Moritz, Muller, Tony Andreas, Wahnschaffe, Linus, Glass, Markus ORCID: 0000-0003-2718-8907, Ommer, Katharina, Franitza, Marek, Gathof, Birgit, Altmueller, Janine, Hallek, Michael ORCID: 0000-0002-7425-4455, Auguin, Daniel ORCID: 0000-0003-4713-9096, Huettelmaier, Stefan, Schrader, Alexandra and Herling, Marco (2022). Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia. Cancer Res., 82 (9). S. 1818 - 1832. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Brieghel, Christian ORCID: 0000-0002-1816-8106, Galle, Veerle, Agius, Rudi, Da Cunha-Bang, Caspar, Andersen, Michael A., Vlummens, Philip ORCID: 0000-0001-8275-2887, Mattsson, Mattias ORCID: 0000-0002-9510-8801, Rosenquist, Richard ORCID: 0000-0002-0211-8788, Smedby, Karin E., Herling, Carmen D., Bahlo, Jasmin, Hallek, Michael ORCID: 0000-0002-7425-4455, Lundgren, Jens D., Offner, Fritz and Niemann, Carsten U. (2022). Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait? Eur. J. Haematol., 108 (5). S. 369 - 379. HOBOKEN: WILEY. ISSN 1600-0609

Brocks, Tania, Fedorchenko, Oleg, Schliermann, Nicola, Stein, Astrid, Moll, Ute M., Seegobin, Seth, Dewor, Manfred, Hallek, Michael, Marquardt, Yvonne, Fietkau, Katharina, Heise, Ruth, Huth, Sebastian, Pfister, Herbert, Bernhagen, Juergen, Bucala, Richard, Baron, Jens M. and Fingerle-Rowson, Guenter (2017). Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin. Faseb J., 31 (2). S. 526 - 544. BETHESDA: FEDERATION AMER SOC EXP BIOL. ISSN 1530-6860

Brown, Jennifer, Tiao, Grace, Kasar, Siddha, Improgo, Ma Reina, Poh, Weijie, Kamburov, Atanas, Landau, Dan-Avi, Tausch, Eugen, Taylor-Weiner, Amaro, Cibulskis, Carrie, Bahl, Samira, Fernandes, Stacey, Hoang, Kevin, Kim, Haesook T., Bahlo, Jasmin, Rheinbay, Esther, Robrecht, Sandra, Fischer, Kirsten, Hallek, Michael, Gabriel, Stacey, Lander, Eric S., Stilgenbauer, Stephan, Wu, Catherine J., Kiezun, Adam and Getz, Gad (2017). Germline rare variant association analysis in chronic lymphocytic leukemia. Leuk. Lymphoma, 58. S. 126 - 128. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Brown, Jennifer R., Cheson, Bruce D., Furman, Richard R., Ghia, Paolo, Hallek, Michael, Hillmen, Peter, O'Brien, Susan M., Sharman, Jeff P., Dubowy, Ronald L., Velasco, Barbara, Waldapfel, Christopher C. and Zelenetz, Andrew D. (2015). Patterns of Lymphocytosis in Patients with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Treated with Idelalisib. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Buehl, Linda, Abel, Thomas, Wolf, Florian, Oberste, Max, Bloch, Wilhelm, Hallek, Michael, Elter, Thomas and Zimmer, Philipp (2019). Feasibility and Potential Benefits of an Exercise Intervention in a Male With Down Syndrome Undergoing High-Dose Chemotherapy for Acute Lymphoblastic Leukemia: A Case Report. Integr. Cancer Ther., 18. THOUSAND OAKS: SAGE PUBLICATIONS INC. ISSN 1552-695X

Cartron, Guillaume ORCID: 0000-0003-0659-9635, de Guibert, Sophie, Dilhuydy, Marie-Sarah, Morschhauser, Franck, Leblond, Veronique, Dupuis, Jehan, Mahe, Beatrice, Bouabdallah, Reda, Lei, Guiyuan, Wenger, Michael, Wassner-Fritsch, Elisabeth and Hallek, Michael (2014). Obinutuzumab (GA101) in relapsed/refractory chronic lymphocytic leukemia: final data from the phase 1/2 GAUGUIN study. Blood, 124 (14). S. 2196 - 2203. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Castelli, Lucia ORCID: 0000-0002-7701-9733, Elter, Thomas, Wolf, Florian, Watson, Matthew, Schenk, Alexander ORCID: 0000-0002-3122-714X, Steindorf, Karen, Bloch, Wilhelm, Hallek, Michael, Joisten, Niklas ORCID: 0000-0002-9947-8746 and Zimmer, Philipp (2022). Sleep problems and their interaction with physical activity and fatigue in hematological cancer patients during onset of high dose chemotherapy. Support. Care Cancer, 30 (1). S. 167 - 177. NEW YORK: SPRINGER. ISSN 1433-7339

Chakupurakal, Geothy, Garcia-Marquez, Maria Alejandra ORCID: 0000-0002-5923-5942, Shimabukuro-Vornhagen, Alexander, Kluth, Sandra, Schlosser, Hans, Theurich, Sebastian ORCID: 0000-0001-5706-8258, Scheid, Christof, Hallek, Michael, Holtick, Udo and von Bergwelt-Baildon, Michael (2017). Regulatory B10 cells display an altered homoeostasis in acute graft-versus-host disease. Eur. J. Haematol., 98 (2). S. 128 - 134. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0609

Chakupurakal, Geothy, Garcia-Marquez, Maria Alejandra ORCID: 0000-0002-5923-5942, Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, Theurich, Sebastian ORCID: 0000-0001-5706-8258, Holtick, Udo, Hallek, Michael, Scheid, Christof and von Bergwelt-Baildon, Michael (2016). Immunological effects in patients with steroid-refractory graft-versus-host disease following treatment with basiliximab, a CD25 monoclonal antibody. Eur. J. Haematol., 97 (2). S. 121 - 128. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0609

Chanan-Khan, Asher, Cramer, Paula, Demirkan, Fatih ORCID: 0000-0002-1172-8668, Fraser, Graeme, Silva, Rodrigo Santucci, Grosicki, Sebastian ORCID: 0000-0003-2644-1050, Pristupa, Aleksander, Janssens, Ann, Mayer, Jiri, Bartlett, Nancy L., Dilhuydy, Marie-Sarah, Pylypenko, Halyna, Loscertales, Javier, Avigdor, Abraham, Rule, Simon, Villa, Diego, Samoilova, Olga, Panagiotidis, Panagiots, Goy, Andre ORCID: 0000-0001-5125-6522, Mato, Anthony, Pavlovsky, Miguel A., Karlsson, Claes, Mahler, Michelle, Salman, Mariya, Sun, Steven, Phelps, Charles, Balasubramanian, Sriram, Howes, Angela, Hallek, Michael, Assouline, S., Bence-Bruckler, I., Buckstein, R., Fraser, G., Larratt, L., Minuk, L., Villa, D., Angevine, A., Bartlett, N., Bixby, D., Caimi, P., Chanan-Khan, A., Craig, M., Forero-Torres, A., Ganguly, S., Goy, A., Heffner, L., Hermann, R., Lansigan, F., Leis, J., Letzer, J., Link, B., Liu, D., McCaul, K., McGuire, E., Skinner, W., Starodub, A., Stuart, R., Thirman, M., Tirumali, N., Yang, J., Janssens, A., Offner, F., Van den Neste, E., Van Hoof, A., Mayer, J., Novak, J., Trneny, M., Cartron, G., Dartigeas, C., Dilhuydy, M., Ghez, D., Haioun, C., Leblond, V., Salles, G., Balser, C., Cramer, P., Dreger, P., Durig, J., Eckart, M., Heinrich, B., Illmer, T., Jentsch-Ullrich, K., Pfreundschuh, M., Schetelig, J., Schlag, R., Soling, U., Stilgenbaue, S., Anagnostopoulos, A., Dimopoulos, A., Panagiotidis, P., Vrakidou, E., Bairey, O., Ben Yehuda, D., Braester, A., Fineman, R., Herishanu, Y., Nagler, A., Ruchlemer, R., Tadmor, T., Grosicki, S., Homenda, W., Jurczak, W., Pluta, A., Woszczyk, D., Espirito Santo, A., Luis, R., Raposo, J., Viveiros, C., Alexeeva, J., Dunaev, Y., Golubeva, M., Khuageva, N., Loginov, A., Lysenko, I., Osmanov, E., Pavlov, V., Pristupa, A., Proydakov, A., Rossiev, V., Samarina, I., Samoilova, O., Serduk, O., Shneider, T., Udovitsa, D., Voloshin, S., Gayoso, J., Gonzalez, M., Gonzalez Barca, E., Hernandez Rivas, J., Jargue, I., Loscertales, J., Karlsson, C., Sender, M., Aktan, M., Arslan, O., Demirkan, F., Ferhanoglu, B., Kaynar, L., Sayinalp, N., Vaural, F., Yagci, M., Dyagil, I., Kaplan, P., Masliak, Z., Oliynyk, H., Popovska, T., Pylypenko, H., Rekhtman, G., Dearden, C., Morley, N., Moss, P., Rule, S., Pavlovsky, M., Riveros, D., Santucci-Silva, R., Romeo, M., Scheliga, A., Salazar, L., Gomez, D., Ramirez, E. and Jung, C. (2016). Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study. Lancet Oncol., 17 (2). S. 200 - 212. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Chanan-Khan, Asher, Cramer, Paula, Demirkan, Fatih ORCID: 0000-0002-1172-8668, Fraser, Graeme, Silva, Rodrigo Santucci, Pylypenko, Halyna, Grosicki, Sebastian, Janssens, Ann, Pristupa, Aleksander, Goy, Andre ORCID: 0000-0001-5125-6522, Mayer, Jiri, Dilhuydy, Marie Sarah, Loscertales, Javier, Bartlett, Nancy L., Avigdor, Abraham, Rule, Simon, Sun, Steven, Phelps, Charles, Mahler, Michelle, Salman, Mariya, Howes, Angela and Hallek, Michael (2015). Insights into the Management of Adverse Events in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Experience from the Phase 3 HELIOS Study of Ibrutinib Combined with Bendamustine/Rituximab. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Chanan-Khan, Asher, Fraser, Graeme, Cramer, Paula, Demirkan, Fatih ORCID: 0000-0002-1172-8668, Silva, Rodrigo Santucci, Pylypenko, Halyna, Grosicki, Sebastian, Janssens, Ann, Pristupa, Aleksander, Goy, Andre ORCID: 0000-0001-5125-6522, Mayer, Jiri, Dilhuydy, Marie-Sarah, Loscertales, Javier, Bartlett, Nancy, Avigdor, Abraham, Rule, Simon, Sun, Steven, Phelps, Charles, Mahler, Michelle, Salman, Masha, Howes, Angela and Hallek, Michael (2015). Ibrutinib combined with bendamustine/rituximab (BR) in previously treated small lymphocytic lymphoma (SLL): analysis of patients in the HELIOS trial. Leuk. Lymphoma, 56. S. 92 - 94. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Chemnitz, Jens Marcus, Uener, Jens, Hallek, Michael and Scheid, Christof (2010). Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab. Ann. Hematol., 89 (10). S. 1029 - 1034. NEW YORK: SPRINGER. ISSN 0939-5555

Chmielewski, Markus, Kuehle, Johannes, Chrobok, Danuta, Riet, Nicole, Hallek, Michael and Abken, Hinrich (2019). FimH-based display of functional eukaryotic proteins on bacteria surfaces. Sci Rep, 9. LONDON: NATURE PUBLISHING GROUP. ISSN 2045-2322

Chyla, Brenda, Stilgenbauer, Stephan, Eichhorst, Barbara, Schetelig, Johannes, Munir, Talha, Hillmen, Peter, Seymour, John F., Roberts, Andrew W., Coutre, Steven, Jurczak, Wojciech, Mulligan, Stephen P., Puvvada, Soham, Wendtner, Clemens, Davids, Matthew S., Boettcher, Sebastian, Cerri, Elisa, Zhou, Lang, Popovic, Relja, Poteracki, Mia, Arzt, Jennifer, Kim, Su Young, Verdugo, Maria, Bhathena, Anahita, Wierda, William and Hallek, Michael (2017). Venetoclax in relapsed/refractory chronic lymphocytic leukemia (CLL) with 17p deletion: outcome and minimal residual disease from the full population of the pivotal M13-982 trial. Leuk. Lymphoma, 58. S. 234 - 236. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Condoluci, Adalgisa, di Bergamo, Lodovico Terzi, Langerbeins, Petra, Hoechstetter, Manuela A., Herling, Carmen D., De Paoli, Lorenzo, Delgado, Julio, Rabe, Kari G., Gentile, Massimo ORCID: 0000-0002-5256-0726, Doubek, Michael, Mauro, Francesca R., Chiodin, Giorgia, Mattsson, Mattias ORCID: 0000-0002-9510-8801, Bahlo, Jasmin, Cutrona, Giovanna ORCID: 0000-0002-3335-1101, Kotaskova, Jana, Deambrogi, Clara, Smedby, Karin E., Spina, Valeria, Bruscaggin, Alessio, Wu, Wei, Moia, Riccardo, Bianchi, Elena, Gerber, Bernhard, Zucca, Emanuele, Gillessen, Silke ORCID: 0000-0001-5746-6555, Ghielmini, Michele, Cavalli, Franco, Stussi, Georg, Hess, Mark A., Baumann, Tycho S., Neri, Antonino, Ferrarini, Manlio, Rosenquist, Richard, Forconi, Francesco, Foa, Robin, Pospisilova, Sarka, Morabito, Fortunato, Stilgenbauer, Stephan, Doehner, Hartmut, Parikh, Sameer A., Wierda, William G., Montserrat, Emili, Gaidano, Gianluca, Hallek, Michael and Rossi, Davide (2020). International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia. Blood, 135 (21). S. 1859 - 1870. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Coutelle, Oliver, Hornig-Do, Hue-Tran, Witt, Axel, Andree, Maria, Schiffmann, Lars M., Piekarek, Michael, Brinkmann, Kerstin, Seeger, Jens M., Liwschitz, Maxim, Miwa, Satomi ORCID: 0000-0002-1239-1198, Hallek, Michael, Kroenke, Martin, Trifunovic, Aleksandra, Eming, Sabine A., Wiesner, Rudolf J., Hacker, Ulrich T. and Kashkar, Hamid (2014). Embelin inhibits endothelial mitochondrial respiration and impairs neoangiogenesis during tumor growth and wound healing. EMBO Mol. Med., 6 (5). S. 624 - 640. HOBOKEN: WILEY. ISSN 1757-4684

Craddock, Charles, Labopin, Myriam, Houhou, Mohamed, Robin, Marie, Finke, Juergen, Chevallier, Patrice, Yakoub-Agha, Ibrahim ORCID: 0000-0003-4524-8782, Bourhis, Jean-Henri, Sengelov, Henrik, Blaise, Didier, Dreger, Peter, Hallek, Michael, Nagler, Arnon, Kroger, N. and Mohty, Mohamad (2014). Activity and Tolerability of Azacitidine in Patients Who Relapse after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) and Myelodysplasia (MDS): a Survey from the European Society for Blood and Marrow Transplantation (EBMT. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Craddock, Charles ORCID: 0000-0001-5041-6678, Labopin, Myriam, Robin, Marie ORCID: 0000-0003-1388-9876, Finke, Juergen, Chevallier, Patrice, Yakoub-Agha, Ibrahim ORCID: 0000-0003-4524-8782, Bourhis, Jean Henri, Sengelov, Henrik ORCID: 0000-0002-5991-2958, Blaise, Didier, Luft, Thomas, Hallek, Michael, Kroeger, Nicolaus, Nagler, Arnon and Mohty, Mohamad (2016). Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia. Haematologica, 101 (7). S. 879 - 884. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Cramer, Paula, Bahlo, Jasmin, Eichhorst, Barbara, Fischer, Kirsten and Hallek, Michael (2014). Extramedullary manifestations of chronic lymphocytic leukaemia are not unusual. Leuk. Res., 38 (3). S. 284 - 286. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 1873-5835

Cramer, Paula, Chanan-Khan, Asher, Fraser, Graeme, Demirkan, Fatih ORCID: 0000-0002-1172-8668, Silva, Rodrigo Santucci, Pylypenko, Halyna, Grosicki, Sebastian, Janssens, Ann, Goy, Andre ORCID: 0000-0001-5125-6522, Mayer, Jiri, Dilhuydy, Marie Sarah, Loscertales, Javier, Bartlett, Nancy L., Avigdor, Abraham, Rule, Simon, Sun, Steven, Phelps, Charles, Mahler, Michelle, Salman, Mariya, Schaffer, Michael, Balasubramanian, Sriram, Howes, Angela and Hallek, Michael (2015). Improvement of Quality of Response with Ibrutinib Plus Bendamustine/Rituximab Vs Placebo Plus Bendamustine/Rituximab for Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL). Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Cramer, Paula, Chanan-Khan, Asher, Fraser, Graeme, Demirkan, Fatih ORCID: 0000-0002-1172-8668, Silva, Rodrigo Santucci, Pylypenko, Halyna, Grosicki, Sebastian, Janssens, Ann, Pristupa, Aleksander, Goy, Andre ORCID: 0000-0001-5125-6522, Mayer, Jiri, Dilhuydy, Marie-Sarah, Loscertales, Javier, Barlett, Nancy, Avigdor, Abraham, Rule, Simon, Sun, Steven, Phelps, Charles, Mahler, Michelle, Salman, Masha, Howes, Angela and Hallek, Michael (2015). Ibrutinib combined with bendamustine/rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): safety analysis in the HELIOS trial. Leuk. Lymphoma, 56. S. 93 - 95. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Cramer, Paula, Eichhorst, Barbara, Reinhardt, Hans Christian and Hallek, Michael (2016). Current strategies to create tailored and risk-adapted therapies for CLL patients. Best Pract. Res. Clin. Haematol., 29 (1). S. 111 - 122. OXFORD: ELSEVIER SCI LTD. ISSN 1532-1924

Cramer, Paula, Fink, Anna-Maria, Busch, Raymonde, Eichhorst, Barbara, Wendtner, Clemens-Martin, Pflug, Natali, Schubert, Friederike, Doehner, Hartmut, Rieger, Michael, Kneba, Michael, Mayer, Jiri, Hallek, Michael and Fischer, Kirsten (2011). Second-Line Therapies After Treatment with Fludarabine, Cyclophosphamide, and Rituximab (FCR) or Fludarabine and Cyclophosphamid Alone (FC) for Chronic Lymphocytic Leukemia (CLL) within the CLL8-Protocol of the German CLL Study Group (GCLLSG). Blood, 118 (21). S. 1235 - 1236. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Cramer, Paula ORCID: 0000-0003-4046-9922, Furstenau, Moritz, Robrecht, Sandra, Giza, Adam, Zhang, Can, Fink, Anna-Maria, Fischer, Kirsten, Langerbeins, Petra, Al-Sawaf, Othman, Tausch, Eugen, Schneider, Christof, Schetelig, Johannes, Dreger, Peter, Bottcher, Sebastian, Kreuzer, Karl-Anton, Schilhabel, Anke, Ritgen, Matthias, Bruggemann, Monika, Kneba, Michael, Stilgenbauer, Stephan, Eichhorst, Barbara and Hallek, Michael (2022). Obinutuzumab, acalabrutinib, and venetoclax, after an optional debulking with bendamustine in relapsed or refractory chronic lymphocytic leukaemia (CLL2-BAAG) a multicentre, open-label, phase 2 trial. Lancet Haematol., 9 (10). S. E745 - 11. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026

Cramer, Paula, Hallek, Michael and Eichhorst, Barbara (2016). State-of-the-Art Treatment and Novel Agents in Chronic Lymphocytic Leukemia. Oncol. Res. Treat., 39 (1-2). S. 25 - 32. BASEL: KARGER. ISSN 2296-5262

Cramer, Paula, Isfort, Susanne, Bahlo, Jasmin, Stilgenbauer, Stephan, Doehner, Hartmut, Bergmann, Manuela, Stauch, Martina, Kneba, Michael, Lange, Elisabeth, Langerbeins, Petra, Pflug, Natali, Kovacs, Gabor, Goede, Valentin, Fink, Anna-Maria, Elter, Thomas, Fischer, Kirsten, Wendtner, Clemens-Martin, Hallek, Michael and Eichhorst, Barbara (2015). Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCLLSG). Haematologica, 100 (11). S. 1451 - 1460. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Cramer, Paula, Langerbeins, Petra, Eichhorst, Barbara and Hallek, Michael (2016). Advances in first-line treatment of chronic lymphocytic leukemia: current recommendations on management and first-line treatment by the German CLL Study Group (GCLLSG). Eur. J. Haematol., 96 (1). S. 9 - 19. HOBOKEN: WILEY. ISSN 1600-0609

Cramer, Paula, Langerbeins, Petra, Fischer, Kirsten, Eichhorst, Barbara, Hallek, Michael and Goede, Valentin (2016). Dose-reduced fludarabine, cyclophosphamide and rituximab (FCR) in older patients with chronic lymphocytic leukemia: does one size fit all? Leuk. Lymphoma, 57 (5). S. 987 - 991. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Cramer, Paula, Langerbeins, Petra and Hallek, Michael (2016). Combination of Targeted Drugs to Control Chronic Lymphocytic Leukemia Harnessing the Power of New Monoclonal Antibodies in Combination With Ibrutinib. Cancer J., 22 (1). S. 62 - 67. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1540-336X

Cramer, Paula, Tausch, Eugen, von Tresckow, Julia, Giza, Adam, Robrecht, Sandra, Schneider, Christof, Furstenau, Moritz, Langerbeins, Petra, Al-Sawaf, Othman, Pelzer, Benedikt W., Fink, Anna Maria ORCID: 0000-0002-7669-7890, Fischer, Kirsten, Wendtner, Clemens-Martin, Eichhorst, Barbara, Kneba, Michael, Stilgenbauer, Stephan and Hallek, Michael (2021). Durable remissions following combined targeted therapy in patients with CLL harboring TP53 deletions and/or mutations. Blood, 138 (19). S. 1805 - 1817. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Cramer, Paula, von Tresckow, Julia, Bahlo, Jasmin, Engelke, Anja, Langerbeins, Petra, Fink, Anna-Maria, Fischer, Kirsten, Wendtner, Clemens-Martin, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Boettcher, Sebastian, Eichhorst, Barbara and Hallek, Michael (2018). CLL2-BXX Phase II trials: sequential, targeted treatment for eradication of minimal residual disease in chronic lymphocytic leukemia. Future Oncol., 14 (6). S. 499 - 514. LONDON: FUTURE MEDICINE LTD. ISSN 1744-8301

Cramer, Paula, von Tresckow, Julia, Bahlo, Jasmin, Engelke, Anja, Langerbeins, Petra, Wesselmann, Johanna Sofie, Annolleck, Tanja, Fink, Anna-Maria, Fischer, Kirsten, Wendtner, Clemens-Martin, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Boettcher, Sebastian, Eichhorst, Barbara and Hallek, Michael (2015). CLL2-BIG, -BAG, -BCG and -BIO: a series of four phase-II trials evaluating a sequential tailored and targeted regimen aiming for total eradication of MRD in treatment-naive and relapsed/refractory chronic lymphocytic leukemia. Leuk. Lymphoma, 56. S. 143 - 145. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Cramer, Paula, von Tresckow, Julia, Bahlo, Jasmin, Robrecht, Sandra, Al-Sawaf, Othman, Langerbeins, Petra, Engelke, Anja, Fink, Anna-Maria, Fischer, Kirsten, Seiler, Till, von Weikersthal, Ludwig Fischer, Hebart, Holger, Kreuzer, Karl-Anton, Rittgen, Matthias, Kneba, Michael, Wendtner, Clemens, Stilgenbauer, Stephan, Eichhorst, Barbara and Hallek, Michael (2017). Sequential treatment with bendamustine, followed by obinutuzumab (GA101) and venetoclax (ABT-199) in patients with chronic lymphocytic leukemia (CLL): results of the CLL2-BAG phase-II-trial of the German CLL study group (GCLLSG). Leuk. Lymphoma, 58. S. 149 - 151. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Cramer, Paula, von Tresckow, Julia, Bahlo, Jasmin, Robrecht, Sandra, Engelke, Anja, Langerbeins, Petra, Fink, Anna-Maria, Balke-Want, Hyatt, Al-Sawaf, Othman, Seiler, Till, von Weikersthal, Ludwig Fischer, Hebart, Holger, Fischer, Kirsten, Wendtner, Clemens-Martin, Stilgenbauer, Stephan, Eichhorst, Barbara F. and Hallek, Michael (2016). Low Incidence of Tumor Lysis Syndromes (TLS) and Infusion Related Reactions (IRR) in the CLL2-Bag Trial Evaluating a Sequential Treatment of Bendamustine (B), Obinutuzumab (GA101, G) and Venetoclax (ABT-199, A) in Patients with Chronic Lymphocytic Leukemia (CLL): Interim Safety Results of a Phase-II-Trial of the German CLL Study Group (GCLLSG). Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Cramer, Paula, von Tresckow, Julia, Bahlo, Jasmin, Robrecht, Sandra, Langerbeins, Petra, Al-Sawaf, Othman, Engelke, Anja, Fink, Anna-Maria, Fischer, Kirsten, Tausch, Eugen, Seiler, Till, von Weikersthal, Ludwig Fischer, Hebart, Holger, Kreuzer, Karl-Anton, Boettcher, Sebastian, Ritgen, Matthias, Kneba, Michael, Wendtner, Clemens-Martin, Stilgenbauer, Stephan, Eichhorst, Barbara and Hallek, Michael (2018). Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial. Lancet Oncol., 19 (9). S. 1215 - 1229. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Cramer, Paula, von Tresckow, Julia, Bahlo, Jasmin, Robrecht, Sandra, Tausch, Eugen, Fuerstenau, Moritz, Langerbeins, Petra, Al-Sawaf, Othman, Fink, Anna-Maria, Fischer, Kirsten, Wendtner, Clemens-Martin, Eichhorst, Barbara, Kneba, Michael, Stilgenbauer, Stephan and Hallek, Michael (2018). Durable Remissions after Discontinuation of Combined Targeted Treatment in Patients with Chronic Lymphocytic Leukemia (CLL) Harbouring a High-Risk Genetic Lesion (del(17p)/TP53 Mutation). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Cramer, Paula, von Tresckow, Julia, Eichhorst, Barbara and Hallek, Michael (2020). Current Diagnosis and Treatment of Chronic Lymphocytic Leukaemia. Dtsch. Med. Wochenschr., 145 (16). S. 1139 - 1145. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Cramer, Paula, von Tresckow, Julia, Robrecht, Sandra, Bahlo, Jasmin, Furstenau, Moritz ORCID: 0000-0002-6593-0140, Langerbeins, Petra, Pflug, Natali, Al-Sawaf, Othman ORCID: 0000-0001-9895-0570, Heinz, Werner J., Vehling-Kaiser, Ursula, Durig, Jan, Tausch, Eugen, Hensel, Manfred, Sasse, Stephanie, Fink, Anna-Maria, Fischer, Kirsten, Kreuzer, Karl-Anton, Boettcher, Sebastian, Ritgen, Matthias, Kneba, Michael, Wendtner, Clemens-Martin, Stilgenbauer, Stephan, Eichhorst, Barbara and Hallek, Michael (2021). Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia: primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO). Haematologica, 106 (2). S. 543 - 555. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Cremer, Birgit, Sandmaier, Brenda M., Bethge, Wolfgang, Lange, Thoralf, Goede, Valentin, Holtick, Udo, Hallek, Michael and Huebel, Kai (2011). Reduced-Intensity Conditioning in Allogeneic Stem Cell Transplantation for Hematological Malignancies: A Historical Perspective. Onkologie, 34 (12). S. 710 - 716. BASEL: KARGER. ISSN 1423-0240

Dassler-Plenker, Juliane, Reiners, Katrin S., van den Boorn, Jasper G., Hansen, Hinrich P., Putschli, Bastian, Barnert, Sabine, Schuberth-Wagner, Christine, Schubert, Rolf, Tueting, Thomas, Hallek, Michael, Schlee, Martin, Hartmann, Gunther ORCID: 0000-0003-1021-2018, von Strandmann, Elke Pogge and Coch, Christoph (2016). RIG-I activation induces the release of extracellular vesicles with antitumor activity. OncoImmunology, 5 (10). PHILADELPHIA: TAYLOR & FRANCIS INC. ISSN 2162-402X

Davids, Matthew S., Hallek, Michael, Wierda, William, Roberts, Andrew W., Stilgenbauer, Stephan, Jones, Jeffrey A., Gerecitano, John F., Kim, Su Young, Potluri, Jalaja, Busman, Todd, Best, Andrea, Verdugo, Maria E., Cerri, Elisa, Desai, Monali, Hillmen, Peter and Seymour, John F. (2018). Comprehensive Safety Analysis of Venetoclax Monotherapy for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia. Clin. Cancer Res., 24 (18). S. 4371 - 4380. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265

Di Cristanziano, Veronica, Meyer-Schwickerath, Charlotte, Eberhardt, Kirsten Alexandra, Rybniker, Jan, Heger, Eva, Knops, Elena, Hallek, Michael, Klein, Florian, Holtick, Udo and Jung, Norma . Detection of SARS-CoV-2 viremia before onset of COVID-19 symptoms in an allo-transplanted patient with acute leukemia. Bone Marrow Transplant.. LONDON: SPRINGERNATURE. ISSN 1476-5365

Dietrich, Sascha, Pircher, Andreas ORCID: 0000-0002-7747-3012, Endris, Volker, Peyrade, Frederic, Wendtner, Clemens-Martin, Follows, George A., Huellein, Jennifer, Jethwa, Alexander ORCID: 0000-0003-3869-8662, Ellert, Elena, Walther, Tatjana, Liu, Xiyang, Dyer, Martin J. S., Elter, Thomas, Brummer, Tilman ORCID: 0000-0003-4387-7905, Zeiser, Robert, Hermann, Michael, Herold, Michael, Weichert, Wilko, Dearden, Claire, Haferlach, Torsten, Seiffert, Martina ORCID: 0000-0001-5155-663X, Hallek, Michael, von Kalle, Christof, Ho, Anthony D., Gaehler, Anita, Andrulis, Mindaugas, Steurer, Michael and Zenz, Thorsten (2016). BRAF inhibition in hairy cell leukemia with low-dose vemurafenib. Blood, 127 (23). S. 2847 - 2856. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Dimier, Natalie, Delmar, Paul, Ward, Carol, Morariu-Zamfir, Rodica, Fingerle-Rowson, Guenter, Bahlo, Jasmin, Fischer, Kirsten, Eichhorst, Barbara, Goede, Valentin, van Dongen, Jacques J. M., Ritgen, Matthias, Boettcher, Sebastian, Langerak, Anton W., Kneba, Michael and Hallek, Michael (2018). A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL. Blood, 131 (9). S. 955 - 963. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Dimier, Natalie, Delmar, Paul, Ward, Carol, Morariu-Zamfir, Rodica, Fingerle-Rowson, Gunter, Bahlo, Jasmin, Fischer, Kirsten, Eichhorst, Barbara F., Goede, Valentin, van Dongen, Jacques J. M., Ritgen, Matthias, Boettcher, Sebastian, Langerak, Anton W., Kneba, Michael and Hallek, Michael (2015). A Model for Predicting Effect of Treatment on Progression-Free Survival Using Minimal Residual Disease As a Surrogate Endpoint in Chronic Lymphocytic Leukemia. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Dreger, Peter, Doehner, Hartmut, Ritgen, Matthias, Boettcher, Sebastian, Busch, Raymonde, Dietrich, Sascha ORCID: 0000-0002-0648-1832, Bunjes, Donald, Cohen, Sandra, Schubert, Joerg, Hegenbart, Ute, Beelen, Dietrich ORCID: 0000-0001-5050-220X, Zeis, Matthias, Stadler, Michael, Hasenkamp, Justin, Uharek, Lutz, Scheid, Christof, Humpe, Andreas, Zenz, Thorsten, Winkler, Dirk, Hallek, Michael, Kneba, Michael, Schmitz, Norbert and Stilgenbauer, Stephan (2010). Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial. Blood, 116 (14). S. 2438 - 2448. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Droessler, Linda, Lehmann, Clara, Toepelt, Karin, Nierhoff, Dirk, Vehreschild, Joerg J., Rybniker, Jan, Hallek, Michael, Fischer, Julia, Stormberg, Verena, Faetkenheuer, Gerd, Wieland, Ulrike and Jung, Norma (2019). HBsAg-negative/anti-HBc-positive patients treated with rituximab: prophylaxis or monitoring to prevent hepatitis B reactivation? Infection, 47 (2). S. 293 - 301. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-0973

Edelmann, Jennifer, Holzmann, Karlheinz, Kuehn, W. M. Michael, Bullinger, Lars, Radtke, Ina, Su, Xiaoping, Ma, Jing, Winkler, Dirk, Buehler, Andreas, Hallek, Michael, Downing, James R., Stilgenbauer, Stephan and Doehner, Hartmut (2010). High-Resolution SNP-Array Profiling of Chronic Lymphocytic Leukemia. Blood, 116 (21). S. 28 - 30. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Edelmann, Jennifer, Holzmann, Karlheinz, Miller, Florian, Winkler, Dirk, Buehler, Andreas, Zenz, Thorsten, Bullinger, Lars ORCID: 0000-0002-5890-5510, Kuehn, Michael W. M., Gerhardinger, Andreas, Bloehdorn, Johannes, Radtke, Ina, Su, Xiaoping, Ma, Jing, Pounds, Stanley, Hallek, Michael, Lichter, Peter, Korbel, Jan, Busch, Raymonde, Mertens, Daniel ORCID: 0000-0003-0227-7188, Downing, James R., Stilgenbauer, Stephan and Doehner, Hartmut (2012). High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. Blood, 120 (24). S. 4783 - 4795. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Edelmann, Jennifer, Holzmann, Karlheinz, Tausch, Eugen, Saunderson, Emily A., Jebaraj, Billy M. C., Steinbrecher, Daniela, Dolnik, Anna, Blaette, Tamara J., Landau, Dan A., Saub, Jenny, Estenfelder, Sven, Ibach, Stefan, Cymbalista, Florence, Leblond, Veronique, Delmer, Alain ORCID: 0000-0002-1430-2574, Bahlo, Jasmin, Robrecht, Sandra, Fischer, Kirsten, Goede, Valentin, Bullinger, Lars, Wu, Catherine J., Mertens, Daniel ORCID: 0000-0003-0227-7188, Ficz, Gabriella, Gribben, John G., Hallek, Michael, Doehner, Hartmut and Stilgenbauer, Stephan (2020). Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription. Haematologica, 105 (5). S. 1379 - 1391. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Edelmann, Jennifer, Saub, Jenny, Ibach, Stefan, Holzmann, Karlheinz, Tausch, Eugen, Bloehdorn, Johannes, Mertens, Daniel, Zenz, Thorsten, Cymbalista, Florence, Leblond, Veronique, Delmer, Alain, Gribben, John G., Hallek, Michael, Doehner, Hartmut and Stilgenbauer, Stephan (2014). High Resolution Genomic Profiling of Primary Ultra High Risk and Refractory Chronic Lymphocytic Leukemia: Results from the CLL2O Trial. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Edelmann, Jennifer, Tausch, Eugen, Bloehdorn, Johannes, Zenz, Thorsten, Fischer, Kirsten, Bahlo, Jasmin, Hallek, Michael, Doehner, Hartmut and Stilgenbauer, Stephan (2014). High-Resolution Genomic Copy Number Analysis on Sequential Samples from the CLL8 Trial: Relation Between Clonal Evolution and Defects in DNA Damage Response? Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Golla, Heidrun ORCID: 0000-0002-4403-630X, Thielen, Indra, Hallek, Michael ORCID: 0000-0002-7425-4455, Voltz, Raymond ORCID: 0000-0002-4761-3395 and Perrar, Klaus Maria (2019). Characteristics and course of patients with advanced hematologic malignancies receiving specialized inpatient palliative care at a German university hospital. Annals of Hematology, 98 (11). pp. 2605-2607. Springer Nature. ISSN 0939-5555

Eichhorst, Barbara, Bahlo, Jasmin, Fink, Anna Maria, Pfreundschuh, Michael, Hebart, Holger, Maschmeyer, Georg, Jentsch-Ulrich, Kathleen, Doerfel, Steffen, Westermann, Anne, Zey, Aline, Fischer, Kirsten, Wendtner, Clemens-Martin, Noesslinger, Thomas, Ghia, Paolo, Bosch, Francesc ORCID: 0000-0001-9241-2886, Kater, Arnon P., Kreuzer, Karl-Anton, Doehner, Hartmut, Stilgenbauer, Stephan, Boettcher, Sebastian and Hallek, Michael (2014). Good Tolerance of Lenalidomide Maintenance Therapy in Patients with High Risk Profile Chronic Lymphocytic Leukemia (CLL) after Frontline Chemoimmunotherapy: Preliminary Safety Overview of the CLLM1 Trial of the German CLL Study Group (GCLLSG). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichhorst, Barbara, Cramer, Paula and Hallek, Michael (2016). Initial therapy of chronic lymphocytic leukemia. Semin. Oncol., 43 (2). S. 241 - 251. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. ISSN 1532-8708

Eichhorst, Barbara, Fink, Anna Maria, Busch, Raymonde, Kovacs, Gabor, Maurer, Christian, Lange, Elisabeth, Koeppler, Hubert, Kiehl, Michael G., Soekler, Martin, Schlag, Rudolf, Vehling-Kaiser, Ursula, Koechling, Georg R. A., Ploeger, Christoph, Gregor, Michael, Plesner, Torben, Trneny, Marek, Fischer, Kirsten, Doehner, Hartmut, Kneba, Michael, Wendtner, Clemens-Martin, Klapper, Wolfram, Kreuzer, Karl Anton, Stilgenbauer, Stephan, Boettcher, Sebastian and Hallek, Michael (2014). Frontline Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Shows Superior Efficacy in Comparison to Bendamustine (B) and Rituximab (BR) in Previously Untreated and Physically Fit Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Final Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Eichhorst, Barbara, Fink, Anna-Maria, Bahlo, Jasmin, Busch, Raymonde, Kovacs, Gabor, Maurer, Christian, Lange, Elisabeth, Koeppler, Hubert, Kiehl, Michael, Soekler, Martin, Schlag, Rudolf, Vehling-Kaiser, Ursula, Koechling, Georg, Ploeger, Christoph, Gregor, Michael, Plesner, Torben, Trneny, Marek ORCID: 0000-0002-6952-6073, Fischer, Kirsten, Doehner, Harmut, Kneba, Michael, Wendtner, Clemens-Martin, Klapper, Wolfram, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Boettcher, Sebastian and Hallek, Michael (2016). First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial. Lancet Oncol., 17 (7). S. 928 - 943. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Eichhorst, Barbara, Fuerstenau, Moritz and Hallek, Michael (2019). Relapsed disease and aspects of undetectable MRD and treatment discontinuation. Hematol.-Am. Soc. Hematol. Educ. Program. S. 482 - 490. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1520-4383

Eichhorst, Barbara and Hallek, Michael (2016). Novel therapy concepts for chronic lymphocytic leukemia. Onkologe, 22 (4). S. 283 - 293. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0415

Eichhorst, Barbara and Hallek, Michael (2016). Prognostication of chronic lymphocytic leukemia in the era of new agents. Hematol.-Am. Soc. Hematol. Educ. Program. S. 149 - 156. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1520-4383

Eichhorst, Barbara, Hallek, Michael and Goede, Valentin (2018). Management of unfit elderly patients with chronic lymphocytic leukemia. Eur. J. Intern. Med., 58. S. 7 - 14. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1879-0828

Eichhorst, Barbara, Hallek, Michael and Goede, Valentin (2016). New treatment approaches in CLL: Challenges and opportunities in the elderly. J. Geriatr. Oncol., 7 (5). S. 375 - 383. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1879-4076

Eichhorst, Barbara F., Bahlo, Jasmin, Maurer, Christian, Lange, Elisabeth, Koppler, Hubert, Kiehl, Michael G., Sokler, Martin, Schlag, Rudolf, Vehling-Kaiser, Ursula, Kochling, Georg, Ploger, Christoph, Gregor, Michael, Plesner, Torben, Herling, Marco, Fischer, Kirsten, Dohner, Hartmut, Kneba, Michael, Wendtner, Clemens, Klapper, Wolfram, Kreuzer, Karl-Anton, Bottcher, Sebastian, Stilgenbauer, Stephan, Fink, Anna Maria and Hallek, Michael (2016). Favorable Toxicity Profile and Long Term Outcome of Elderly, but Physically Fit CLL Patients (pts) Receiving First Line Bendamustine and Rituximab (BR) Frontline Chemoimmunotherapy in Comparison to Fludarabine, Cyclophosphamide, and Rituximab (FCR) in Advanced Chronic Lymphocytic Leukemia (CLL): Update Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study). Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Elter, Thomas, Gercheva-Kyuchukova, Liana, Pylylpenko, Halyna, Robak, Tadesuz, Jaksic, Branimir, Rekhtman, Grigoriy, Kyrcz-Krzemien, Slawomira, Vatutin, Mykola, Wu, Jingyang, Sirard, Cynthia, Hallek, Michael and Engert, Andreas (2011). Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial. Lancet Oncol., 12 (13). S. 1204 - 1214. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Estenfelder, Sven, Tausch, Eugen, Robrecht, Sandra, Bahlo, Jasmin, Goede, Valentin, Ritgen, Matthias, van Dongen, Jacques J. M., Langerak, Anton W., Fingerle-Rowson, Gunter, Kneba, Michael, Fischer, Kirsten, Hallek, Michael, Dohner, Hartmut and Stilgenbauer, Stephan (2016). Gene Mutations and Treatment Outcome in the Context of Chlorambucil (Clb) without or with the Addition of Rituximab (R) or Obinutuzumab (GA-101, G) - Results of an Extensive Analysis of the Phase III Study CLL11 of the German CLL Study Group. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fedorchenko, Oleg, Rosen, Natascha, Koch, Maximilian, Barthel, Romy, Winarski, Tomasz, Florin, Alexandra, Wunderlich, F. Thomas, Reinart, Nina and Hallek, Michael (2016). LYN Kinase in the Tumor Microenvironment Is Essential for the Progression of Chronic Lymphocytic Leukemia. Cancer Cell, 30 (4). S. 610 - 623. CAMBRIDGE: CELL PRESS. ISSN 1878-3686

Fink, Anna, Busch, Raymonde, Pflug, Natali, Boettcher, Sebastian, Winkler, Dirk, Buehler, Andreas, Ritgen, Matthias, Fischer, Kirsten, Eichhorst, Barbara, Wendtner, Clemens-Martin, Mendila, Myriam, Wenger, Michael K., Doehner, Hartmut, Kneba, Michael, Stilgenbauer, Stephan and Hallek, Michael (2011). Prediction of Poor Outcome in CLL Patients Treated with FCR (Fludarabine, Cyclophosphamide, Rituximab) in the CLL8 Trial of the German CLL Study Group (GCLLSG). Blood, 118 (21). S. 446 - 448. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Fink, Anna Maria, Bahlo, Jasmin, Robrecht, Sandra, Al-Sawaf, Othman, Aldaoud, Ali, Hebart, Holger, Jentsch-Ullrich, Kathleen, Doerfel, Steffen, Fischer, Kirsten, Wendtner, Clemens-Martin, Noesslinger, Thomas, Ghia, Paolo ORCID: 0000-0003-3750-7342, Bosch, Francesc ORCID: 0000-0001-9241-2886, Kater, Arnon P., Dohner, Hartmut, Kneba, Michael, Kreuzer, Karl-Anton, Tausch, Eugen, Stilgenbauer, Stephan, Ritgen, Matthias, Boettcher, Sebastian, Eichhorst, Barbara and Hallek, Michael (2017). Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study. Lancet Haematol., 4 (10). S. E475 - 12. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026

Fink, Anna Maria, Bahlo, Jasmin, Sandra, Robrecht, Al-Sawaf, Othman, Aldaoud, Ali, Hebart, Holger, Jentsch-Ulrich, Kathleen, Doerfel, Steffen, Fischer, Kirsten, Wendtner, Clemens Martin, Noesslinger, Thomas, Ghia, Paolo, Bosch, Francesc ORCID: 0000-0001-9241-2886, Kater, Arnon P., Kreuzer, Karl-Anton, Dohner, Hartmut, Kneba, Michael, Stilgenbauer, Stephan, Boettcher, Sebastian, Eichhorst, Barbara and Hallek, Michael (2016). Lenalidomide Maintenance after Front Line Therapy Substantially Prolongs Progression Free Survival in High Risk CLL: Interim Results of a Phase 3 Study (CLL M1 study of the German CLL Study Group). Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fink, Anna-Maria, Robrecht, Sandra, Bahlo, Jasmin, Fuerstenau, Moritz, Aldaoud, Ali, Hebart, Holger, Jentsch-Ullrich, Kathleen, Doerfel, Steffen, Fischer, Kirsten, Wendtner, Clemens Martin, Noesslinger, Thomas, Ghia, Paolo, Kater, Arnon, Kreuzer, Karl-Anton, Tausch, Eugen, Stilgenbauer, Stephan, Rittgen, Matthias, Boettcher, Sebastian, Eichhorst, Barbara and Hallek, Michael (2020). Long-term efficacy and safety of maintenance with lenalidomide in patients with chronic lymphocytic leukaemia and a high risk of progression after first-line immunochemotherapy. Leuk. Lymphoma, 61. S. 272 - 274. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Fischer, Kirsten, Al-Sawaf, Othman, Fink, Anna-Maria, Dixon, Mark, Bahlo, Jasmin, Warburton, Simon, Kipps, Thomas J., Weinkove, Robert ORCID: 0000-0003-3645-7988, Robinson, Sue, Dreyling, Martin H., Opat, Stephen, Owen, Carolyn J., Lopez, Javier, Humphrey, Kathryn, Humerickhouse, Rod A., Tausch, Eugen, Eichhorst, Barbara, Wendtner, Clemens-M., Langerak, Anton W., van Dongen, Jacques J. M., Ritgen, Matthias, Boettcher, Sebastian, Stilgenbauer, Stephan, Goede, Valentin, Mobasher, Mehrdad and Hallek, Michael (2016). Safety and Efficacy of Venetoclax and Obinutuzumab in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) and Coexisting Medical Conditions: Final Results of the Run-in Phase of the Randomized CLL14 Trial (BO25323). Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fischer, Kirsten, Al-Sawaf, Othman, Fink, Anna-Maria, Dixon, Mark, Bahlo, Jasmin, Warburton, Simon, Kipps, Thomas J., Weinkove, Robert ORCID: 0000-0003-3645-7988, Robinson, Sue, Seiler, Till, Opat, Stephen, Owen, Carolyn, Lopez, Javier, Humphrey, Kathryn, Humerickhouse, Rod, Tausch, Eugen, Frenzel, Lukas, Eichhorst, Barbara, Wendtner, Clemens-M., Stilgenbauer, Stephan, Langerak, Anton W., van Dongen, Jacque J. M., Boettcher, Sebastian, Ritgen, Matthias, Goede, Valentin, Mobasher, Mehrdad and Hallek, Michael (2017). Venetoclax and obinutuzumab in chronic lymphocytic leukemia. Blood, 129 (19). S. 2702 - 2706. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fischer, Kirsten, Al-Sawaf, Othman and Hallek, Michael (2020). Preventing and monitoring for tumor lysis syndrome and other toxicities of venetoclax during treatment of chronic lymphocytic leukemia. Hematol.-Am. Soc. Hematol. Educ. Program (1). S. 357 - 363. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1520-4383

Fischer, Kirsten, Bahlo, Jasmin, Fink, Anna Maria, Goede, Valentin, Herling, Carmen Diana, Cramer, Paula, Langerbeins, Petra, von Tresckow, Julia, Engelke, Anja, Maurer, Christian, Kovacs, Gabor, Herling, Marco, Tausch, Eugen, Kreuzer, Karl-Anton, Eichhorst, Barbara, Boettcher, Sebastian, Seymour, John F., Ghia, Paolo ORCID: 0000-0003-3750-7342, Marlton, Paula, Kneba, Michael, Wendtner, Clemens-Martin, Doehner, Hartmut, Stilgenbauer, Stephan and Hallek, Michael (2016). Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial. Blood, 127 (2). S. 208 - 216. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fischer, Kirsten, Bahlo, Jasmin, Fink, Anna-Maria, Busch, Raymonde, Boettcher, Sebastian, Mayer, Jiri, Dreger, Peter, Maurer, Christian, Engelke, Anja, Kneba, Michael, Doehner, Hartmut, Eichhorst, Barbara F., Wendtner, Clemens-Martin, Stilgenbauer, Stephan and Hallek, Michael (2012). Extended Follow up of the CLL8 Protocol, a Randomized Phase-III Trial of the German CLL Study Group (GCLLSG) Comparing Fludarabine and Cyclophosphamide (FC) to FC Plus Rituximab (FCR) for Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL): Results On Survival, Progression-Free Survival, Delayed Neutropenias and Secondary Malignancies Confirm Superiority of the FCR Regimen. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Fischer, Kirsten, Cramer, Paula, Busch, Raymonde, Boettcher, Sebastian, Bahlo, Jasmin, Schubert, Joeerg, Pflueger, Karl H., Schott, Silke, Goede, Valentin, Isfort, Susanne, von Tresckow, Julia, Fink, Anna-Maria, Buehler, Andreas, Winkler, Dirk, Kreuzer, Karl-Anton, Staib, Peter, Ritgen, Matthias, Kneba, Michael, Doehner, Hartmut, Eichhorst, Barbara F., Hallek, Michael, Stilgenbauer, Stephan and Wendtner, Clemens-Martin (2012). Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group. J. Clin. Oncol., 30 (26). S. 3209 - 3217. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Fischer, Kirsten, Cramer, Paula, Busch, Raymonde, Stilgenbauer, Stephan, Bahlo, Jasmin, Schweighofer, Carmen D., Boettcher, Sebastian, Staib, Peter, Kiehl, Michael, Eckart, Michael J., Kranz, Gabriele, Goede, Valentin, Elter, Thomas, Buehler, Andreas, Winkler, Dirk, Kneba, Michael, Doehner, Hartmut, Eichhorst, Barbara F., Hallek, Michael and Wendtner, Clemens-Martin (2011). Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group. J. Clin. Oncol., 29 (26). S. 3559 - 3567. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Fischer, Kirsten, Fink, Anna-Maria, Bishop, Helen, Dixon, Mark, Bahlo, Jasmin, Chol, Michael Y., Weinkove, Robert ORCID: 0000-0003-3645-7988, Robinson, Sue, Dreyling, Martin, Seiler, Till, Opat, Stephen, Owen, Carolyn, Lopez, Javier, Sr., Kutsch, Nadine, Tausch, Eugen, Ritgen, Matthias, Humerickhouse, Rod A., Humphrey, Kathryn, Wenger, Michael K., Goede, Valentin, Eichhorst, Barbara, Wendtner, Clemens-Martin, Stilgenbauer, Stephan, Kipps, Thomas J. and Hallek, Michael (2015). Results of the Safety Run-in Phase of CLL14 (BO25323): A Prospective, Open-Label, Multicenter Randomized Phase Ill Trial to Compare the Efficacy and Safety of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) with Obinutuzumab and Chlorambucil in Patients with Previously Untreated CLL and Coexisting Medical Conditions. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fischer, Kirsten and Hallek, Michael (2017). Optimizing frontline therapy of CLL based on clinical and biological factors. Hematol.-Am. Soc. Hematol. Educ. Program. S. 338 - 346. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1520-4383

Flinn, Ian, Jaeger, Ulrich, Offner, Fritz, Cymbalista, Florence, Hallek, Michael, Callgarls-Capplo, Federico, Delgado, Julio ORCID: 0000-0002-5157-4376, Hillman, Peter, Davids, Matthew Steven, Wright, David Donald, Easell, James H., Baker, Bartrum W., Cosolo, Walter, Kelly, Patrick Francis, Harris, Patricia, Han, Lixin, Patterson, Fiona and Stilgenbauer, Stephan (2014). DUO: A phase 3 trial of the PL3K-delta,gamma inhibitor IPI-145 versusofatumumab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphorytic lymphoma. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Fraser, Graeme, Chanan-Khan, Asher, Cramer, Paula, Demirkan, Fatih ORCID: 0000-0002-1172-8668, Silva, Rodrigo Santucci, Pylypenko, Halyna, Grosicki, Sebastian, Janssens, Ann, Pristupa, Aleksander, Goy, Andre ORCID: 0000-0001-5125-6522, Mayer, Jiri, Dilhuydy, Marie-Sarah, Loscertales, Javier, Bartlett, Nancy, Avigdor, Abraham, Rule, Simon, Sun, Steven, Phelps, Charles, Mahler, Michelle, Salman, Masha, Howes, Angela and Hallek, Michael (2015). Ibrutinib combined with bendamustine/rituximab (BR) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): subgroup efficacy analyses from the HELIOS trial. Leuk. Lymphoma, 56. S. 98 - 101. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Fraser, Graeme, Chanan-Khan, Asher, Demirkan, Faith, Silva, Rodrigo Santucci, Grosicki, Sebastian, Janssens, Ann, Mayer, Jiri, Bartlett, Nancy, Dilhuydy, Marie Sarah, Loscertales, Javier, Avigdor, Abraham, Rule, Simon, Samoilova, Olga, Pavlosky, Miguel, Hallek, Michael, Salman, Mariya, Tamegnon, Monelle, Sun, Steven, Connor, Anne, Nottage, Kerri, Balasubramanian, Sriram, Howes, Angela and Cramer, Paula (2020). Final 5-year updated results from a phase 3 study (HELIOS) of ibrutinib plus bendamustine and rituximab (BR) in patients with relapsed/refractory chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). Leuk. Lymphoma, 61. S. 106 - 109. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Fraser, Graeme A. M., Chanan-Khan, Asher, Demirkan, Fatih, Santucci Silva, Rodrigo, Grosicki, Sebastian, Janssens, Ann, Mayer, Jiri, Bartlett, Nancy L., Dilhuydy, Marie-Sarah, Loscertales, Javier, Avigdor, Abraham, Rule, Simon, Samoilova, Olga, Pavlovsky, Miguel A., Goy, Andre, Mato, Anthony, Hallek, Michael, Salman, Mariya, Tamegnon, Monelle, Sun, Steven, Connor, Anne, Nottage, Kerri, Schuier, Natasha, Balasubramanian, Sriram, Howes, Angela and Cramer, Paula (2020). Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk. Lymphoma, 61 (13). S. 3188 - 3198. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Freeman, Ciara L., Morschhauser, Franck, Sehn, Laurie, Dixon, Mark, Houghton, Richard, Lamy, Thierry, Fingerle-Rowson, Guenter, Wassner-Fritsch, Elisabeth, Gribben, John G., Hallek, Michael, Salles, Gilles and Cartron, Guillaume ORCID: 0000-0003-0659-9635 (2015). Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions. Blood, 126 (24). S. 2646 - 2650. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Freeman, Ciara Louise, Dixon, Mark, Houghton, Richard, Humphrey, Kathryn, Fingerle-Rowson, Gunter, Kreuzer, Karl-Anton, Engelke, Anja, Hallek, Michael and Goede, Valentin (2014). Risk Factors Associated with the Development of Infusion-Related Reactions in Patients with Chronic Lymphocytic Leukaemia Treated with Anti-CD20 Monoclonal Antibodies: Analysis of the CLL11 Study Dataset. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Freeman, Ciara Louise, Morschhauser, Franck, Sehn, Laurie H., Dixon, Mark, Houghton, Richard, Lamy, Thierry, Fingerle-Rowson, Gunter, Wassner-Fritsch, Elisabeth, Hallek, Michael, Salles, Gilles and Cartron, Guillaume (2014). Pattern of Cytokine Release in Patients with Chronic Lymphocytic Leukemia Treated with Obinutuzumab and Possible Relationship with Development of Infusion Related Reactions (IRR). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fuerstenau, Moritz, Fink, Anna Maria, Schilhabel, Anke, Weiss, Jonathan, Robrecht, Sandra, Eckert, Robert, de la Serna, Javier, Crespo, Marta ORCID: 0000-0002-7732-7808, Coscia, Marta, Vitale, Candida, Boettcher, Sebastian, Weppner, Gesche, Ritgen, Matthias, Stilgenbauer, Stephan, Tausch, Eugen, Fischer, Kirsten, Hallek, Michael, Eichhorst, Barbara, Brueggemann, Monika and Herling, Carmen D. (2021). B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide. Blood, 137 (16). S. 2267 - 2272. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fuerstenau, Moritz, Giza, Adam, Stumpf, Thomas, Robrecht, Sandra, Maurer, Christian, Linde, Hartmut, Jacobasch, Lutz, Doerfel, Steffen, Aldaoud, Ali, von Tresckow, Julia, Koenigsmann, Michael, Gaska, Tobias, Kaiser, Ulrich, Harich, Hanns-Detlev, Fischer, Kirsten, Eichhorst, Barbara, Hallek, Michael and Fink, Anna-Maria (2021). Second primary malignancies in treated and untreated patients with chronic lymphocytic leukemia. Am. J. Hematol., 96 (12). S. E457 - 4. HOBOKEN: WILEY. ISSN 1096-8652

Fuerstenau, Moritz, Hallek, Michael and Eichhorst, Barbara (2019). Sequential and combination treatments with novel agents in chronic lymphocytic leukemia. Haematologica, 104 (11). S. 2144 - 2155. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Fuerstenau, Moritz, Hopfinger, Georg, Robrecht, Sandra, Fink, Anna-Maria, Al-Sawaf, Othman, Langerbeins, Petra, Cramer, Paula, Von Tresckow, Julia, Maurer, Christian, Kutsch, Nadine, Hoechstetter, Manuela, Dreyling, Martin, Lange, Elisabeth, Kneba, Michael, Stilgenbauer, Stephan, Doehner, Hartmut, Hensel, Manfred, Kiehl, Michael G., Jaeger, Ulrich, Wendtner, Clemens-Martin, Goede, Valentin, Fischer, Kirsten, von Bergwelt-Baildon, Michael, Eichhorst, Barbara, Hallek, Michael and Theurich, Sebastian ORCID: 0000-0001-5706-8258 (2020). Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy. Leukemia, 34 (4). S. 1177 - 1182. LONDON: SPRINGERNATURE. ISSN 1476-5551

Fuerstenau, Moritz, Hopfinger, Georg, Robrecht, Sandra, Fink, Anna-Maria, Al-Sawaf, Othman, Langerbeins, Petra, Cramer, Paula, Von Tresckow, Julia, Maurer, Christian, Kutsch, Nadine, Hoechstetter, Manuela, Dreyling, Martin, Lange, Elisabeth, Kneba, Michael, Stilgenbauer, Stephan, Doehner, Hartmut, Hensel, Manfred, Kiehl, Michael G., Jaeger, Ulrich, Wendtner, Clemens-Martin, Goede, Valentin, Fischer, Kirsten, Hallek, Michael, Eichhorst, Barbara and Theurich, Sebastian (2018). Obesity Negatively Impacts Outcome in Female Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Fludarabine, Cyclophosphamide and Rituximab (FCR): An Analysis of Three Phase III Studies of the German CLL Study Group (GCLLSG). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fuerstenau, Moritz, Langerbeins, Petra, De Silva, Nisha, Fink, Anna Maria, Robrecht, Sandra, von Tresckow, Julia, Simon, Florian, Hohloch, Karin, Droogendijk, Jolanda, van der Klift, Marjolein, van der Spek, Ellen, Illmer, Thomas, Schoettker, Bjoern, Fischer, Kirsten, Wendtner, Clemens M., Tausch, Eugen, Stilgenbauer, Stephan, Niemann, Carsten U., Gregor, Michael, Kater, Arnon P., Hallek, Michael and Eichhorst, Barbara (2020). COVID-19 among fit patients with CLL treated with venetoclax-based combinations. Leukemia, 34 (8). S. 2225 - 2230. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Fuerstenau, Moritz, Simon, Florian, Cornely, Oliver A., Hicketier, Tillman, Eichhorst, Barbara, Hallek, Michael and Mellinghoff, Sibylle C. (2020). Invasive Aspergillosis in Patients Treated With Ibrutinib. Hemasphere, 4 (2). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241

Furman, Richard R., Hallek, Michael, Sharman, Jeffrey P., Hillmen, Peter, Zelenetz, Andrew D., Flinn, Ian W., Jurczak, Wojciech, Munugalavadla, Veerendra, Xiao, Yuanyuan, Zheng, Lianqing, Rao, Arati V., Dreiling, Lyndah K., Salles, Gilles A. and O'Brien, Susan M. (2016). Evaluation of Immune Mechanisms to Understand Idelalislib-Associated Diarrhea-Colitis. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Furman, Richard R., Sharman, Jeff P., Coutre, Steven E., Cheson, Bruce D., Pagel, John M., Hillmen, Peter, Barrientos, Jacqueline C., Zelenetz, Andrew D., Kipps, Thomas J., Flinn, Ian ORCID: 0000-0001-6724-290X, Ghia, Paolo ORCID: 0000-0003-3750-7342, Eradat, Herbert, Ervin, Thomas, Lamanna, Nicole ORCID: 0000-0003-3331-9491, Coiffier, Bertrand, Pettitt, Andrew R., Ma, Shuo, Stilgenbauer, Stephan, Cramer, Paula, Aiello, Maria, Johnson, Dave M., Miller, Langdon L., Li, Daniel, Jahn, Thomas M., Dansey, Roger D., Hallek, Michael and O'Brien, Susan M. (2014). Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia. N. Engl. J. Med., 370 (11). S. 997 - 1008. WALTHAM: MASSACHUSETTS MEDICAL SOC. ISSN 1533-4406

Furman, Richard R., Sharman, Jeff P., Coutre, Steven E., Cheson, Bruce D., Pagel, John M., Hillmen, Peter, Barrientos, Jacqueline C., Zelenetz, Andrew D., Kipps, Thomas J., Flinn, Ian, Ghia, Paolo ORCID: 0000-0003-3750-7342, Eradat, Herbert, Ervin, Thomas, Lamanna, Nicole ORCID: 0000-0003-3331-9491, Hallek, Michael, Coiffier, Bertrand, Pettitt, Andrew R., Ma, Shuo, Stilgenbauer, Stephan, Cramer, Paula, Aiello, Maria, Johnson, Dave M., Miller, Langdon L., Li, Daniel, Jahn, Thomas M., Dansey, Roger D. and O'Brien, Susan M. (2013). A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Idelalisib and Rituximab for Previously Treated Patients with Chronic Lymphocytic Leukemia (CLL). Blood, 122 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Furstenau, Moritz, Bahlo, Jasmin, Fink, Anna-Maria, Lange, Elisabeth, Dreger, Peter, Dreyling, Martin, Hess, Georg, Ritgen, Matthias, Kneba, Michael, Doehner, Hartmut, Stilgenbauer, Stephan, Wendtner, Clemens-Martin, Goede, Valentin, Fischer, Kirsten, Boettcher, Sebastian, Hallek, Michael and Eichhorst, Barbara (2018). Residual Abdominal Lymphadenopathy after Intensive Frontline Chemoimmunotherapy Is Associated with Inferior Outcome Regardless of MRD Status in Advanced Chronic Lymphocytic Leukemia (CLL). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Furstenau, Moritz, Thus, Yvonne, Robrecht, Sandra, Mellink, Clemens, Van der Kevie-Kersemaekers, Anne-Marie, Dubois, Julie M. N., Von Tresckow, Julia, Patz, Michaela, Gregor, Michael, Thornton, Patrick, Staber, Philipp B., Tadmor, Tamar, Levin, Mark-David, Da Cunha-Bang, Caspar, Schneider, Christof, Poulsen, Christian Bjorn, Illmer, Thomas, Schoettker, Bjorn, Janssens, Ann, Christiansen, Ilse, Baumann, Michael, Noesslinger, Thomas, Regelink, Josien, Dompeling, Ellen C., Lindstroem, Vesa, Juliusson, Gunnar, Widmer, Anouk, Goede, Jeroen Simon, Goldschmidt, Neta, Simon, Florian, De Silva, Nisha, Fink, Anna-Maria, Fischer, Kirsten, Wendtner, Clemens-Martin, Ritgen, Matthias, Brueggemann, Monika, Tausch, Eugen, Stilgenbauer, Stephan, Eldering, Eric, Niemann, Carsten Utoft, Hallek, Michael, Eichhorst, Barbara, Kreuzer, Karl-Anton and Kater, Arnon P. (2022). High Karyotypic Complexity and Translocations Are Adverse Prognostic Features in Patients with Chronic Lymphocytic Leukemia without TP53 Aberrations Treated with Venetoclax-Based Time-Limited Combinations. Blood, 140. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Furstenau, Moritz ORCID: 0000-0002-6593-0140, Weiss, Jonathan, Giza, Adam, Franzen, Fabian, Robrecht, Sandra, Fink, Anna-Maria, Fischer, Kirsten, Schneider, Christof, Tausch, Eugen, Stilgenbauer, Stephan, Ritgen, Matthias, Schilhabel, Anke, Brueggemann, Monika, Eichhorst, Barbara, Hallek, Michael and Cramer, Paula ORCID: 0000-0003-4046-9922 (2022). Circulating Tumor DNA-Based MRD Assessment in Patients with CLL Treated with Obinutuzumab, Acalabrutinib, and Venetoclax. Clin. Cancer Res., 28 (19). S. 4203 - 4212. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265

Gaertner, Jan ORCID: 0000-0002-8824-7117, Wolf, Juergen, Ostgathe, Christoph ORCID: 0000-0003-4449-5036, Toepelt, Karin, Glossmann, Jan-Peter, Hallek, Michael and Voltz, Raymond (2010). Specifying WHO Recommendation: Moving toward Disease-Specific Guidelines. J. Palliat. Med., 13 (10). S. 1273 - 1277. NEW ROCHELLE: MARY ANN LIEBERT, INC. ISSN 1557-7740

Garcia Borrega, Jorge, Heger, Jan-Michel, Koehler, Philipp ORCID: 0000-0002-7386-7495, Holtick, Udo, Hallek, Michael, Scheid, Christof, Boell, Boris, Shimabukuro-Vornhagen, Alexander, Kochanek, Matthias and Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514 (2022). Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes-results of a retrospective analysis from a German university hospital. Ann. Hematol., 101 (2). S. 389 - 396. NEW YORK: SPRINGER. ISSN 1432-0584

Gartner, Jan, Daun, Marion, Wolf, Juergen, von Bergwelt-Baildon, Michael and Hallek, Michael (2019). Early Palliative Care: Pro, but Please Be Precise! Oncol. Res. Treat., 42 (1-2). S. 11 - 18. BASEL: KARGER. ISSN 2296-5262

Gehlsen, Uta ORCID: 0000-0001-9057-9199, Stern, Michael E., Franklin, Jeremy ORCID: 0000-0003-1536-0925, Tahmaz, Volkan ORCID: 0000-0002-7939-4027, Hallek, Michael, Holtick, Udo, Scheid, Christof and Steven, Philipp ORCID: 0000-0001-6892-3619 (2022). Desiccating Stress Significantly Increases the Risk for Chronic Ocular Graft-versus-Host-Disease. Transpl. Cell. Ther., 28 (11). NEW YORK: ELSEVIER SCIENCE INC. ISSN 2666-6367

George, Julie, Lim, Jing Shan, Jang, Se Jin, Cun, Yupeng ORCID: 0000-0002-4241-8099, Ozretic, Luka, Kong, Gu, Leenders, Frauke, Lu, Xin, Fernandez-Cuesta, Lynnette ORCID: 0000-0002-0724-6703, Bosco, Graziella, Mueller, Christian, Dahmen, Ilona, Jahchan, Nadine S., Park, Kwon-Sik, Yang, Dian, Karnezis, Anthony N., Vaka, Dedeepya ORCID: 0000-0001-7951-5514, Torres, Angela, Wang, Maia Segura, Korbel, Jan O., Menon, Roopika, Chun, Sung-Min ORCID: 0000-0002-3357-1382, Kim, Deokhoon, Wilkerson, Matt, Hayes, Neil, Engelmann, David, Puetzer, Brigitte, Bos, Marc, Michels, Sebastian, Vlasic, Ignacija, Seidel, Danila ORCID: 0000-0003-4388-3117, Pinther, Berit, Schaub, Philipp, Becker, Christian, Altmueller, Janine, Yokota, Jun, Kohno, Takashi, Iwakawa, Reika, Tsuta, Koji, Noguchi, Masayuki, Muley, Thomas, Hoffmann, Hans, Schnabel, Philipp A., Petersen, Iver, Chen, Yuan, Soltermann, Alex, Tischler, Verena ORCID: 0000-0002-6673-8329, Choi, Chang-min, Kim, Yong-Hee, Massion, Pierre P., Zou, Yong, Jovanovic, Dragana, Kontic, Milica, Wright, Gavin M., Russell, Prudence A., Solomon, Benjamin, Koch, Ina, Lindner, Michael, Muscarella, Lucia A., la Torre, Annamaria ORCID: 0000-0003-4199-1077, Field, John K. ORCID: 0000-0003-3951-6365, Jakopovic, Marko, Knezevic, Jelena, Castanos-Velez, Esmeralda ORCID: 0000-0002-2670-1118, Roz, Luca ORCID: 0000-0001-5817-7149, Pastorino, Ugo ORCID: 0000-0001-9974-7902, Brustugun, Odd-Terje, Lund-Iversen, Marius, Thunnissen, Erik, Koehler, Jens, Schuler, Martin, Botling, Johan, Sandelin, Martin ORCID: 0000-0002-0370-8819, Sanchez-Cespedes, Montserrat, Salvesen, Helga B., Achter, Viktor, Lang, Ulrich ORCID: 0000-0001-7166-0805, Bogus, Magdalena, Schneider, Peter M. ORCID: 0000-0003-0744-2349, Zander, Thomas, Ansen, Sascha, Hallek, Michael, Wolf, Juergen, Vingron, Martin, Yatabe, Yasushi ORCID: 0000-0003-1788-559X, Travis, William D., Nuernberg, Peter, Reinhardt, Christian, Perner, Sven, Heukamp, Lukas ORCID: 0000-0002-3388-3482, Buettner, Reinhard, Haas, Stefan A., Brambilla, Elisabeth, Peifer, Martin ORCID: 0000-0002-5243-5503, Sage, Julien and Thomas, Roman K. (2015). Comprehensive genomic profiles of small cell lung cancer. Nature, 524 (7563). S. 47 - 54. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-4687

Ghia, Paolo, Coutre, Steven E., Cheson, Bruce D., Barrientos, Jacqueline C., Hillmen, Peter, Pettitt, Andrew R., Zelenetz, Andrew D., Shreay, Sanatan, Hallek, Michael and Furman, Richard R. (2020). Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial. Haematologica, 105 (10). S. E519 - 4. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Ghia, Paolo ORCID: 0000-0003-3750-7342 and Hallek, Michael (2014). Management of chronic lymphocytic leukemia. Haematologica, 99 (6). S. 965 - 973. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Goeckeritz, Elisa, Kerwien, Susan, Baumann, Michael, Wigger, Marion, Vondey, Verena, Neumann, Lars, Landwehr, Thomas, Wendtner, Clemens M., Klein, Christian ORCID: 0000-0001-7594-7280, Liu, Ningshu, Hallek, Michael, Frenzel, Lukas P. and Krause, Guenter (2015). Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells. Int. J. Cancer, 137 (9). S. 2234 - 2243. HOBOKEN: WILEY-BLACKWELL. ISSN 1097-0215

Goeckeritz, Elisa, Vondey, Verena, Guastafierro, Anna, Pizevska, Maja, Hassenrueck, Floyd, Neumann, Lars, Hallek, Michael and Krause, Guenter (2017). Establishing a chemical genetic link between Bruton tyrosine kinase activity in malignant B cells and cell functions involved in the micro-environmental dialogue. Br. J. Haematol., 178 (6). S. 949 - 954. HOBOKEN: WILEY. ISSN 1365-2141

Goede, Valentin, Bahlo, Jasmin, Chataline, Viktoria, Eichhorst, Barbara, Duerig, Jan, Stilgenbauer, Stephan, Kolb, Gerald, Honecker, Friedemann, Wedding, Ulrich and Hallek, Michael (2016). Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group. Leuk. Lymphoma, 57 (4). S. 789 - 797. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Goede, Valentin, Bahlo, Jasmin, Kutsch, Nadine, Fischer, Kirsten, Fink, Anna Maria, Fingerle-Rowson, Guenter, Stilgenbauer, Stephan, Bergmann, Manuela A., Eichhorst, Barbara F. and Hallek, Michael (2016). Evaluation of the International Prognostic Index for Chronic Lymphocytic Leukemia (CLL-IPI) in Elderly Patients with Comorbidities: Analysis of the CLL11 Study Population. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Goede, Valentin, Bahlo, Jasmin, Robrecht, Sandra, Al-Sawaf, Othman, Fink, Anna-Maria, Stilgenbauer, Stephan, Fischer, Kirsten, Eichhorst, Barbara, Hallek, Michael and Wendtner, Clemens (2017). Cumulative Illness Rating Scale (CIRS) provides prognostic information beyond the International Prognostic Index for chronic lymphocytic leukemia (CLL-IPI): analysis of 3 randomized trials of the German CLL Study Group. Leuk. Lymphoma, 58. S. 96 - 99. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Goede, Valentin, Busch, Raymonde, Bahlo, Jasmin, Chataline, Viktoria, Kremers, Stephan, Mueller, Lothar, Reschke, Daniel, Schlag, Rudolf, Schmidt, Burkhard, Vehling-Kaiser, Ursula, Wedding, Ulrich, Stilgenbauer, Stefan and Hallek, Michael (2016). Low-dose fludarabine with or without darbepoetin alfa in patients with chronic lymphocytic leukemia and comorbidity: primary results of the CLL9 trial of the German CLL Study Group. Leuk. Lymphoma, 57 (3). S. 596 - 604. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Goede, Valentin, Cramer, Paula, Busch, Raymonde, Bergmann, Manuela, Stauch, Martina, Hopfinger, Georg, Stilgenbauer, Stephan, Doehner, Hartmut, Westermann, Anne, Wendtner, Clemens M., Eichhorst, Barbara and Hallek, Michael (2014). Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials. Haematologica, 99 (6). S. 1095 - 1101. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Goede, Valentin, Engelke, Anja, Fischer, Kirsten, Lopez Jimenez, Javier, Kuzmin, Alexej, Dyer, Martin J. S., Le Du, Katell, Liberati, Anna Marina, Schlag, Rudolf, Langerak, Anton W., Ritgen, Matthias, Stilgenbauer, Stephan, Asikanius, Elina, Humphrey, Kathryn, Wenger, Michael K., Fingerle-Rowson, Guenter and Hallek, Michael (2014). Salvage Therapy with Obinutuzumab (GA101) Plus Chlorambucil (Clb) after Treatment Failure of Clb Alone in Patients with Chronic Lymphocytic Leukemia (CLL) and Comorbidities: Results of the CLL11 Study. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Goede, Valentin, Fischer, Kirsten, Bosch, Francesc ORCID: 0000-0001-9241-2886, Follows, George, Frederiksen, Henrik ORCID: 0000-0001-8905-0220, Cuneo, Antonio, Ludwig, Heinz, Crompton, Noelle, Maurer, Joerg, Uguen, Marianne, Fingerle-Rowson, Gunter and Hallek, Michael (2015). Updated Survival Analysis from the CLL11 Study: Obinutuzumab Versus Rituximab in Chemoimmunotherapy-Treated Patients with Chronic Lymphocytic Leukemia. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Goede, Valentin, Fischer, Kirsten, Busch, Raymonde, Engelke, Anja, Eichhorst, Barbara, Wendtner, Clemens M., Chagorova, Tatiana, de la Serna, Javier, Dilhuydy, Marie-Sarah, Illmer, Thomas, Opat, Stephen, Owen, Carolyn J., Samoylova, Olga, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Doehner, Hartmut, Langerak, Anton W., Ritgen, Matthias, Kneba, Michael, Asikanius, Elina, Humphrey, Kathryn, Wenger, Michael and Hallek, Michael (2014). Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions. N. Engl. J. Med., 370 (12). S. 1101 - 1111. WALTHAM: MASSACHUSETTS MEDICAL SOC. ISSN 1533-4406

Goede, Valentin, Fischer, Kirsten and Hallek, Michael (2014). Chemoimmunotherapy for Chronic Lymphocytic Leukemia REPLY. N. Engl. J. Med., 370 (24). S. 2348 - 2350. WALTHAM: MASSACHUSETTS MEDICAL SOC. ISSN 1533-4406

Goede, Valentin, Fischer, Kirsten, Raymonde, Busch, Ulrich, Jaeger, Dilhuydy, Marie-Sarah, Wickham, Nicholas, De Guibert, Sophie, Fink, Anna Maria, Hagist, Susanne, Pflug, Natali, Bahlo, Jasmin, Kranz, Gabriele, Bieska, Gabriel, Humphrey, Kathryn, Bishop, Helen, Wenger, Michael and Hallek, Michael (2010). Chemoimmunotherapy with Chlorambucil and the Type II CD20-Antibody GA101 In Patients with Chronic Lymphocytic Leukemia and Comorbidity: Results of the Run-In Phase of the CLL11 (BO21004) Trial. Blood, 116 (21). S. 597 - 598. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Goede, Valentin and Hallek, Michael (2015). Pharmacotherapeutic Management of Chronic Lymphocytic Leukaemia in Patients with Comorbidities: New Agents, New Hope. Drugs Aging, 32 (11). S. 877 - 887. NORTHCOTE: ADIS INT LTD. ISSN 1179-1969

Goede, Valentin and Hallek, Michael (2018). Which haemato-oncological Drugs are dispensable or unsuitable in Old Age? Dtsch. Med. Wochenschr., 143 (4). S. 244 - 253. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Golfmann, Kristina, Meder, Lydia ORCID: 0000-0002-9547-5812, Koker, Mirjam, Volz, Caroline, Borchmann, Sven, Tharun, Lars, Dietlein, Felix, Malchers, Florian, Florin, Alexandra, Buettner, Reinhard, Rosen, Neal, Rodrik-Outmezguine, Vanessa, Hallek, Michael and Ullrich, Roland T. (2018). Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer. Oncogene, 37 (42). S. 5682 - 5694. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5594

Grimm, Christina ORCID: 0000-0002-4676-8870, Herling, Carmen Diana, Komnidi, Anastasia, Hussong, Michelle, Kreuzer, Karl-Anton, Hallek, Michael ORCID: 0000-0002-7425-4455 and Schweiger, Michal R. (2022). Evaluation of a Prognostic Epigenetic Classification System in Chronic Lymphocytic Leukemia Patients. Biomark. Insights, 17. LONDON: SAGE PUBLICATIONS LTD. ISSN 1177-2719

Groneck, Laura, Quaas, Alexander, Hallek, Michael, Zander, Thomas and Weihrauch, Martin R. (2016). Ultrasound-guided core needle biopsies for workup of lymphadenopathy and lymphoma. Eur. J. Haematol., 97 (4). S. 379 - 387. HOBOKEN: WILEY. ISSN 1600-0609

Grossek, Anja, Oberste, Max, Bloch, Wilhelm, Wolf, Florian, Hallek, Michael, Elter, Thomas and Zimmer, Philipp (2020). Evaluating The Suitability Of A Graded Exercise Test In Patients With Acute Leukemia Or Lymphoma. Med. Sci. Sports Exerc., 52 (17). S. 332 - 333. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1530-0315

Gruell, Henning ORCID: 0000-0002-0725-7138, Hamacher, Laura, Jennissen, Veronika ORCID: 0000-0002-8730-7712, Tuchscherer, Armin ORCID: 0000-0001-9534-4639, Ostendorf, Norbert ORCID: 0000-0002-4070-0840, Loeffler, Thorsten, Hallek, Michael ORCID: 0000-0002-7425-4455, Kochanek, Matthias ORCID: 0000-0002-4766-4651, Tannich, Egbert ORCID: 0000-0002-4714-7275, Böll, Boris ORCID: 0000-0002-6432-0981 and Fätkenheuer, Gerd ORCID: 0000-0002-5054-1871 (2017). On Taking a Different Route: An Unlikely Case of Malaria by Nosocomial Transmission. Clin. Infect. Dis., 65 (8). S. 1404 - 1407. CARY: OXFORD UNIV PRESS INC. ISSN 1537-6591

Guerreiro, Alexandra da Palma, Dorweiler, Cornelia, Halmer, Ismini, Merkel, Olaf, Hartmann, Elena Maria, Berg, Valeska, Reinart, Nina, Fingerle-Rowson, Guenter, Knittel, Gero, Pallasch, Christian, Rosenwald, Andreas, Reinhardt, Christian, Wendtner, Clemens-Martin, Hallek, Michael and Frenzel, Lukas P. (2018). FcmR Shapes BCR Signaling in IgM-Positive Leukemia. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Guerreiro, Alexandra da Palma, Dorweiler, Cornelia, Kintzele, Laurent, Baatout, Dunja, Huelsemann, Malte, Berg, Valeska, Merkel, Olaf, Reinart, Nina, Fingerle-Rowson, Guenter, Knittel, Gero, Pallasch, Christian, Reinhardt, Hans Christian, Wendtner, Clemens Martin, Hallek, Michael and Frenzel, Lukas P. (2016). Loss of TOSO Promotes Richter's Transformation of TCL1A Driven CLL. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Hallek, Michael (2021). Cellular immunotherapies. Internist, 62 (6). S. 581 - 583. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289

Hallek, Michael (2014). Choosing wisely - avoiding unnecessary medical procedures. Dtsch. Med. Wochenschr., 139 (40). S. 1975 - 1976. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Hallek, Michael (2017). Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment. Am. J. Hematol., 92 (9). S. 946 - 966. HOBOKEN: WILEY. ISSN 1096-8652

Hallek, Michael (2019). Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment. Am. J. Hematol., 94 (11). S. 1266 - 1288. HOBOKEN: WILEY. ISSN 1096-8652

Hallek, Michael (2015). Clinical Research in Germany: Cutting Red Tape dare now! Dtsch. Med. Wochenschr., 140 (7). S. 463 - 465. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Hallek, Michael (2014). Germany is to become an internationally visible Center of Innovation in Health Research. Dtsch. Med. Wochenschr., 139 (6). S. 227 - 228. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Hallek, Michael (2016). Innovation Fund: An Opportunity not to be missed! Dtsch. Med. Wochenschr., 141 (3). S. 153 - 155. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Hallek, Michael (2020). Non-cellular immunotherapy in oncology. Internist, 61 (7). S. 651 - 652. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289

Hallek, Michael (2018). On the architecture of translational research designed to control chronic lymphocytic leukemia. Hematol.-Am. Soc. Hematol. Educ. Program. S. 1 - 9. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1520-4383

Hallek, Michael (2015). One Year of ONCOLOGY RESEARCH AND TREATMENT. Oncol. Res. Treat., 38 (1-2). S. 7 - 8. BASEL: KARGER. ISSN 2296-5262

Hallek, Michael (2016). Pathogenesis, Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Exciting Times. Oncol. Res. Treat., 39 (1-2). S. 8 - 9. BASEL: KARGER. ISSN 2296-5262

Hallek, Michael (2012). Professor Hans-Joachim Schmoll - 10 Years Editor-in-Chief of ONKOLOGIE. Onkologie, 35 (12). S. 728 - 729. BASEL: KARGER. ISSN 0378-584X

Hallek, Michael (2017). Role and timing of new drugs in CLL. Hematol. Oncol., 35. S. 30 - 33. HOBOKEN: WILEY. ISSN 1099-1069

Hallek, Michael (2013). Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies. Hematol.-Am. Soc. Hematol. Educ. Program. S. 138 - 151. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1520-4383

Hallek, Michael (2013). Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies. Blood, 122 (23). S. 3723 - 3735. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Hallek, Michael (2018). Towards control of chronic lymphocytic leukemia using chemotherapy-free combinations. Hemasphere, 2. S. 51 - 53. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241

Hallek, Michael (2016). An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data. Lancet Oncol., 17 (6). S. 779 - 791. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Hallek, Michael and Al-Sawaf, Othman (2021). Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures. Am. J. Hematol., 96 (12). S. 1679 - 1706. HOBOKEN: WILEY. ISSN 1096-8652

Hallek, Michael, Cheson, Bruce D., Catovsky, Daniel, Caligaris-Cappio, Federico, Dighiero, Guillaume, Doehner, Hartmut, Hillmen, Peter, Keating, Michael J., Montserrat, Emili, Rai, Kanti R. and Kipps, Thomas J. (2010). Defining response criteria in CLL patients treated in clinical research trials Response. Blood, 116 (10). S. 1817 - 1820. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Hallek, Michael, Cheson, Bruce D., Catovsky, Daniel, Caligaris-Cappio, Federico, Dighiero, Guillermo, Doehner, Hartmut, Hillmen, Peter, Keating, Michael, Montserrat, Emili, Chiorazzi, Nicholas, Stilgenbauer, Stephan, Rai, Kanti R., Byrd, John C., Eichhorst, Barbara, O'Brien, Susan, Robak, Tadeusz, Seymour, John F. and Kipps, Thomas J. (2018). iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood, 131 (25). S. 2745 - 2761. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Hallek, Michael and Fischer, Kirsten (2016). Why this Trial Is Important to Us. Oncol. Res. Treat., 39 (1-2). S. 71 - 72. BASEL: KARGER. ISSN 2296-5262

Hallek, Michael, Fraser, Graeme, Cramer, Paula, Demirkan, Fatih ORCID: 0000-0002-1172-8668, Silva, Rodrigo Santucci, Grosicki, Sebastian, Janssens, Ann, Pristupa, Aleksander, Mayer, Jiri, Dilhuydy, Marie Sarah, Loscertales, Javier, Bartlett, Nancy, Avigdor, Abraham, Rule, Simon, Sun, Steven, Mahler, Michelle, Phelps, Charles, Salman, Mariya, Howes, Angela and Chanan-Khan, Asher (2017). Three-year follow-up of patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) receiving ibrutinib plus bendamustine and rituximab (BR) versus placebo plus BR: an update of the HELIOS study. Leuk. Lymphoma, 58. S. 192 - 195. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Hallek, Michael and Furstenau, Moritz (2019). How to approach CLL in clinical practice. Hematol. Oncol., 37. S. 38 - 43. HOBOKEN: WILEY. ISSN 1099-1069

Hallek, Michael, Kay, Neil E., Osterborg, Anders, Chanan-Khan, Asher A., Mahler, Michelle, Salman, Mariya, Wan, Ying, Sun, Steven, Zhuang, Sen Hong and Howes, Angela (2015). The HELIOS trial protocol: a Phase III study of ibrutinib in combination with bendamustine and rituximab in relapsed/refractory chronic lymphocytic leukemia. Future Oncol., 11 (1). S. 51 - 60. LONDON: FUTURE MEDICINE LTD. ISSN 1744-8301

Hallek, Michael, Ockenfels, Axel ORCID: 0000-0003-1456-0191 and Wiesen, Daniel ORCID: 0000-0003-4627-1730 (2022). Behavioral economics interventions to improve medical decision-making. Deutsches Ärzteblatt international, 38. pp. 633-639. Dt. Ärzte-Verl.. ISSN 1866-0452

Hallek, Michael, Ockenfels, Axel ORCID: 0000-0003-1456-0191 and Wiesen, Daniel ORCID: 0000-0003-4627-1730 (2022). Einsatz verhaltensökonomischer Interventionen zur Verbesserung ärztlicher Entscheidungen. Deutsches Ärzteblatt, 119 (38). pp. 633-639. Dt. Ärzte-Verl.. ISSN 0012-1207 Open Access

Hallek, Michael and Pflug, Natali (2010). Chronic lymphocytic leukemia. Ann. Oncol., 21. S. 154 - 165. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041

Hallek, Michael ORCID: 0000-0002-7425-4455 and Riemann, J. F. (2022). What is the State of Prevention in Germany? Interview with Prof. Dr. Michael Hallek, Director of Internal Medicine Clinic I at the University Hospital Cologne and Director of the Center for Integrated Oncology CIO Aachen-Bonn-Cologne-Duesseldorf. Gastroenterologe, 17 (3). S. 219 - 222. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1861-969X

Hallek, Michael, Shanafelt, Tait D. and Eichhorst, Barbara (2018). Chronic lymphocytic leukaemia. Lancet, 391 (10129). S. 1524 - 1538. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X

Hansen, Hinrich P., Engels, Hanna-Mareike, Dams, Maria, Paes Leme, Adriana F., Pauletti, Bianca Alves, Simhadri, Vijaya Lakshmi, Duerkop, Horst, Reiners, Katrin S., Barnert, Sabine, Engert, Andreas, Schubert, Rolf, Quondamatteo, Fabio, Hallek, Michael and von Strandmann, Elke Pogge (2014). Protrusion-guided extracellular vesicles mediate CD30 trans-signalling in the microenvironment of Hodgkin's lymphoma. J. Pathol., 232 (4). S. 405 - 415. HOBOKEN: WILEY. ISSN 1096-9896

Hansen, Hinrich P., Leme, Adriana F. Paes and Hallek, Michael (2020). Role of ADAM10 as a CD30 Sheddase in Classical Hodgkin Lymphoma. Front. Immunol., 11. LAUSANNE: FRONTIERS MEDIA SA. ISSN 1664-3224

Hansen, Hinrich P., Trad, Ahmad, Dams, Maria, Zigrino, Paola ORCID: 0000-0002-7470-0064, Moss, Marcia, Tator, Maximilian, Schoen, Gisela, Grenzi, Patricia C., Bachurski, Daniel ORCID: 0000-0001-9168-9680, Aquino, Bruno, Duerkop, Horst, Reiners, Katrin S., von Bergwelt-Baildon, Michael, Hallek, Michael, Groetzinger, Joachim, Engert, Andreas, Paes Leme, Adriana F. and von Strandmann, Elke Pogge (2016). CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro. Oncotarget, 7 (21). S. 30523 - 30536. ORCHARD PARK: IMPACT JOURNALS LLC. ISSN 1949-2553

Hassenrueck, Floyd, Knoedgen, Eva, Goeckeritz, Elisa, Midda, Safi Hasan ORCID: 0000-0002-2822-6293, Vondey, Verena, Neumann, Lars, Herter, Sylvia, Klein, Christian ORCID: 0000-0001-7594-7280, Hallek, Michael and Krause, Guenter (2018). Sensitive Detection of the Natural Killer Cell-Mediated Cytotoxicity of Anti-CD20 Antibodies and Its Impairment by B-Cell Receptor Pathway Inhibitors. Biomed Res. Int., 2018. LONDON: HINDAWI LTD. ISSN 2314-6141

Heger, Jan-Michel, Mattlener, Julia, Godel, Philipp, Balke-Want, Hyatt, Sieg, Noelle, Kutsch, Nadine, Becker, Kerstin, Weiss, Jonathan, Reinhardt, H. Christian, Hallek, Michael, Borchmann, Peter, von Tresckow, Bastian and Borchmann, Sven (2022). Noninvasive, Dynamic Risk Profiling of Primary Central Nervous System Lymphoma By Peripheral Blood Ctdna-Sequencing. Blood, 140. S. 3537 - 3539. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Heimann, Sebastian M., Cornely, Oliver A., Vehreschild, Maria J. G. T., Glossmann, Jan, Kochanek, Matthias, Kreuzer, Karl-Anton, Hallek, Michael and Vehreschild, Joerg J. (2014). Treatment cost development of patients undergoing remission induction chemotherapy: a pharmacoeconomic analysis before and after introduction of posaconazole prophylaxis. Mycoses, 57 (2). S. 90 - 98. HOBOKEN: WILEY. ISSN 1439-0507

Held, Gerhard, Zeynalova, Samira, Murawski, Niels, Ziepert, Marita, Kempf, Barbara, Viardot, Andreas, Dreyling, Martin, Hallek, Michael, Witzens-Harig, Mathias ORCID: 0000-0002-2799-4661, Fleckenstein, Jochen, Ruebe, Christian, Zwick, Carsten, Glass, Bertram, Schmitz, Norbert and Pfreundschuh, Michael (2013). Impact of Rituximab and Radiotherapy on Outcome of Patients With Aggressive B-Cell Lymphoma and Skeletal Involvement. J. Clin. Oncol., 31 (32). S. 4115 - 4126. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Hellmich, Silke, Schreiber, Natalie, Fath, Birgit and Hallek, Michael (2016). Progress due to networking structures. Challenges for the Competence Network Malignant Lymphomas in the Era of Precision Medicine. Bundesgesundheitsblatt-Gesund., 59 (4). S. 454 - 465. NEW YORK: SPRINGER. ISSN 1437-1588

Herling, Carmen D., Abedpour, Nima, Weiss, Jonathan, Schmitt, Anna, Jachimowicz, Ron Daniel, Merkel, Olaf ORCID: 0000-0001-5089-344X, Cartolano, Maria, Oberbeck, Sebastian, Mayer, Petra, Berg, Valeska, Thomalla, Daniel, Kutsch, Nadine, Stiefelhagen, Marius, Cramer, Paula, Wendtner, Clemens-Martin ORCID: 0000-0003-2866-2260, Persigehl, Thorsten, Saleh, Andreas, Altmueller, Janine, Nuernberg, Peter, Pallasch, Christian, Achter, Viktor, Lang, Ulrich, Eichhorst, Barbara, Castiglione, Roberta ORCID: 0000-0002-9828-4405, Schaefer, Stephan C., Buettner, Reinhard, Kreuzer, Karl-Anton, Reinhardt, Hans Christian, Hallek, Michael, Frenzel, Lukas P. and Peifer, Martin ORCID: 0000-0002-5243-5503 (2018). Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia. Nat. Commun., 9. LONDON: NATURE PUBLISHING GROUP. ISSN 2041-1723

Herling, Carmen D., Coombes, Kevin R., Benner, Axel, Bloehdorn, Johannes, Barron, Lynn L., Abrams, Zachary B., Majewski, Tadeusz, Bondaruk, Jolanta E., Bahlo, Jasmin, Fischer, Kirsten, Hallek, Michael, Stilgenbauer, Stephan, Czerniak, Bogdan A., Oakes, Christopher C., Ferrajoli, Alessandra, Keating, Michael J. and Abruzzo, Lynne V. (2019). Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort study. Lancet Oncol., 20 (11). S. 1576 - 1587. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Herling, Carmen D., Cymbalista, Florence, Gross-Ophoff-Mueller, Carolin, Bahlo, Jasmin, Robrecht, Sandra, Langerbeins, Petra, Fink, Anna-Maria, Al-Sawaf, Othman, Busch, Raymonde, Porcher, Raphael ORCID: 0000-0002-5277-4679, Cazin, Bruno, Dreyfus, Brigitte, Ibach, Stefan, Lepretre, Stephane, Fischer, Kirsten, Kaiser, Florian, Eichhorst, Barbara, Wentner, Clemens-Martin, Hoechstetter, Manuela A., Doehner, Hartmut, Leblond, Veronique, Kneba, Michael, Letestu, Remi, Boettcher, Sebastian, Stilgenbauer, Stephan, Hallek, Michael and Levy, Vincent (2020). Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial. Leukemia, 34 (8). S. 2038 - 2051. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Herling, Carmen Diana, Klaumuenzer, Marion, Rocha, Cristiano Krings, Altmueller, Janine, Thiele, Holger, Bahlo, Jasmin, Kluth, Sandra, Crispatzu, Giuliano, Herling, Marco, Schiller, Joanna, Engelke, Anja, Tausch, Eugen, Doehner, Hartmut, Fischer, Kirsten, Goede, Valentin, Nuernberg, Peter, Reinhardt, Hans Christian, Stilgenbauer, Stephan, Hallek, Michael and Kreuzer, Karl-Anton (2016). Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy. Blood, 128 (3). S. 395 - 405. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Hermine, Olivier ORCID: 0000-0003-2574-3874, Hoster, Eva ORCID: 0000-0002-0749-1389, Walewski, Jan ORCID: 0000-0003-4247-2674, Bosly, Andre, Stilgenbauer, Stephan, Thieblemont, Catherine ORCID: 0000-0002-9941-2448, Szymczyk, Michal, Bouabdallah, Reda, Kneba, Michael, Hallek, Michael, Salles, Gilles ORCID: 0000-0002-9541-8666, Feugier, Pierre, Ribrag, Vincent, Birkmann, Josef, Forstpointner, Roswitha, Haioun, Corinne, Haenel, Mathias, Casasnovas, Rene Olivier, Finke, Juergen, Peter, Norma, Bouabdallah, Kamal, Sebban, Catherine, Fischer, Thomas, Duehrsen, Ulrich, Metzner, Bernd, Maschmeyer, Georg, Kanz, Lothar, Schmidt, Christian, Delarue, Richard, Brousse, Nicole, Klapper, Wolfram, Macintyre, Elizabeth, Delfau-Larue, Marie-Helene, Pott, Christiane, Hiddemann, Wolfgang, Unterhalt, Michael and Dreyling, Martin (2016). Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network. Lancet, 388 (10044). S. 565 - 576. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X

Hermine, Olivier, Hoster, Eva, Walewski, Jan, Ribrag, Vincent, Brousse, Nicole, Thieblemont, Catherine ORCID: 0000-0002-9941-2448, Bouabdallah, Reda, Dohner, Hartrnut, Feugier, Pierre, Forspointner, Roswitha, Haioun, Corinne, Kneba, Michael, Haenel, Mathias, Casasnovas, Olivier, Mertelsmann, Roland H., Hallek, Michael, Bosly, Andre, Nowacki, M., Klapper, Wolfram, Gisselbrecht, Christian, Coiffier, Bertrand, Unterhalt, Michael, Hiddemann, Wolfgang and Dreyling, Martin H. (2012). Alternating Courses of 3x CHOP and 3x DHAP Plus Rituximab Followed by a High Dose ARA-C Containing Myeloablative Regimen and Autologous Stem Cell Transplantation (ASCT) Increases Overall Survival When Compared to 6 Courses of CHOP Plus Rituximab Followed by Myeloablative Radiochemotherapy and ASCT in Mantle Cell Lymphoma: Final Analysis of the MCL Younger Trial of the European Mantle Cell Lymphoma Network (MCL net). Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Hieber, Marie-Lisa, Sprute, Rosanne ORCID: 0000-0003-2457-6437, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Hallek, Michael ORCID: 0000-0002-7425-4455 and Jachimowicz, Ron D. (2022). Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination. Infection, 50 (5). S. 1399 - 1405. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-0973

Hoechstetter, Manuela A., Busch, Raymonde, Eichhorst, Barbara, Buhler, Andreas, Winkler, Dirk, Bahlo, Jasmin, Robrecht, Sandra, Eckart, Michael J., Vehling-Kaiser, Ursula, Jacobs, Georg, Jaeger, Ulrich, Hurtz, Hans Juergen, Hopfinger, Georg, Hartmann, Frank, Fuss, Harald, Abenhardt, Wolfgang, Blau, Ilona, Freier, Werner, Mueller, Lothar, Goebeler, Maria, Wendtner, Clemens, Fischer, Kirsten, Herling, Carmen D., Starck, Michael, Bentz, Martin, Emmerich, Bertold, Doehner, Hartmut, Stilgenbauer, Stephan and Hallek, Michael (2020). Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group. Leukemia, 34 (4). S. 1038 - 1052. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Holtick, Udo, Chemnitz, Jens-Markus, Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, Theurich, Sebastian ORCID: 0000-0001-5706-8258, Chakupurakal, Geothy, Krause, Anke, Fiedler, Anne, Luznik, Leo, Hellmich, Martin, Wolf, Dominik, Hallek, Michael, von Bergwelt-Baildon, Michael and Scheid, Christof (2016). OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation. Eur. J. Haematol., 96 (1). S. 27 - 36. HOBOKEN: WILEY. ISSN 1600-0609

Holtick, Udo, Herling, Marco, Frenzel, Lukas P., Herling, Carmen, Schiller, Joanna, Aguilar, Marta Rebecca Cruz, Theurich, Sebastian, Hallek, Michael and Scheid, Christof (2020). A Phase II Study to Investigate the Efficacy of shortterm Everolimus in Addition to post-transplant Cyclophosphamide as graft-versus-host-prophylaxis after Allogeneic Stem Cell Transplantation (Octet-ever). Bone Marrow Transplant., 55 (SUPPL 1). S. 290 - 292. LONDON: SPRINGERNATURE. ISSN 1476-5365

Holtick, Udo, Herling, Marco, Pflug, Natali, Chakupurakal, Geothy, Leitzke, Silke, Wolf, Dominik, Hallek, Michael, Scheid, Christof and Chemnitz, Jens M. (2017). Similar outcome after allogeneic stem cell transplantation with a modified FLAMSA conditioning protocol substituting 4 Gy TBI with treosulfan in an elderly population with high-risk AML. Ann. Hematol., 96 (3). S. 479 - 488. NEW YORK: SPRINGER. ISSN 1432-0584

Holtick, Udo, Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, Chakupurakal, Geothy, Theurich, Sebastian ORCID: 0000-0001-5706-8258, Leitzke, Silke, Burst, Anke, Hallek, Michael, von Bergwelt-Baildon, Michael, Scheid, Christof and Chemnitz, Jens M. (2016). FLAMSA reduced-intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remission. Eur. J. Haematol., 96 (5). S. 475 - 483. HOBOKEN: WILEY. ISSN 1600-0609

Holtick, Udo, Shimabukuro-Vornhagen, Alexander, Chakupurakal, Geothy, Theurich, Sebastian, Leitzke, Silke, Wolf, Dominik, Hallek, Michael, von Bergwelt-Baildon, Michael S., Scheid, Christof and Chemnitz, Jens (2014). Flamsa Reduced-Intensity Conditioning Regimen in AML Patients - Role of Re-Induction and Disease State Prior to Transplant. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Hoster, Eva ORCID: 0000-0002-0749-1389, Klapper, Wolfram, Hermine, Olivier ORCID: 0000-0003-2574-3874, Kluin-Nelemans, Hanneke C., Walewski, Jan ORCID: 0000-0003-4247-2674, van Hoof, Achiel, Trneny, Marek ORCID: 0000-0002-6952-6073, Geisler, Christian H., Di Raimondo, Francesco, Szymczyk, Michal, Stilgenbauer, Stephan, Thieblemont, Catherine ORCID: 0000-0002-9941-2448, Hallek, Michael, Forstpointner, Roswitha, Pott, Christiane, Ribrag, Vincent, Doorduijn, Jeanette, Hiddemann, Wolfgang, Dreyling, Martin H. and Unterhalt, Michael (2014). Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network. J. Clin. Oncol., 32 (13). S. 1338 - 1347. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Hoster, Eva ORCID: 0000-0002-0749-1389, Rosenwald, Andreas, Berger, Francoise, Bernd, Heinz-Wolfram, Hartmann, Sylvia, Loddenkemper, Christoph, Barth, Thomas F. E., Brousse, Nicole, Pileri, Stefano, Rymkiewicz, Grzegorz ORCID: 0000-0002-3478-8014, Kodet, Roman, Stilgenbauer, Stephan, Forstpointner, Roswitha, Thieblemont, Catherine ORCID: 0000-0002-9941-2448, Hallek, Michael, Coiffier, Bertrand, Vehling-Kaiser, Ursula, Bouabdallah, Reda, Kanz, Lothar, Pfreundschuh, Michael, Schmidt, Christian, Ribrag, Vincent, Hiddemann, Wolfgang, Unterhalt, Michael, Kluin-Nelemans, Johanna C., Hermine, Olivier ORCID: 0000-0003-2574-3874, Dreyling, Martin H. and Klapper, Wolfram (2016). Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network. J. Clin. Oncol., 34 (12). S. 1386 - 1396. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Hoster, Eva, Unterhalt, Michael, Pfreundschuh, Michael, Hallek, Michael, Forstpointner, Roswitha, Metzner, Bernd, Einsele, Hermann, Krauter, Juergen, Duehrsen, Ulrich, Ludwig, Wolf-Dieter, Birkmann, Josef, Peter, Norma, Klapper, Wolfram, Dreyling, Martin H. and Hiddemann, Wolfgang (2014). The Addition of Rituximab to CHOP Improves Failure-Free and Overall Survival of Mantle-Cell Lymphoma Patients - a Pooled Trials Analysis of the German Low-Grade Lymphoma Study Group (GLSG). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Huber, Henriette, Edenhofer, Simone, von Tresckow, Julia, Robrecht, Sandra, Zhang, Can, Tausch, Eugen, Schneider, Christof, Bloehdorn, Johannes ORCID: 0000-0003-1433-9702, Fuerstenau, Moritz, Dreger, Peter, Ritgen, Matthias, Illmer, Thomas, Illert, Anna L., Duerig, Jan, Boettcher, Sebastian, Niemann, Carsten U., Kneba, Michael, Fink, Anna-Maria, Fischer, Kirsten, Doehner, Hartmut, Hallek, Michael ORCID: 0000-0002-7425-4455, Eichhorst, Barbara and Stilgenbauer, Stephan (2022). Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia. Blood, 139 (9). S. 1318 - 1330. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Huber, Henriette, Tausch, Eugen, Schneider, Christof, Edenhofer, Simone, Von Tresckow, Julia, Robrecht, Sandra, Giza, Adam, Zhang, Can, Furstenau, Moritz, Dreger, Peter, Ritgen, Matthias, Illmer, Thomas, Illert, Anna Lena, Duerig, Jan, Boettcher, Sebastian, Niemann, Carsten Utoft, Kneba, Michael, Fink, Anna-Maria, Fischer, Kirsten, Doehner, Hartmut, Hallek, Michael, Eichhorst, Barbara and Stilgenbauer, Stephan (2022). Final Analysis of the Prospective Multicenter CLL2-Give Trial of Obinutuzumab (GA101, G), Ibrutinib (I), and Venetoclax (Ve) in Untreated Patients with CLL with 17p Deletion/TP53 Mutation. Blood, 140. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Huelsemann, Malte F., Patz, Michaela, Beckmann, Laura, Brinkmann, Kerstin, Otto, Teresa, Fandrey, Joachim, Becker, Hans Jiro, Theurich, Sebastian, von Bergwelt-Baildon, Michael S., Pallasch, Christian P., Zahedi, Rene P., Kashkar, Hamid, Reinhardt, Christian, Hallek, Michael, Wendtner, Clemens-Martin and Frenzel, Lukas P. (2014). p38 MAPK Controls Sensitivity Towards BH3 Mimetics By Regulating Mcl-1 Expression of Chronic Lymphocytic Leukemia in Hypoxia and Acquired Resistance. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Izquierdo, Elena, Vorholt, Daniela, Blakemore, Stuart, Sackey, Benedict ORCID: 0000-0003-1016-7720, Nolte, Janica L., Barbarino, Verena, Schmitz, Jan, Nickel, Nadine, Bachurski, Daniel ORCID: 0000-0001-9168-9680, Lobastova, Liudmila, Nikolic, Milos, Michalik, Michael, Brinker, Reinhild, Merkel, Olaf, Franitza, Marek, Georgomanolis, Theodoros, Neuhaus, Rene, Koch, Maximilian, Nasada, Niklas, Knittel, Gero, Chapuy, Bjoern ORCID: 0000-0002-6485-8773, Ludwig, Nicole, Meese, Eckart, Frenzel, Lukas, Reinhardt, Hans Christian, Peifer, Martin ORCID: 0000-0002-5243-5503, Rebollido-Rios, Rocio, Bruns, Heiko, Krueger, Marcus, Hallek, Michael and Pallasch, Christian P. (2022). Extracellular vesicles and PD-L1 suppress macrophages, inducing therapy resistance in TP53-deficient B-cell malignancies. Blood, 139 (25). S. 3617 - 3630. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Jacob, Anne Sophie, Kaul, Helen, Fuchs, Michael, Gillessen, Sarah, Kreissl, Stefanie, Pluetschow, Annette, Momotow, Jesko, Schaub, Valdete, Huettmann, Andreas, Haenel, Mathias, Zimmermann, Andreas, Dierlamm, Judith, Meissner, Julia, Mathas, Stephan, Martin, Sonja, Engert, Andreas, Hallek, Michael ORCID: 0000-0002-7425-4455, Borchmann, Peter and Lehmann, Clara (2022). Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma. Infection, 50 (4). S. 925 - 933. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-0973

Jakob, Carolin E. M., Classen, Annika Y., Stecher, Melanie, Engert, Andreas, Freund, Meike, Hamprecht, Axel ORCID: 0000-0003-1449-5780, Jazmati, Nathalie, Wisplinghoff, Hilmar, Hallek, Michael, Cornely, Oliver A. and Vehreschild, Joerg J. (2021). Association between the dietary regimen and infection-related complications in neutropenic high-risk patients with cancer. Eur. J. Cancer, 155. S. 281 - 291. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Jakobs, Florian, Drost, Ruben M. W. A., Kron, Anna, Heinen, Julia, Hallek, Michael, Reinhardt, Hans Christian, Zander, Thomas and Kron, Florian (2020). Economic Impact of the Introduction of Outpatient Medical Specialist Care (ASV) of Gastrointestinal Cancer Patients from a German Hospital Management Perspective. Oncol. Res. Treat., 43 (10). S. 498 - 505. BASEL: KARGER. ISSN 2296-5262

Jaramillo, Sonia, Agathangelidis, Andreas, Schneider, Christof, Bahlo, Jasmin, Robrecht, Sandra, Tausch, Eugen, Bloehdorn, Johannes, Hoechstetter, Manuela, Fischer, Kirsten, Eichhorst, Barbara, Goede, Valentin, Hallek, Michael, Doehner, Hartmut, Rosenquist, Richard, Ghia, Paolo, Stamatopoulos, Kostas and Stilgenbauer, Stephan (2020). Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group. Haematologica, 105 (11). S. 2598 - 2608. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Jebaraj, Billy Michael Chelliah, Tausch, Eugen, Landau, Dan A., Bahlo, Jasmin, Robrecht, Sandra, Taylor-Weiner, Amaro N., Bloehdorn, Johannes, Scheffold, Annika, Mertens, Daniel ORCID: 0000-0003-0227-7188, Boettcher, Sebastian, Kneba, Michael, Jaeger, Ulrich, Zenz, Thorsten, Wenger, Michael K., Fingerle-Rowson, Guenter, Wendtner, Clemens, Fink, Anna-Maria, Wu, Catherine J., Eichhorst, Barbara, Fischer, Kirsten, Hallek, Michael, Doehner, Hartmut and Stilgenbauer, Stephan (2019). Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia. Leukemia, 33 (9). S. 2183 - 2195. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Jenke, Petra, Eichhorst, Barbara, Busch, Raymonde, Anheier, Nadine, Duehrsen, Ulrich, Duerig, Jan, Dreyling, Martin H., Bergmann, Manuela, Goebeler, Maria Elisabeth, Hurts, Hans Juergen, Stauch, Martina Beate, Stilgenbauer, Stephan, Doehner, Hartmut, Fink, Anna-Maria, Fischer, Kirsten, Wendtner, Clemens-Martin and Hallek, Michael (2011). Cyclophosphamide, Adriamycin, Vincristine and Prednisone Plus Rituximab (CHOP-R) in Fludarabine (F) Refractory Chronic Lymphocytic Leukemia (CLL) or CLL with Autoimmune Cytopenia (AIC) or Richter's Transformation (RT): Final Analysis of a Phase II Study of the German CLL Study Group. Blood, 118 (21). S. 1233 - 1235. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Jenniches, Imke, Lemmen, Clarissa ORCID: 0000-0001-9205-6551, Cwik, Jan Christopher ORCID: 0000-0002-2290-353X, Kusch, Michael, Labouvie, Hildegard, Scholten, Nadine ORCID: 0000-0002-7793-7745, Gerlach, Alexander L. ORCID: 0000-0001-6794-5349, Stock, Stephanie ORCID: 0000-0002-1726-9300, Samel, Christina, Hagemeier, Anna, Hellmich, Martin ORCID: 0000-0001-5174-928X, Haas, Peter, Hallek, Michael ORCID: 0000-0002-7425-4455, Pfaff, Holger ORCID: 0000-0001-9154-6575 and Dresen, Antje ORCID: 0000-0001-7684-9391 (2020). Evaluation of a complex integrated, cross-sectoral psycho-oncological care program (isPO): a mixed-methods study protocol. BMJ Open, 10 (3). e034141. BMJ Publ. Group. ISSN 2044-6055

Jung, Norma, Hellmann, Matthias, Hoheisel, Reimund, Lehmann, Clara ORCID: 0000-0002-7042-1578, Haase, Ingo, Perniok, Andreas, Hallek, Michael and Rubbert, Andrea (2010). An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX). Clin. Rheumatol., 29 (10). S. 1169 - 1174. LONDON: SPRINGER LONDON LTD. ISSN 1434-9949

Kaddu-Mulindwa, Dominic, Altmann, Bettina, Robrecht, Sandra, Ziepert, Morita, Regitz, Evi, Tausch, Eugen, Held, Gerhard, Poeschel, Viola, Lesan, Vadim, Bittenbring, Joerg Thomas ORCID: 0000-0003-3864-8315, Thurner, Lorenz, Pfreundschuht, Michael, Christofyllakis, Konstantinos ORCID: 0000-0002-0308-388X, Truemper, Lorenz, Loeffler, Markus, Schmitz, Norbert, Hoth, Markus ORCID: 0000-0001-7080-4643, Hallek, Michael ORCID: 0000-0002-7425-4455, Fischer, Kirsten, Stilgenbauer, Stephan, Bewarder, Moritz and Rixecker, Torben Millard (2022). KIR2DS1-HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trials. Lancet Haematol., 9 (2). S. E133 - 10. OXFORD: ELSEVIER SCI LTD. ISSN 2352-3026

Kajueter, Hiltraud, Wellmann, Ina, Khil, Laura, Jockel, Karl-Heinz, Zhang, Can, Fink, Anna-Maria, Hallek, Michael and Stang, Andreas (2021). Survival of patients with chronic lymphocytic leukemia before and after the introduction of chemoimmunotherapy in Germany. Blood Cancer J., 11 (10). LONDON: SPRINGERNATURE. ISSN 2044-5385

Kipps, Thomas J., Fraser, Graeme, Coutre, Steven E., Brown, Jennifer R., Barrientos, Jacqueline C., Barr, Paul M., Byrd, John C., O'Brien, Susan M., Dilhuydy, Marie-Sarah, Hillmen, Peter, Jaeger, Ulrich, Moreno, Carol, Cramer, Paula, Stilgenbauer, Stephan, Chanan-Khan, Asher A., Mahler, Michelle, Salman, Mariya, Eckert, Karl, Solman, Isabelle G., Balasubramanian, Sriram, Cheng, Mei, Londhe, Anil, Ninomoto, Joi, Howes, Angela, James, Danelle F. and Hallek, Michael (2019). Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia. Clin. Lymphoma Myeloma Leuk., 19 (11). S. 715 - 729. DALLAS: CIG MEDIA GROUP, LP. ISSN 2152-2669

Kipps, Thomas J., Hillmen, Peter, Demirkan, Fatih ORCID: 0000-0002-1172-8668, Grosicki, Sebastian, Coutre, Steven E., Barrientos, Jacqueline C., Barr, Paul M., Janssens, Ann, Byrd, John C., O'Brien, Susan M., Fraser, Graeme, Jaeger, Ulrich, Cramer, Paula, Stilgenbauer, Stephan, Chanan-Khan, Asher A., Salman, Mariya, Solman, Isabelle, Cheng, Mei, Phelps, Charles, Ninomoto, Joi, Howes, Angela, James, Danelle F. and Hallek, Michael (2016). 11q Deletion (del11q) Is Not a Prognostic Factor for Adverse Outcomes for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Treated with Ibrutinib: Pooled Data from 3 Randomized Phase 3 Studies. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kipps, Thomas J., Mahler, Michelle, Fraser, Graeme, Coutre, Steven, Brown, Jennifer, Barrientos, Jacqueline, Barr, Paul ORCID: 0000-0002-9733-401X, Byrd, John C., O'Brien, Susan, Dilhuydy, Marie Sarah, Jaeger, Ulrich, Moreno, Carol, Cramer, Paula, Stilgenbauer, Stephan, Chanan-Khan, Asher, Salman, Mariya, Cheng, Mei, Londhe, Anil, Ninomoto, Joi, Howes, Angela, James, Danelle, Hallek, Michael and Hillmen, Peter (2017). Outcomes of ibrutinib-treated patients with chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL) with high-risk prognostic factors in an integrated analysis of 3 randomized phase 3 studies. Leuk. Lymphoma, 58. S. 10 - 13. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Klaeger, Susan, Tausch, Eugen, Knisbacher, Binyamin A., Apffel, Annie, Clauser, Karl R., Williams, Corinne, Clish, Clary, Rassenti, Laura Z., Kipps, Thomas J., Fischer, Kirsten, Hallek, Michael, Gillette, Michael A., Neuberg, Donna S., Getz, Gad, Mani, Dr, Stilgenbauer, Stephan, Wu, Catherine J. and Carr, Steven A. (2022). Proteogenomic Analysis of SF3B1mut CLL Reveals Altered Protein Signaling Cascades and Metabolomic Pathways. Blood, 140. S. 9838 - 9840. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Knisbacher, Binyamin A., Lin, Ziao ORCID: 0000-0002-8495-6995, Hahn, Cynthia K., Nadeu, Ferran ORCID: 0000-0003-2910-9440, Duran-Ferrer, Marti ORCID: 0000-0003-1666-5819, Stevenson, Kristen E., Tausch, Eugen, Delgado, Julio ORCID: 0000-0002-5157-4376, Barbera-Mourelle, Alex, Taylor-Weiner, Amaro, Bousquets-Munoz, Pablo, Diaz-Navarro, Ander, Dunford, Andrew, Anand, Shankara, Kretzmer, Helene ORCID: 0000-0002-0723-4980, Gutierrez-Abril, Jesus, Lopez-Tamargo, Sara, Fernandes, Stacey M., Sun, Clare, Sivina, Mariela, Rassenti, Laura Z., Schneider, Christof, Li, Shuqiang, Parida, Laxmi, Meissner, Alexander, Aguet, Francois, Burger, Jan A., Wiestner, Adrian, Kipps, Thomas J., Brown, Jennifer R., Hallek, Michael ORCID: 0000-0002-7425-4455, Stewart, Chip, Neuberg, Donna S., Martin-Subero, Jose, I, Puente, Xose S., Stilgenbauer, Stephan, Wu, Catherine J., Campo, Elias and Getz, Gad (2022). Molecular map of chronic lymphocytic leukemia and its impact on outcome. Nature Genet., 54 (11). S. 1664 - 1695. BERLIN: NATURE PORTFOLIO. ISSN 1546-1718

Knittel, Gero, Rehkaemper, Tim, Korovkina, Darya, Liedgens, Paul, Fritz, Christian, Torgovnick, Alessandro, Al-Baldawi, Yussor, Al-Maarri, Mona, Cun, Yupeng ORCID: 0000-0002-4241-8099, Fedorchenko, Oleg, Riabinska, Arina, Beleggia, Filippo ORCID: 0000-0003-0234-7094, Wunderlich, F. Thomas, Ortmann, Monika, Montesinos-Rongen, Manuel, Tausch, Eugen, Stilgenbauer, Stephan, Frenzel, Lukas P., Herling, Marco, Herling, Carmen, Bahlo, Jasmin, Hallek, Michael, Peifer, Martin ORCID: 0000-0002-5243-5503, Buettner, Reinhard, Persigehl, Thorsten and Reinhardt, H. Christian (2017). Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia. Nat. Commun., 8. LONDON: NATURE PUBLISHING GROUP. ISSN 2041-1723

Knuever, Jana, Weiss, Jonathan, Persa, Oana-Diana, Kreuzer, Karl, Mauch, Cornelia, Hallek, Michael and Schlaak, Max (2020). The use of circulating cell-free tumor DNA in routine diagnostics of metastatic melanoma patients. Sci Rep, 10 (1). LONDON: NATURE PUBLISHING GROUP. ISSN 2045-2322

Koch, Maximilian, Hallek, Michael and Nguyen, Phuong-Hien (2020). Significant sex differences in CLL progression in the Em-TCL1 transgenic mouse model. Leuk. Lymphoma, 61. S. 237 - 239. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Koch, Maximilian, Reinartz, Sebastian, Saggau, Julia, Knittel, Gero, Rosen, Natascha, Fedorchenko, Oleg, Thelen, Lisa, Barthel, Romy, Reinart, Nina, Seeger-Nukpezah, Tamina, Reinhardt, Hans Christian, Hallek, Michael and Nguyen, Phuong-Hien (2020). Meta-Analysis Reveals Significant Sex Differences in Chronic Lymphocytic Leukemia Progression in theE mu-TCL1Transgenic Mouse Model. Cancers, 12 (7). BASEL: MDPI. ISSN 2072-6694

Kochanek, Matthias ORCID: 0000-0002-4766-4651, Kochanek, Jan, Boell, Boris, Eichenauer, Dennis A., Beutel, Gernot, Bracht, Hendrik, Braune, Stephan, Eisner, Florian, Friesecke, Sigrun, Guenther, Ulf, Heinz, Gottfried, Hallek, Michael ORCID: 0000-0002-7425-4455, Karagiannidis, Christian, Kluge, Stefan, Kogelmann, Klaus, Lebiedz, Pia, Lepper, Philipp M., Liebregts, Tobias, Lueck, Catherina, Muellenbach, Ralf M., Hansen, Matthias, Putensen, Christian, Schellongowski, Peter, Schewe, Jens-Christian, Schumann-Stoiber, Kathrin, Seiler, Frederik, Spieth, Peter ORCID: 0000-0003-3953-3253, Weber-Carstens, Steffen, Brodie, Daniel, Azoulay, Elie and Shimabukuro-Vornhagen, Alexander (2022). Veno-venous extracorporeal membrane oxygenation (vv-ECMO) for severe respiratory failure in adult cancer patients: a retrospective multicenter analysis. Intensive Care Med., 48 (3). S. 332 - 343. NEW YORK: SPRINGER. ISSN 1432-1238

Koehler, Philipp ORCID: 0000-0002-7386-7495, Cornely, Oliver A., Boettiger, Bernd W., Dusse, Fabian ORCID: 0000-0001-7762-6966, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Fuchs, Frieder ORCID: 0000-0001-7075-5378, Hallek, Michael, Jung, Norma, Klein, Florian, Persigehl, Thorsten, Rybniker, Jan, Kochanek, Matthias ORCID: 0000-0002-4766-4651, Boell, Boris and Shimabukuro-Vornhagen, Alexander (2020). COVID-19 associated pulmonary aspergillosis. Mycoses, 63 (6). S. 528 - 535. HOBOKEN: WILEY. ISSN 1439-0507

Kohlhas, Viktoria, Hallek, Michael and Nguyen, Phuong-Hien (2020). Constitutive activation of Lyn kinase enhances BCR responsiveness, but not the development of CLL in E mu-TCL1 mice. Blood Adv., 4 (24). S. 6106 - 6117. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 2473-9537

Kovacs, Gabor, Bahlo, Jasmin, Kluth, Sandra, Cramer, Paula, Fink, Anna-Maria, Fischer, Kirsten, Gross-Ophoff-Mueller, Carolin, Langerbeins, Petra, Maurer, Christian, von Tresckow, Julia, Wendtner, Clemens-Martin, Stilgenbauer, Stephan, Hallek, Michael, Eichhorst, Barbara and Goede, Valentin (2015). Prognostic Impact and Risk Factors of Reducing Prescribed Doses of Fludarabine, Cyclophosphamide and Rituximab (FCR) during Frontline Treatment of Chronic Lymphocytic Leukemia (CLL). Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kovacs, Gabor, Boettcher, Sebastian, Bahlo, Jasmin, Kluth, Sandra, Ritgen, Matthias, Fink, Anna Maria, Stodden, Irene, Cramer, Paula, von Tresckow, Julia, Maurer, Christian, Doehner, Hartmut, Stilgenbauer, Stephan, Kneba, Michael, Fischer, Kirsten, Hallek, Michael and Eichhorst, Barbara (2014). Value of Minimal Residual Disease (MRD) Negative Status at Response Evaluation in Chronic Lymphocytic Leukemia (CLL): Combined Analysis of Two Phase III Studies of the German CLL Study Group (GCLLSG). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kovacs, Gabor, Robrecht, Sandra, Fink, Anna Maria, Bahlo, Jasmin, Cramer, Paula, von Tresckow, Julia, Maurer, Christian, Langerbeins, Petra, Fingerle-Rowson, Gunter, Ritgen, Matthias, Kneba, Michael, Doehner, Hartmut, Stilgenbauer, Stephan, Klapper, Wolfram, Wendtner, Clemens-Martin, Fischer, Kirsten, Hallek, Michael, Eichhorst, Barbara and Boettcher, Sebastian (2016). Minimal Residual Disease Assessment Improves Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia (CLL) Who Achieve Partial Response: Comprehensive Analysis of Two Phase III Studies of the German CLL Study Group. J. Clin. Oncol., 34 (31). S. 3758 - 3775. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kraemer, Isabelle, Stilgenbauer, Stephan, Dietrich, Sascha, Boettcher, Sebastian, Zeis, Matthias, Stadler, Michael, Bittenbring, Jorg, Uharek, Lutz, Scheid, Christof, Hegenbart, Ute, Ho, Anthony, Hallek, Michael, Kneba, Michael, Schmitz, Norbert, Doehner, Hartmut and Dreger, Peter (2017). Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial. Blood, 130 (12). S. 1477 - 1483. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kramer, Isabelle, Stilgenbauer, Stephan, Dietrich, Sascha, Bottcher, Sebastian, Ritgen, Matthias, Bunjes, Donald, Zeis, Matthias, Stadler, Michael, Bittenbring, Joerg Thomas, Hegenbart, Ute, Hallek, Michael, Kneba, Michael, Schmitz, Norbert, Dohner, Hartmut and Dreger, Peter (2016). Long-Term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Lymphocytic Leukemia (CLL): 10-Year Follow-up of the Gcllsg CLL3X Trial. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Krause, Guenter, Baki, Imaan, Kerwien, Susan, Knoedgen, Eva, Neumann, Lars, Goeckeritz, Elisa, Landwehr, Thomas, Heider, Karl-Heinz and Hallek, Michael (2016). Cytotoxicity of the CD37 antibody BI 836826 against chronic lymphocytic leukaemia cells in combination with chemotherapeutic agents or PI3K inhibitors. Br. J. Haematol., 173 (5). S. 791 - 795. HOBOKEN: WILEY-BLACKWELL. ISSN 1365-2141

Krause, Guenter, Hassenrueck, Floyd and Hallek, Michael (2020). Cell line-based assessment of BTK inhibitors. Br. J. Pharmacol., 177 (9). S. 2163 - 2166. HOBOKEN: WILEY. ISSN 1476-5381

Krause, Guenter, Hassenrueck, Floyd and Hallek, Michael (2018). Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with considerable differences to idelalisib. Drug Des. Dev. Ther., 12. S. 2577 - 2591. ALBANY: DOVE MEDICAL PRESS LTD. ISSN 1177-8881

Krause, Guenter ORCID: 0000-0003-3905-0921, Hassenrueck, Floyd and Hallek, Michael (2020). Relevant Cytokines in the B Cell Lymphoma Micro-Environment. Cancers, 12 (9). BASEL: MDPI. ISSN 2072-6694

Krause, Stefan W., Oldenburg, Michael, Hallek, Michael and Neubauer, Andreas (2017). Priorities of German Oncologists. Results of the choosing wisely survey of the German Society of Hematology and Medical Oncology (DGHO). Dtsch. Med. Wochenschr., 142 (18). S. E124 - 7. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

Kreuzer, Karl-Anton, Furman, Richard, Stilgenbauer, Stephan, Dubowy, Ronald, Kim, Yeonhee, Munugalavadla, Veerendra, Lilienweisz, Esther, Reinhardt, Hans Christian, Cramer, Paula, Eichhorst, Barbara, Hillmen, Peter, O'Brien, Susan, Pettitt, Andrew and Hallek, Michael (2017). Improved overall survival of relapsed chronic lymphocytic leukemia (CLL) patients exhibiting a complex karyotype and treated with idelalisib plus rituximab. Leuk. Lymphoma, 58. S. 167 - 169. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Kreuzer, Karl-Anton, Furman, Richard R., Stilgenbauer, Stephan, Dubowy, Ronald L., Kim, Yeonhee, Munugalavadla, Veerendra, Lilienweiss, Esther, Reinhardt, Hans Christian, Cramer, Paula, Eichhorst, Barbara, Hillmen, Peter, O'Brien, Susan M., Pettitt, Andrew R. and Hallek, Michael (2020). The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab. Leukemia, 34 (1). S. 296 - 301. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

Kreuzer, Karl-Anton, Furman, Richard R., Stilgenbauer, Stephan, Dubowy, Ronald L., Kim, Yeonhee, Munugalavadla, Veerendra, Lilienweiss, Esther, Reinhardt, Hans Christian, Pettitt, Andrew R. and Hallek, Michael (2016). Outcome of Patients with Complex Karyotype in a Phase 3 Randomized Study of Idelalisib Plus Rituximab for Relapsed Chronic Lymphocytic Leukemia. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kron, Florian, Kostenko, Anna, Glossmann, Jan P., Hallek, Michael, Dohle, Ines, Hoss, Alexander, Scheffler, Matthias, Zander, Thomas and Wolf, Juergen (2015). Economic Burden of Lung Cancer Patients Treated in Clinical Trials: Experience from a Comprehensive Cancer Center in Germany. J. Thorac. Oncol., 10 (9). S. S273 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1556-1380

Kron, Florian, Kutsch, Nadine, Kostenko, Anna, Dohle, Ines, Glossmann, Jan-Peter, Mueller, Dirk, Heimann, Sebastian M., Bahlo, Jasmin, von Bergwelt-Baildon, Michael, Eichhorst, Barbara, Wolf, Juergen, Hallek, Michael and Zander, Thomas (2017). Economic evaluation of chronic lymphocytic leukemia from a hospital management perspective. Eur. J. Haematol., 98 (2). S. 169 - 177. HOBOKEN: WILEY-BLACKWELL. ISSN 1600-0609

Kurtz, David M., Esfahani, Mohammad S., Scherer, Florian, Soo, Joanne, Jin, Michael C., Liu, Chih Long, Newman, Aaron M., Duehrsen, Ulrich, Huettmann, Andreas, Casasnovas, Olivier, Westin, Jason R., Ritgen, Matthais, Boettcher, Sebastian, Langerak, Anton W., Roschewski, Mark, Wilson, Wyndham H., Gaidano, Gianluca, Rossi, Davide, Bahlo, Jasmin, Hallek, Michael, Tibshirani, Robert, Diehn, Maximilian and Alizadeh, Ash A. (2019). Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction. Cell, 178 (3). S. 699 - 733. CAMBRIDGE: CELL PRESS. ISSN 1097-4172

Kusch, Michael, Labouvie, Hildegard, Schiewer, Vera, Talalaev, Natalie, Cwik, Jan C. ORCID: 0000-0002-2290-353X, Bussmann, Sonja, Vaganian, Lusine, Gerlach, Alexander L. ORCID: 0000-0001-6794-5349, Dresen, Antje, Cecon, Natalia, Salm, Sandra, Krieger, Theresia, Pfaff, Holger, Lemmen, Clarissa, Derendorf, Lisa, Stock, Stephanie, Samel, Christina, Hagemeier, Anna, Hellmich, Martin, Leicher, Bernd, Hültenschmidt, Gregor, Swoboda, Jessica, Haas, Peter, Arning, Anna, Göttel, Andrea, Schwickerath, Kathrin, Graeven, Ullrich, Houwaart, Stefanie, Kerek-Bodden, Hedy, Krebs, Steffen, Muth, Christiana, Hecker, Christina, Reiser, Marcel, Mauch, Cornelia, Benner, Jennifer, Schmidt, Gerdamarie, Karlowsky, Christiane, Vimalanandan, Gisela, Matyschik, Lukas, Galonska, Lars, Francke, Annette, Osborne, Karin, Nestle, Ursula, Bäumer, Markus, Schmitz, Kordula, Wolf, Jürgen and Hallek, Michael (2022). Integrated, cross-sectoral psycho-oncology (isPO): a new form of care for newly diagnosed cancer patients in Germany. BMC Health Services Research, 22 (1). Springer Nature. ISSN 1472-6963

Kutsch, Nadine, Bahlo, Jasmin, Bergmann, Manuela, Byrd, John, Doehner, Hartmut, Eichhorst, Barbara, Else, Monica, Geisler, Christian, Grever, Michael, Lepretre, Stephane, Neuberg, Donna, Oscier, David, Rosenquist, Richard, Robak, Tadeusz, Shanafelt, Tait, Stilgenbauer, Stephan and Hallek, Michael (2015). The international prognostic index for patients with CLL(CLL-IPI) - an international meta-analysis. Leuk. Lymphoma, 56. S. 127 - 128. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Kutsch, Nadine, Bahlo, Jasmin, Robrecht, Sandra, Franklin, Jeremy, Zhang, Can, Maurer, Christian, De Silva, Nisha, Lange, Elisabeth, Weide, Rudolf, Kiehl, Michael G., Soekler, Martin, Schlag, Rudolf, Vehling-Kaiser, Ursula, Koechling, Georg, Ploeger, Christoph, Gregor, Michael, Plesner, Torben, Herling, Marco, Fischer, Kirsten, Doehner, Hartmut, Kneba, Michael, Wendtner, Clemens-Martin, Klapper, Wolfram, Kreuzer, Karl-Anton, Boettcher, Sebastian, Stilgenbauer, Stephan, Fink, Anna Maria, Hallek, Michael and Eichhorst, Barbara (2020). Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG). Hemasphere, 4 (1). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241

Kutsch, Nadine, Bahlo, Jasmin, Robrecht, Sandra, Maurer, Christian, Lange, Elisabeth, Koeppler, Hubert, Kiehl, Michael, Soekler, Martin, Schlag, Rudolf, Fink, Anna-Maria, Vehling-Kaiser, Ursula, Gregor, Michael, Plesner, Torben, Herling, Marco, Fischer, Kirsten, Doehner, Hartmut, Kneba, Michael, Wendtner, Clemens, Klapper, Wolfram, Kreuzer, Karl-Anton, Boettcher, Sebastian, Stilgenbauer, Stephan, Hallek, Michael and Eichhorst, Barbara (2017). Health related quality of life (HRQOL) of patients treated with FCR vs BR within the CLL10 trial. Leuk. Lymphoma, 58. S. 109 - 111. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Kutsch, Nadine, Busch, Raymonde, Bahlo, Jasmin, Mayer, Jiri, Hensel, Manfred, Hopfinger, Georg ORCID: 0000-0002-8321-1342, Hess, Georg, von Gruenhagen, Ulrich, Wendtner, Clemens-Martin, Fink, Anna Maria, Fischer, Kirsten, Hallek, Michael and Eichhorst, Barbara (2017). FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemia. Leuk. Lymphoma, 58 (2). S. 399 - 408. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Kutsch, Nadine, Fink, Anna Maria, Federhen, Anno, Giza, Adam, Robrecht, Sandra, Stumpf, Janina, Stoltefuss, Andrea, Vehling-Kaiser, Ursula, Koenigsmann, Michael, Tausch, Eugen, Schneider, Christof, Stilgenbauer, Stephan, Illmer, Thomas, Schlag, Rudolf, Doerfel, Steffen, Gaska, Tobias, Kiehl, Michael G., Fischer, Kirsten, Eichhorst, Barbara and Hallek, Michael (2022). Fludarabine, Cyclophosphamide and Rituximab (FCR) As First Line Treatment in Patients with Chronic Lymphocytic Leukemia (CLL): A Long-Term Analysis of the German CLL Study Group (GCLLSG) Registry. Blood, 140. S. 9879 - 9882. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kutsch, Nadine, Goedel, Philipp, Voltin, Conrad-Amadeus, Kobe, Carsten, Hallek, Michael ORCID: 0000-0002-7425-4455, Scheid, Christof, Borchmann, Peter and Holtick, Udo (2022). Sustained Remission of Relapsed Diffuse Large B-cell Lymphoma After Safe Administration of CD19-directed CAR T-cells in a Patient With Chronic Intestinal and Pulmonal GvHD. Hemasphere, 6 (7). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241

Kutsch, Nadine, Hallek, Michael and Eichhorst, Barbara (2015). Emerging therapies for refractory chronic lymphocytic leukemia. Leuk. Lymphoma, 56 (2). S. 285 - 293. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Kutsch, Nadine, Holmes, Emily Eva, Robrecht, Sandra, Schueler, Gudrun, Vehling-Kaiser, Ursula, Decker, Thomas, Mueller-Hagen, Sigrun, Heinisch, Karin, Boettcher, Sebastian, Ritgen, Matthias, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Fink, Anna Maria, Fischer, Kirsten, Eichhorst, Barbara, Hallek, Michael and Wendtner, Clemens-Martin (2023). Efficacy and safety of obinutuzumab combined with fludarabine and cyclophosphamide (FCG) or bendamustine (BG) in relapsed or refractory CLL patients followed by maintenance therapy with obinutuzumab for responding patients. Leuk. Lymphoma, 64 (2). S. 478 - 483. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Kutsch, Nadine, Pallasch, Christian, Decker, Thomas ORCID: 0000-0003-3814-8775, Hebart, Holger, Chow, Kai Uwe, Graeven, Ullrich, Kisro, Jens, Kroeber, Alexander, Tausch, Eugen, Fischer, Kirsten, Fink, Anna-Maria, Wendtner, Clemens-Martin, Ritgen, Matthias, Stilgenbauer, Stephan, Zhang, Danjie, Li, Biao, Jurgensmeier, Juliane M., Rajakumaraswamy, Nishanthan, Bhargava, Pankaj, Hallek, Michael ORCID: 0000-0002-7425-4455 and Eichhorst, Barbara (2022). Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia. Hemasphere, 6 (6). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241

Kutsch, Nadine, Pallasch, Christian, Tausch, Eugen, Boehme, Volkmar, Ritgen, Matthias, Liersch, Ruediger, Wacker, Alexander, Jacobs, Georg, Trappe, Ralf Ulrich ORCID: 0000-0001-7565-7160, Dreger, Peter, Fischer, Kirsten, Fink, Anna-Maria, Stilgenbauer, Stephan, Zhai, Shuyan, Li, Biao, Jurgensmeier, Juliane M., Rajakumaraswamy, Nishanthan, Bhargava, Pankaj, Hallek, Michael ORCID: 0000-0002-7425-4455 and Eichhorst, Barbara F. (2022). Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia. Hemasphere, 6 (4). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241

Labouvie, Hildegard, Hellmich, Silke, Fath, Birgit, Hallek, Michael and Kusch, Michael (2019). Psycho-oncological healthcare needs of patients with non-Hodgkin's lymphoma. Onkologe, 25 (10). S. 914 - 919. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0415

Landau, Dan A., Tausch, Eugen, Boettcher, Sebastian, Stewart, Chip, Bozic, Ivana, Leischner, Iganty, Rosebrock, Daniel, Taylor-Weiner, Amaro, Mertens, Daniel, Sougnez, Carrie, Kless, Sabrina, Kneba, Michael, Ritgen, Matthias, Kluth, Sandra, Bahlo, Jasmin, Fink, Anna-Maria, Fischer, Kirsten, Gabriel, Stacey, Lander, Eric, Dohner, Hartmut ORCID: 0000-0003-2116-5536, Hallek, Michael, Neuberg, Donna S., Nowak, Martin, Getz, Gad, Stilgenbauer, Stephan and Wu, Catherine J. (2015). Quantitative Clonal Dynamics Define Mechanisms of CLL Evolution in Response to Combination Chemotherapy. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Landau, Dan A., Tausch, Eugen, Taylor-Weiner, Amaro N., Bottcher, Sebastian, Bahlo, Jasmin, Stewart, Chip, Edelmann, Jennifer, Kluth, Sandra, Mertens, Daniel, Kneba, Michael, Kless, Sabrina, Sougnez, Carrie, Fischer, Kirsten, Ritgen, Matthias, Gabriel, Stacey, Lander, Eric, Dohner, Hartmut ORCID: 0000-0003-2116-5536, Hallek, Michael, Getz, Gad, Neuberg, Donna, Stilgenbauer, Stephan and Wu, Catherine J. (2014). Subclonal Driver Mutations Predict Shorter Progression Free Survival in Chronic Lymphocytic Leukemia Following First-Line Chemo(immuno) Therapy: Results from the CLL8 Trial. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Landau, Dan A., Tausch, Eugen, Taylor-Weiner, Amaro N., Stewart, Chip, Reiter, Johannes G. ORCID: 0000-0002-0170-7353, Bahlo, Jasmin, Kluth, Sandra, Bozic, Ivana ORCID: 0000-0003-2761-825X, Lawrence, Mike, Boettcher, Sebastian, Carter, Scott L., Cibulskis, Kristian, Mertens, Daniel ORCID: 0000-0003-0227-7188, Sougnez, Carrie L., Rosenberg, Mara ORCID: 0000-0001-6400-3161, Hess, Julian M., Edelmann, Jennifer, Kless, Sabrina, Kneba, Michael, Ritgen, Matthias, Fink, Anna, Fischer, Kirsten, Gabriel, Stacey, Lander, Eric S., Nowak, Martin A., Doehner, Hartmut, Hallek, Michael, Neuberg, Donna, Getz, Gad, Stilgenbauer, Stephan and Wu, Catherine J. (2015). Mutations driving CLL and their evolution in progression and relapse. Nature, 526 (7574). S. 525 - 542. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-4687

Langerak, Anton W., Ritgen, Matthias, Goede, Valentin, Robrecht, Sandra, Bahlo, Jasmin, Fischer, Kirsten, Steurer, Michael, Trneny, Marek, Mulligan, Stephen P., Mey, Ulrich J. M., Trunzer, Kerstin, Fingerle-Rowson, Guenter, Humphrey, Kathryn, Stilgenbauer, Stephan, Boettcher, Sebastian, Brueggemann, Monika, Hallek, Michael, Kneba, Michael and van Dongen, Jacques J. M. (2019). Prognostic value of MRD in CLL patients with comorbidities receiving chlorambucil plus obinutuzumab or rituximab. Blood, 133 (5). S. 494 - 498. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Langerbeins, Petra, Bahlo, Jasmin, Rhein, Christina, Cramer, Paula, Fink, Anna Maria, Pflug, Natali, Stilgenbauer, Stephan, Kreuzer, Karl-Anton, Wendtner, Clemens-Martin, Fischer, Kirsten, Eichhorst, Barbara and Hallek, Michael (2015). Preliminary safety results of a placebo-controlled Phase III study of ibrutinib in treatment-nayve early stage CLL patients with risk of disease progression. Leuk. Lymphoma, 56. S. 20 - 22. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Langerbeins, Petra, Bahlo, Jasmin, Rhein, Christina, Cramer, Paula, Fink, Anna-Maria, Pflug, Natali, von Tresckow, Julia, Stilgenbauer, Stephan, Kreuzer, Karl-Anton, Eckart, Michael J., Vehling-Kaiser, Ursula, Schlag, Rudolf, Balser, Christina, Mueller, Lothar, Reiser, Marcel, Wendtner, Clemens, Fischer, Kirsten, Eichhorst, Barbara and Hallek, Michael (2017). Serious adverse events (SAE) and suspected unexpected serious adverse reactions (SUSAR) in early stage patients with CLL treated with ibrutinib or placebo: safety results of the ongoing randomized CLL12 phase III-trial. Leuk. Lymphoma, 58. S. 161 - 163. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Langerbeins, Petra, Bahlo, Jasmin, Rhein, Christina, Cramer, Paula, Fink, Anna-Maria, Pflug, Natali, von Tresckow, Julia, Stilgenbauer, Stephan, Kreuzer, Karl-Anton, Eckart, Michael J., Vehling-Kaiser, Ursula, Schlag, Rudolf, Balser, Christina, Mueller, Lothar, Wendtner, Clemens-Martin, Fischer, Kirsten, Eichhorst, Barbara and Hallek, Michael (2015). Ibrutinib in Early Stage CLL: Preliminary Safety Results of a Placebo-Controlled Phase III Study. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Langerbeins, Petra, Bahlo, Jasmin, Rhein, Christina, Cramer, Paula, Pflug, Natali, Fischer, Kirsten, Stilgenbauer, Stephan, Kreuzer, Karl Anton, Wendtner, Clemens-Martin, Eichhorst, Barbara and Hallek, Michael (2015). The CLL12 trial protocol: a placebo-controlled double-blind Phase III study of ibrutinib in the treatment of early-stage chronic lymphocytic leukemia patients with risk of early disease progression. Future Oncol., 11 (13). S. 1895 - 1904. LONDON: FUTURE MEDICINE LTD. ISSN 1744-8301

Langerbeins, Petra, Bahlo, Jasmin, Rhein, Christina, Gerwin, Henrik, Cramer, Paula, Fuerstenau, Moritz, Al-Sawaf, Othman, von Tresckow, Julia, Fink, Anna-Maria, Kreuzer, Karl-Anton, Vehling-Kaiser, Ursula, Tausch, Eugen, Mueller, Lothar, Eckart, Michael J., Schlag, Rudolf, Freier, Werner, Gaska, Tobias, Balser, Christina, Reiser, Marcel, Stauch, Martina, Wendtner, Clemens Martin, Reiser, Marcel, Stauch, Martina, Fischer, Kirsten, Stilgenbauer, Stephan, Eichhorst, Barbara and Hallek, Michael (2020). Ibrutinib versus placebo in patients with asymptomatic, treatment-naive early stage chronic lymphocytic leukemia (CLL): primary endpoint results of the phase 3 double-blind randomized CLL12 trial. Leuk. Lymphoma, 61. S. 18 - 21. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Langerbeins, Petra, Busch, Raymonde, Anheier, Nadine, Duerig, Jan, Bergmann, Manuela, Goebeler, Maria-Elisabeth, Hurtz, Hans-Juergen, Stauch, Martina B., Stilgenbauer, Stephan, Doehner, Hartmut, Fink, Anna-Maria, Cramer, Paula, Fischer, Kirsten, Wendtner, Clemens-Martin, Hallek, Michael and Eichhorst, Barbara (2014). Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation. Am. J. Hematol., 89 (12). S. E239 - 5. HOBOKEN: WILEY. ISSN 1096-8652

Langerbeins, Petra, Eichhorst, Barbara and Hallek, Michael (2022). 72 years old male with an Incidental Finding of Lymphocytosis. Onkologie, 28. S. S137 - 7. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 2731-7234

Langerbeins, Petra, Eichhorst, Barbara and Hallek, Michael (2019). Current treatment strategies for chronic lymphocytic leukemia. Onkologe, 25 (11). S. 1004 - 1009. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0415

Langerbeins, Petra, Fuerstenau, Moritz, Gruell, Henning, Klein, Florian, Persigehl, Thorsten, Rybniker, Jan, Seeger-Nukpezah, Tamina, Kochanek, Matthias, Hallek, Michael, Eichhorst, Barbara, Koehler, Philipp ORCID: 0000-0002-7386-7495 and Boell, Boris (2020). COVID-19 complicated by parainfluenza co-infection in a patient with chronic lymphocytic leukemia. Eur. J. Haematol., 105 (4). S. 508 - 512. HOBOKEN: WILEY. ISSN 1600-0609

Langerbeins, Petra and Hallek, Michael ORCID: 0000-0002-7425-4455 (2022). COVID-19 in patients with hematologic malignancy. Blood, 140 (3). S. 236 - 253. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Langerbeins, Petra, Zhang, Can, Robrecht, Sandra, Cramer, Paula, Fuerstenau, Moritz, Al-Sawaf, Othman, von Tresckow, Julia, Fink, Anna-Maria, Kreuzer, Karl-Anton, Vehling-Kaiser, Ursula, Tausch, Eugen, Mueller, Lothar, Eckart, Michael Josef, Schlag, Rudolf, Freier, Werner, Gaska, Tobias, Balser, Christina, Reiser, Marcel, Stauch, Martina, Wendtner, Clemens-Martin, Fischer, Kirsten, Stilgenbauer, Stephan, Eichhorst, Barbara and Hallek, Michael (2021). The CLL12 trial: ibrutinib vs placebo in treatment-naive, early-stage chronic lymphocytic leukemia. Blood, 139 (2). S. 177 - 188. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Lehmann, Clara, Kochanek, Matthias, Abdulla, Diana, Becker, Stephan, Boell, Boris, Bunte, Anne, Cadar, Daniel ORCID: 0000-0002-8063-2766, Dormann, Arno, Eickmann, Markus, Emmerich, Petra, Feldt, Torsten, Frank, Christina ORCID: 0000-0001-6776-8450, Fries, Jochen ORCID: 0000-0003-2054-6345, Gabriel, Martin, Goetsch, Udo, Gottschalk, Rene, Guenther, Stephan, Hallek, Michael, Haeussinger, Dieter, Herzog, Christian, Jensen, Bjoern, Kolibay, Felix, Krakau, Michael, Langebartels, Georg, Rieger, Toni ORCID: 0000-0002-7863-1916, Schaade, Lars, Schmidt-Chanasit, Jonas, Schoemig, Edgar, Schuettfort, Gundolf, Shimabukuro-Vornhagen, Alexander, von Bergwelt-Baildon, Michael, Wieland, Ulrike, Wiesmueller, Gerhard, Wolf, Timo and Faetkenheuer, Gerd (2017). Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016. Eurosurveillance, 22 (39). S. 15 - 24. STOCKHOLM: EUR CENTRE DIS PREVENTION & CONTROL. ISSN 1560-7917

Lehmann, Clara ORCID: 0000-0002-7042-1578, Kochanek, Matthias ORCID: 0000-0002-4766-4651, Abdulla, Diana ORCID: 0000-0002-8267-9971, Becker, Stephan, Böll, Boris ORCID: 0000-0002-6432-0981, Bunte, Anne, Cadar, Daniel ORCID: 0000-0002-8063-2766, Dormann, Arno, Eickmann, Markus, Emmerich, Petra ORCID: 0000-0001-5093-4539, Feldt, Torsten ORCID: 0000-0002-6755-4492, Frank, Christina ORCID: 0000-0001-6776-8450, Fries, Jochen ORCID: 0000-0003-2054-6345, Gabriel, Martin, Götsch, Udo, Gottschalk, René ORCID: 0000-0003-0422-6456, Günther, Stephan ORCID: 0000-0002-6562-0230, Hallek, Michael ORCID: 0000-0002-7425-4455, Häussinger, Dieter ORCID: 0000-0002-5936-682X, Herzog, Christian ORCID: 0000-0003-3706-5011, Jensen, Björn, Kolibay, Felix ORCID: 0000-0003-0051-256X, Krakau, Michael, Langebartels, Georg ORCID: 0000-0002-2448-2433, Rieger, Toni ORCID: 0000-0002-7863-1916, Schaade, Lars ORCID: 0000-0001-6577-5139, Schmidt-Chanasit, Jonas ORCID: 0000-0003-4433-0231, Schömig, Edgar, Schüttfort, Gundolf, Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, von Bergwelt-Baildon, Michael, Wieland, Ulrike ORCID: 0000-0003-3480-4413, Wiesmüller, Gerhard, Wolf, Timo ORCID: 0000-0002-3819-9540 and Fätkenheuer, Gerd ORCID: 0000-0002-5054-1871 (2017). Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016. Eurosurveillance, 22 (39). European Centre for Disease Prevention and Control. ISSN 1560-7917

Lengerke, Claudia and Hallek, Michael (2022). Clonal hematopoiesis-sign of aging or precursor of disease? Innere Med., 63 (11). S. 1105 - 1107. Berlin: SPRINGER MEDIZIN. ISSN 2731-7099

Lilienthal, Nils, Lohmann, Gregor, Crispatzu, Giuliano, Vasyutina, Elena ORCID: 0000-0001-9722-3419, Zittrich, Stefan, Mayer, Petra, Herling, Carmen Diana, Tur, Mehmet Kemal ORCID: 0000-0002-9259-6723, Hallek, Michael, Pfitzer, Gabriele, Barth, Stefan ORCID: 0000-0001-9589-653X and Herling, Marco (2016). A Novel Recombinant Anti-CD22 Immunokinase Delivers Proapoptotic Activity of Death-Associated Protein Kinase (DAPK) and Mediates Cytotoxicity in Neoplastic B Cells. Mol. Cancer Ther., 15 (5). S. 971 - 985. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-8514

Lobastova, Liudmila, Lettau, Marcus, Babatz, Felix, de Oliveira, Thais Dolzany, Nguyen, Phuong-Hien, Pauletti, Bianca Alves, Schauss, Astrid C., Duerkop, Horst, Janssen, Ottmar ORCID: 0000-0002-9612-8900, Leme, Adriana F. Paes, Hallek, Michael and Hansen, Hinrich P. (2021). CD30-Positive Extracellular Vesicles Enable the Targeting of CD30-Negative DLBCL Cells by the CD30 Antibody-Drug Conjugate Brentuximab Vedotin. Front. Cell. Dev. Biol., 9. LAUSANNE: FRONTIERS MEDIA SA. ISSN 2296-634X

Lobastova, Liudmila, Lettau, Marcus ORCID: 0000-0002-3824-9923, Babatz, Felix, de Oliveira, Thais Dolzany, Nguyen, Phuong-Hien, Pauletti, Bianca Alves, Schauss, Astrid C., Duerkop, Horst, Janssen, Ottmar, Paes Leme, Adriana F., Hallek, Michael and Hansen, Hinrich P. (2021). CD30-Positive Extracellular Vesicles Enable the Targeting of CD30-Negative DLBCL Cells by the CD30 Antibody-Drug Conjugate Brentuximab Vedotin. Front. Cell. Dev. Biol., 9. LAUSANNE: FRONTIERS MEDIA SA. ISSN 2296-634X

Maerker-Hermann, Elisabeth and Hallek, Michael ORCID: 0000-0002-7425-4455 (2022). Biologics in internal medicine. Internist, 63 (2). S. 133 - 135. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289

Maersch, Stephan, Huber, Anke, Hallek, Michael, Buening, Hildegard and Perabo, Luca (2010). A Novel Directed Evolution Method to Enhance Cell-Type Specificity of Adeno-Associated Virus Vectors. Comb. Chem. High Throughput Screen, 13 (9). S. 807 - 813. SHARJAH: BENTHAM SCIENCE PUBL LTD. ISSN 1875-5402

Malard, Florent, Labopin, Myriam, Stuhler, Gernot, Bittenbring, Joerg, Ganser, Arnold, Tischer, Johanna, Michallet, Mauricette, Kroeger, Nicolaus, Schmid, Christoph, Hallek, Michael, Savani, Bipin N., Mohty, Mohamad and Nagler, Arnon (2017). Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Biol. Blood Marrow Transplant., 23 (2). S. 278 - 285. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1523-6536

Malard, Florent, Labopin, Myriam, Stuhler, Gernot, Tischer, Johanna, Bittenbring, Joerg Thomas, Ganser, Arnold, Kroeger, Nicolaus, Bunjes, Donald, Schmid, Christoph, Mayer, Jiri, Michallet, Mauricette, Hallek, Michael, Savani, Bipin N., Mohty, Mohamad and Nagler, Arnon (2015). Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with High-Risk AML in Complete Remission: A Survey from the ALWP of the EBMT. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Malin, Jakob J. ORCID: 0000-0002-2989-0436, Di Cristanziano, Veronica, Horn, Carola, Pracht, Elisabeth, Borrega, Jorge Garcia, Heger, Eva, Knops, Elena ORCID: 0000-0001-7398-3026, Kaiser, Rolf, Boll, Boris, Lehmann, Clara, Jung, Norma, Borchmann, Peter, Fatkenheuer, Gerd, Klein, Florian ORCID: 0000-0003-1376-1792, Hallek, Michael ORCID: 0000-0002-7425-4455 and Rybniker, Jan (2022). SARS-CoV-2-neutralizing antibody treatment in patients with COVID-19 and immunodeficiency due to B-cell non-Hodgkin lymphoma. Blood Adv., 6 (5). S. 1580 - 1585. AMSTERDAM: ELSEVIER. ISSN 2473-9537

Maurer, Christian, Pflug, Natali, Bahlo, Jasmin, Kluth, Sandra, Rhein, Christina, Cramer, Paula, Gross-Ophoff, Carolin, Langerbeins, Petra, Fink, Anna-Maria, Eichhorst, Barbara, Kreuzer, Karl-Anton, Fischer, Norbert, Tausch, Eugen, Stilgenbauer, Stephan, Boettcher, Sebastian, Doehner, Hartmut, Kneba, Michael, Dreyling, Martin, Binder, Mascha ORCID: 0000-0003-0663-3004, Hallek, Michael, Wendtner, Clemens-Martin, Bergmann, Manuela and Fischer, Kirsten (2016). Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia. Eur. J. Haematol., 97 (3). S. 253 - 261. HOBOKEN: WILEY. ISSN 1600-0609

Meder, Lydia ORCID: 0000-0002-9547-5812, Schuldt, Philipp, Thelen, Martin ORCID: 0000-0002-2785-9726, Schmitt, Anna, Dietlein, Felix, Klein, Sebastian, Borchmann, Sven, Wennhold, Kerstin, Vlasic, Ignacija, Oberbeck, Sebastian, Riedel, Richard, Florin, Alexandra, Golfmann, Kristina, Schloesser, Hans A., Odenthal, Margarete, Buettner, Reinhard, Wolf, Juergen, Hallek, Michael, Herling, Marco, von Bergwelt-Baildon, Michael, Reinhardt, H. Christian and Ullrich, Roland T. (2018). Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung Cancer. Cancer Res., 78 (15). S. 4270 - 4282. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

Mellinghoff, Sibylle C., Mayer, Leonie, Robrecht, Sandra, Weskamm, Leonie M., Dahlke, Christine ORCID: 0000-0002-2056-9195, Gruell, Henning, Schlotz, Maike, Vanshylla, Kanika ORCID: 0000-0003-4552-9170, Schloesser, Hans A., Thelen, Martin ORCID: 0000-0002-2785-9726, Fink, AnnaMaria, Fischer, Kirsten, Klein, Florian ORCID: 0000-0003-1376-1792, Addo, Marylyn M., Eichhorst, Barbara, Hallek, Michael and Langerbeins, Petra (2022). SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia. Haematologica, 107 (10). S. 2480 - 2485. PAVIA: FERRATA STORTI FOUNDATION. ISSN 1592-8721

Mellinghoff, Sibylle C., Robrecht, Sandra, Mayer, Leonie ORCID: 0000-0001-7102-4358, Weskamm, Leonie M., Dahlke, Christine, Gruell, Henning, Vanshylla, Kanika ORCID: 0000-0003-4552-9170, Schloesser, Hans A., Thelen, Martin ORCID: 0000-0002-2785-9726, Fink, Anna-Maria, Fischer, Kirsten, Klein, Florian, Addo, Marylyn M., Eichhorst, Barbara, Hallek, Michael and Langerbeins, Petra (2022). SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia. Leukemia, 36 (2). S. 562 - 566. LONDON: SPRINGERNATURE. ISSN 1476-5551

Michels, Sebastian, Wolf, Juergen and Hallek, Michael (2019). New concepts for approval of drugs in oncology beyond randomized clinical studies. Onkologe, 25. S. 83 - 90. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0415

Montesinos-Rongen, Manuel, Brunn, Anna, Tuchscherer, Armin, Borchmann, Peter, Schorb, Elisabeth, Kasenda, Benjamin, Altmueller, Janine, Illerhaus, Gerald, Ruge, Maximilian, I, Maarouf, Mohammad, Buettner, Reinhard, Hansmann, Martin-Leo, Hallek, Michael, Prinz, Marco, Siebert, Reiner and Deckert, Martina (2020). Analysis of Driver Mutational Hot Spots in Blood-Derived Cell-Free DNA of Patients with Primary Central Nervous System Lymphoma Obtained before Intracerebral Biopsy. J. Mol. Diagn., 22 (10). S. 1300 - 1308. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1943-7811

Mueller, Dirk, Fischer, Kirsten, Kaiser, Peter, Eichhorst, Barbara, Walshe, Ronald, Reiser, Marcel, Kellermann, Lenka, Borsi, Lisa, Civello, Daniele, Mensch, Alexander, Bahlo, Jasmin, Hallek, Michael, Stock, Stephanie and Fingerle-Rowson, Guenter (2016). Cost-effectiveness of rituximab in addition to fludarabine and cyclophosphamide (R-FC) for the first-line treatment of chronic lymphocytic leukemia. Leuk. Lymphoma, 57 (5). S. 1130 - 1140. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Murawski, Niels, Miriam, Josif, Altmann, Bettina, Ziepert, Marita, Haenel, Mathias, Viardot, Andreas, Neubauer, Andreas, Held, Gerhard, Truemper, Lorenz, Schmidt, Christian, Kanz, Lothar, Hallek, Michael, Schmitz, Norbert, Heintges, Tobias, Koelbel, Christian, Poeschel, Viola and Pfreundschuh, Michael (2017). Anti-infective prophylaxis with aciclovir and cotrimoxazole to reduce the rate of infections and therapy-associated deaths in elderly patients with DLBCL undergoing R-CHOP immunochemotherapy. J. Clin. Oncol., 35. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Nickel, Nadine, Al-Maarri, Mona, Pal, Martin, Roth, Andreas, Knittel, Gero, Herling, Carmen D., Reinart, Nina, Schafer, Stephan, Hartmann, Elena M., Rosenwald, Andreas, Klapper, Wolfram, Buttner, Reinhard, Herling, Marco, Bruening, Jens, Reinhardt, Christian, Hallek, Michael, Wunderlich, Thomas and Pallasch, Christian (2016). Transformation of Chronic Lymphocytic Leukemia Towards Richter's Syndrome Is Induced By AKT Activation. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Niesen, Emanuel and Hallek, Michael (2019). New roles for B cell receptor associated kinases: when the B cell is not the target. Leukemia, 33 (3). S. 576 - 588. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

O'Brien, Susan, Jones, Jeffrey A., Coutre, Steven, Mato, Anthony R., Hillmen, Peter, Tam, Constantine, Osterborg, Anders, Siddiqi, Tanya, Thirman, Michael J., Furman, Richard R., Ilhan, Osman, Keating, Michael, Call, Timothy G., Brown, Jennifer R., Stevens-Brogan, Michelle, Li, Yunfeng, Fardis, Maria, Clow, Fong, James, Danelle F., Chu, Alvina D., Hallek, Michael and Stilgenbauer, Stephan (2014). Efficacy and Safety of Ibrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia with 17p Deletion: Results from the Phase II RESONATE (TM)-17 Trial. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

O'Brien, Susan, Jones, Jeffrey A., Coutre, Steven E., Mato, Anthony R., Hillmen, Peter, Tam, Constantine ORCID: 0000-0002-9759-5017, Osterborg, Anders, Siddiqi, Tanya ORCID: 0000-0001-5292-8298, Thirman, Michael J., Furman, Richard R., Ilhan, Osman, Keating, Michael J., Call, Timothy G., Brown, Jennifer R., Stevens-Brogan, Michelle, Li, Yunfeng, Clow, Fong, James, Danelle F., Chu, Alvina D., Hallek, Michael and Stilgenbauer, Stephan (2016). Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study. Lancet Oncol., 17 (10). S. 1409 - 1419. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Pacholewska, Alicja ORCID: 0000-0002-4888-4883, Grimm, Christina ORCID: 0000-0002-4676-8870, Herling, Carmen D., Lienhard, Matthias ORCID: 0000-0002-2549-3142, Koenigs, Anja, Timmermann, Bernd, Altmueller, Janine, Muecke, Oliver, Reinhardt, Hans Christian, Plass, Christoph, Herwig, Ralf, Hallek, Michael and Schweiger, Michal R. (2021). Altered DNA Methylation Profiles in SF3B1 Mutated CLL Patients. Int. J. Mol. Sci., 22 (17). BASEL: MDPI. ISSN 1422-0067

Pallasch, Christian P. ORCID: 0000-0001-5675-6905 and Hallek, Michael (2014). Incorporating Targeted Agents Into Future Therapy of Chronic Lymphocytic Leukemia. Semin. Hematol., 51 (3). S. 235 - 249. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. ISSN 1532-8686

Pallasch, Christian P., Ilya, Leskov, Soto, Yadira M., Braun, Christian J., Kutsch, Nadine, Drake, Adam, Frenzel, Lukas P., Iliopoulou, Bettina, van Rooijen, Nico, Wendtner, Clemens, Hallek, Michael, Chen, Jianzhu and Hemann, Michael T. (2012). Drug-Induced Cytokine Release Sensitizes Protective Tumor Microenvironments to Antibody-Mediated Therapy. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Pallasch, Christian P. ORCID: 0000-0001-5675-6905, Leskov, Ilya, Braun, Christian J., Vorholt, Daniela, Drake, Adam, Soto-Feliciano, Yadira M., Bent, Eric H., Schwamb, Janine, Iliopoulou, Bettina, Kutsch, Nadine, van Rooijen, Nico, Frenzel, Lukas P., Wendtner, Clemens M., Heukamp, Lukas ORCID: 0000-0002-3388-3482, Kreuzer, Karl Anton, Hallek, Michael, Chen, Jianzhu and Hemann, Michael T. (2014). Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy. Cell, 156 (3). S. 590 - 603. CAMBRIDGE: CELL PRESS. ISSN 1097-4172

Pan, Heng, Renaud, Loic ORCID: 0000-0001-7213-9464, Chaligne, Ronan, Bloehdorn, Johannes ORCID: 0000-0003-1433-9702, Tausch, Eugen, Mertens, Daniel ORCID: 0000-0003-0227-7188, Fink, Anna Maria ORCID: 0000-0002-7669-7890, Fischer, Kirsten, Zhang, Chao, Betel, Doron ORCID: 0000-0002-8006-7752, Gnirkell, Andreas, Imielinski, Marcin, Moreaux, Jerome, Hallek, Michael, Meissner, Alexander, Stilgenbauer, Stephan, Wu, Catherine J., Elemento, Olivier and Landau, Dan A. (2021). Discovery of Candidate DNA Methylation Cancer Driver Genes. Cancer Discov., 11 (9). S. 2266 - 2282. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 2159-8290

Pasternack, Helen, Fassunke, Jana, Plum, Patrick Sven, Chon, Seung-Hun ORCID: 0000-0002-8923-6428, Hescheler, Daniel Alexander, Gassa, Asmae, Merkelbach-Bruse, Sabine, Bruns, Christiane Josephine, Perner, Sven, Hallek, Michael, Buettner, Reinhard, Bollschweiler, Elfriede, Hoelscher, Arnulf Heinrich, Quaas, Alexander, Zander, Thomas, Weiss, Jonathan and Alakus, Hakan (2018). Somatic alterations in circulating cell-free DNA of oesophageal carcinoma patients during primary staging are indicative for post-surgical tumour recurrence. Sci Rep, 8. LONDON: NATURE PUBLISHING GROUP. ISSN 2045-2322

Patz, Michaela, Pentok, Barbara, Cremer, Kathrin, Linnartz, Stefanie, Lilienweiss, Esther, Kleinert, Fanni, Hallek, Michael and Kreuzer, Karl-Anton (2017). Minimal residual disease (MRD) detection in chronic lymphocytic leukemia (CLL) via an 8 color flow cytometry panel comprising the signature gene ROR1. Leuk. Lymphoma, 58. S. 93 - 95. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Patz, Michaela, Pentok, Barbara, Cremer, Kathrin, Linnartz, Stefanie, Lilienweiss, Esther, Kleinert, Fanni, Hallek, Michael and Kreuzer, Karl-Anton (2016). ROR-1 Is a Highly Discriminative Marker in Flow Cytometric Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL). Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Peifer, Martin ORCID: 0000-0002-5243-5503, Fernandez-Cuesta, Lynnette ORCID: 0000-0002-0724-6703, Sos, Martin L., George, Julie, Seidel, Danila ORCID: 0000-0003-4388-3117, Kasper, Lawryn H., Plenker, Dennis, Leenders, Frauke, Sun, Ruping, Zander, Thomas, Menon, Roopika, Koker, Mirjam, Dahmen, Ilona, Mueller, Christian, Di Cerbo, Vincenzo ORCID: 0000-0002-2920-1274, Schildhaus, Hans-Ulrich, Altmueller, Janine, Baessmann, Ingelore, Becker, Christian, de Wilde, Bram, Vandesompele, Jo ORCID: 0000-0001-6274-0184, Boehm, Diana, Ansen, Sascha, Gabler, Franziska, Wilkening, Ines, Heynck, Stefanie, Heuckmann, Johannes M., Lu, Xin, Carter, Scott L., Cibulskis, Kristian, Banerji, Shantanu, Getz, Gad, Park, Kwon-Sik, Rauh, Daniel ORCID: 0000-0002-1970-7642, Gruetter, Christian, Fischer, Matthias, Pasqualucci, Laura, Wright, Gavin ORCID: 0000-0002-7000-9305, Wainer, Zoe, Russell, Prudence, Petersen, Iver, Chen, Yuan, Stoelben, Erich, Ludwig, Corinna, Schnabel, Philipp, Hoffmann, Hans, Muley, Thomas, Brockmann, Michael, Engel-Riedel, Walburga, Muscarella, Lucia A., Fazio, Vito M., Groen, Harry, Timens, Wim ORCID: 0000-0002-4146-6363, Sietsma, Hannie, Thunnissen, Erik ORCID: 0000-0001-5355-8508, Smit, Egbert, Heideman, Danielle A. M., Snijders, Peter J. F., Cappuzzo, Federico, Ligorio, Claudia, Damiani, Stefania, Field, John, Solberg, Steinar, Brustugun, Odd Terje, Lund-Iversen, Marius, Saenger, Joerg, Clement, Joachim H. ORCID: 0000-0002-6601-2456, Soltermann, Alex, Moch, Holger, Weder, Walter, Solomon, Benjamin, Soria, Jean-Charles, Validire, Pierre, Besse, Benjamin ORCID: 0000-0001-5090-8189, Brambilla, Elisabeth, Brambilla, Christian, Lantuejoul, Sylvie, Lorimier, Philippe, Schneider, Peter M. ORCID: 0000-0003-0744-2349, Hallek, Michael, Pao, William, Meyerson, Matthew ORCID: 0000-0002-9133-8108, Sage, Julien, Shendure, Jay ORCID: 0000-0002-1516-1865, Schneider, Robert, Buettner, Reinhard, Wolf, Juergen, Nuernberg, Peter, Perner, Sven, Heukamp, Lukas C., Brindle, Paul K., Haas, Stefan ORCID: 0000-0003-3418-3688 and Thomas, Roman K. (2012). Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nature Genet., 44 (10). S. 1104 - 1113. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1546-1718

Peiffer, Lukas, Poll-Wolbeck, Simon Jonas, Flamme, Hanna, Gehrke, Iris, Hallek, Michael and Kreuzer, Karl-Anton (2014). Trichostatin A effectively induces apoptosis in chronic lymphocytic leukemia cells via inhibition of Wnt signaling and histone deacetylation. J. Cancer Res. Clin. Oncol., 140 (8). S. 1283 - 1294. NEW YORK: SPRINGER. ISSN 1432-1335

Pflug, Natali, Bahlo, Jasmin, Shanafelt, Tait D., Eichhorst, Barbara F., Bergmann, Manuela A., Elter, Thomas, Bauer, Kathrin, Malchau, Gebhart, Rabe, Kari G., Stilgenbauer, Stephan, Doehner, Hartmut, Jaeger, Ulrich, Eckart, Michael J., Hopfinger, Georg, Busch, Raymonde, Fink, Anna-Maria, Wendtner, Clemens-Martin, Fischer, Kirsten, Kay, Neil E. and Hallek, Michael (2014). Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia. Blood, 124 (1). S. 49 - 63. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Pflug, Natali, Chakupurakal, Geothy, Fink, Anna-Maria, Robrecht, Sandra, Herling, Marco, Cramer, Paula, Holtick, Udo, Theurich, Sebastian ORCID: 0000-0001-5706-8258, Schetelig, Johannes, Fischer, Kirsten, Ritgen, Matthias, Scheid, Christof, Eichhorst, Barbara, Dreger, Peter, Hallek, Michael and von Bergwelt-Baildon, Michael (2021). Obinutuzumab in Allogeneic Transplantation for CLL and Richter's Transformation in the Age of Targeted Therapies. Hemasphere, 5 (12). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241

Pflug, Natali, Cramer, Paula, Robrecht, Sandra, Bahlo, Jasmin, Westermann, Anne, Fink, Anna-Maria, Schrader, Alexandra, Mayer, Petra, Oberbeck, Sebastian, Seiler, Till, Zenz, Thorsten, Duerig, Jan, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Eichhorst, Barbara, Hallek, Michael, Herling, Marco and Hopfinger, Georg (2019). New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance. Leuk. Lymphoma, 60 (3). S. 649 - 658. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Pflug, Natali, Hopfinger, Georg, Cramer, Paula, Schrader, Alexandra, Weit, Nicole, Meister, Rita, Thiel, Miriam, Annolleck, Tanja, Westermann, Anne, Seiler, Till M., Zenz, Thorsten, Duerig, Jan, Bahlo, Jasmin, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Fink, Anna-Maria, Eichhorst, Barbara, Hallek, Michael and Herling, Marco (2014). Induction Treatment with Alemtuzumab Combined with Polychemotherapy Containing Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) Followed By Alemtuzumab Maintenance in Patients with T-Cell Prolymphocytic Leukaemia (T-PLL): First Analysis of a Prospective Multicenter Phase-II-Trial (T-PLL2) Conducted By the German CLL Study Group (GCLLSG). Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Pflug, Natali, Kluth, Sandra, Vehreschild, Joerg J., Bahlo, Jasmin, Tacke, Daniela, Biehl, Lena, Eichhorst, Barbara, Fischer, Kirsten, Cramer, Paula, Fink, Anna-Maria, von Bergwelt-Baildon, Michael, Stilgenbauer, Stephan, Hallek, Michael, Cornely, Oliver A. and Vehreschild, Maria J. G. T. (2016). Efficacy of antineoplastic treatment is associated with the use of antibiotics that modulate intestinal microbiota. OncoImmunology, 5 (6). PHILADELPHIA: TAYLOR & FRANCIS INC. ISSN 2162-402X

Pfreundschuh, Michael, Poeschel, Viola, Zeynalova, Samira, Haenel, Mathias, Held, Gerhard, Schmitz, Norbert, Viardot, Andreas, Dreyling, Martin H., Hallek, Michael, Mueller, Carsten, Wiesen, Martin H. J., Witzens-Harig, Mathias ORCID: 0000-0002-2799-4661, Truemper, Lorenz, Keller, Ulrich, Rixecker, Tanja, Zwick, Carsten and Murawski, Niels (2014). Optimization of Rituximab for the Treatment of Diffuse Large B-Cell Lymphoma (II): Extended Rituximab Exposure Time in the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group. J. Clin. Oncol., 32 (36). S. 4127 - 4135. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Pohlen, Michele, Thoennissen, Nils H., Braess, Jan, Thudium, Johannes, Schmid, Christoph, Kochanek, Matthias, Kreuzer, Karl-Anton, Lebiedz, Pia, Goerlich, Dennis, Gerth, Hans U., Rohde, Christian, Kessler, Torsten ORCID: 0000-0001-7679-5362, Mueller-Tidow, Carsten, Stelljes, Matthias, Buechner, Thomas, Schlimok, Guenter, Hallek, Michael, Waltenberger, Johannes, Hiddemann, Wolfgang, Berdel, Wolfgang E., Heilmeier, Bernhard and Krug, Utz (2016). Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction. PLoS One, 11 (8). SAN FRANCISCO: PUBLIC LIBRARY SCIENCE. ISSN 1932-6203

Prinz, Christian, Vasyutina, Elena ORCID: 0000-0001-9722-3419, Lohmann, Gregor, Schrader, Alexandra, Romanski, Steffen, Hirschhaeuser, Christoph, Mayer, Petra, Frias, Corazon, Herling, Carmen D., Hallek, Michael, Schmalz, Hans-Guenther ORCID: 0000-0003-0489-1827, Prokop, Aram, Mougiakakos, Dimitrios and Herling, Marco (2015). Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden. Mol. Cancer, 14. LONDON: BMC. ISSN 1476-4598

Ram, Ron, Scheid, Christof, Amit, Odelia, Chemnitz, Jens Markus, Moshe, Yakir, Hallek, Michael, Wolf, Dominik, Avivi, Irit and Holtick, Udo (2019). Sequential therapy or patients with primary refractory acute myeloid leukemia: a historical prospective analysis of the German and Israeli experience. Haematologica, 104 (9). S. 1798 - 1804. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Rassaf, Tienush, Totzeck, Matthias, Backs, Johannes, Bokemeyer, Carsten, Hallek, Michael, Hilfiker-Kleiner, Denise, Hochhaus, Andreas, Lueftner, Diana, Mueller, Oliver J., Neudorf, Ulrich, Pfister, Roman, von Haehling, Stephan, Lehmann, Lorenz H. and Bauersachs, Johann (2020). Onco-Cardiology Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology. Kardiologe, 14 (4). S. 267 - 294. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1864-9726

Rassaf, Tienush, Totzeck, Matthias, Backs, Johannes, Bokemeyer, Carsten, Hallek, Michael, Hilfiker-Kleiner, Denise, Hochhaus, Andreas, Lueftner, Diana, Mueller, Oliver J., Neudorf, Ulrich, Pfister, Roman, von Haehling, Stephan, Lehmann, Lorenz H. and Bauersachs, Johann (2020). Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology. Clin. Res. Cardiol., 109 (10). S. 1197 - 1223. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1861-0692

Rawstron, Andy, Fazi, Claudia, Villamor, Neus, Delgado, Julio ORCID: 0000-0002-5157-4376, Letestu, Remi, Cymbalista, Florence, Palacio, Carlos, Bosch, Francesc ORCID: 0000-0001-9241-2886, De Tute, Ruth M., Liptrot, Stuart, O'Brien, David, Spacek, Martin ORCID: 0000-0001-5250-8218, Dobber, Johan, Kater, Arnon P., Gambell, Peter C., Westerman, David A., Soosapilla, Asha, Mulligan, Stephen P., Lozanski, Gerard, Lin, Ke, Pettitt, Andrew R., Brachtl, Gabi, Egle, Alexander, Williamson, David W., Sanders, Catherine M., Robins, Harlan, Boysen, Justin, Shanafelt, Tait D., Hanson, Curtis A., Jorgensen, Jeffrey L., Wierda, William G., Yuan, Constance, Stetler-Stevenson, Maryalice, Rassenti, Laura, Broome, H. Elizabeth, Kipps, Thomas J., Hauwel, Mathieu, Marinov, Iuri, Craig, Fiona E., Josep, Nomdedeu, Moreno, Carol, Stehlikova, Olga, Doubek, Michael, Pospisilova, Sarka, Kreuzer, Karl-Anton, Hallek, Michael, Hillmen, Peter, Montserrat, Emili and Ghia, Paolo (2014). A Complementary Role of High Throughput Sequencing and Multiparameter Cytometry for Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL):an European Research Initiative (ERIC) Study. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Rawstron, Andy C., Kreuzer, Karl-Anton, Soosapilla, Asha, Spacek, Martin ORCID: 0000-0001-5250-8218, Gambell, Peter, McIver-brown, Neil, Psarra, Katherina, Arroz, Maria, Milani, Raffaella, de la Serna, Javier, Teresa Cedena, M., Jaksic, Ozren, Nomdedeu, Josep F., Moreno, Carol, Rigolin, Gian Matteo, Cuneo, Antonio, Johansen, Preben, Johnsen, Hans Erik ORCID: 0000-0001-8253-2913, Rosenquist, Richard, Niemann, Carsten Utoft, Kern, Wolfgang, Westerman, David A., Trneny, Marek, Mulligan, Stephen P., Hillmen, Peter, Oscier, David G., Hallek, Michael, Ghia, Paolo and Montserrat, Emili (2015). Reproducible Diagnosis of Chronic Lymphocytic Leukemia (CLL) By Flow Cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation Project. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Rawstron, Andy C., Kreuzer, Karl-Anton, Soosapilla, Asha, Spacek, Martin ORCID: 0000-0001-5250-8218, Stehlikova, Olga, Gambell, Peter, McIver-Brown, Neil, Villamor, Neus, Psarra, Katherina, Arroz, Maria, Milani, Raffaella, de la Serna, Javier, Teresa Cedena, M., Jaksic, Ozren, Nomdedeu, Josep ORCID: 0000-0003-3399-346X, Moreno, Carol, Rigolin, Gian Matteo, Cuneo, Antonio, Johansen, Preben, Johnsen, Hans E., Rosenquist, Richard, Niemann, Carsten Utoft, Kern, Wolfgang, Westerman, David, Trneny, Marek, Mulligan, Stephen, Doubek, Michael, Pospisilova, Sarka, Hillmen, Peter, Oscier, David, Hallek, Michael, Ghia, Paolo ORCID: 0000-0003-3750-7342 and Montserrat, Emili (2018). Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project. Cytom. Part B-Clin. Cytom., 94 (1). S. 121 - 129. HOBOKEN: WILEY. ISSN 1552-4957

Reinart, Nina and Hallek, Michael (2015). Functional role of LYN kinase in CLL progression - an in vivo analysis. Leuk. Lymphoma, 56. S. 9 - 11. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Reiners, Katrin S., Shatnyeva, Olga, Vasyutina, Elena, Boesl, Teresa, Hansen, Hinrich P., Hallek, Michael, Herling, Marco and von Strandmann, Elke Pogge (2017). Extracellular vesicles released from chronic lymphocytic leukemia cells exhibit a disease relevant mRNA signature and transfer mRNA to bystander cells. Haematologica, 102 (3). S. E100 - 4. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Rice, Carmel, Eikema, Dirk-Jan, Marsh, Judith C. W., Knol, Cora, Hebert, Kyle, Putter, Hein ORCID: 0000-0001-5395-1422, Peterson, Eefke, Deeg, H. Joachim, Halkes, Stijn, Pidala, Joseph, Anderlini, Paolo, Tischer, Johanna, Kroger, Nicolaus, McDonald, Andrew, Antin, Joseph H., Schaap, Nicolaas P., Hallek, Michael, Einsele, Herman, Mathews, Vikram, Kapoor, Neena, Boelens, Jaap-Jan, Mufti, Ghulam J., Potter, Victoria, de la Tour, Regis Pefault, Eapen, Mary and Dufour, Carlo (2019). Allogeneic Hematopoietic Cell Transplantation in Patients Aged 50 Years or Older with Severe Aplastic Anemia. Biol. Blood Marrow Transplant., 25 (3). S. 488 - 496. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1523-6536

Ringden, Olle, Labopin, Myriam, Kolb, Hans Jochem, Michallet, Mauricette, Kroeger, Nicolaus, Ganser, Arnold, Bunjes, Donald, Hallek, Michael, Kanz, Lothar, Schwerdtfeger, Rainer, Holler, Ernst, Arnold, Renate, Huynh, Anne, Nagler, Arnon, Schmid, Christoph and Mohty, Mohamad (2012). Sequential Chemotherapy Followed by Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation (allo-SCT) in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML): A Survey From the Acute Leukemia Working Party of EBMT. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Robak, Tadeusz, Hellman, Andrzej, Loscertales, Javier, Lech-Maranda, Ewa ORCID: 0000-0001-9592-0851, Pagel, John M., Mato, Anthony R., Byrd, John C., Awan, Farrukh ORCID: 0000-0003-1813-9812, Hebart, Holger, Garcia-Marco, Jose A., Hill, Brian T., Hallek, Michael, Stromatt, Scott and Kloczko, Janusz (2014). Phase 2 Study of Otlertuzumab (TRU-016), an Anti-CD37 ADAPTIR (TM) Protein, in Combination with Bendamustine Vs Bendamustine Alone in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL) - Updated Results. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Robak, Tadeusz, Hellmann, Andrzej, Kloczko, Janusz, Loscertales, Javier, Lech-Maranda, Ewa ORCID: 0000-0001-9592-0851, Pagel, John M., Mato, Anthony, Byrd, John C., Awan, Farrukh T., Hebart, Holger, Garcia-Marco, Jose A., Hill, Brian T., Hallek, Michael, Eisenfeld, Amy J., Stromatt, Scott C. and Jaeger, Ulrich (2017). Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia. Br. J. Haematol., 176 (4). S. 618 - 629. HOBOKEN: WILEY. ISSN 1365-2141

Roberts, Andrew W., Ma, Shuo, Kipps, Thomas J., Coutre, Steven E., Davids, Matthew S., Eichhorst, Barbara, Hallek, Michael, Byrd, John C., Humphrey, Kathryn, Zhou, Lang, Chyla, Brenda, Nielsen, Jacqueline, Potluri, Jalaja, Kim, Su Young, Verdugo, Maria, Stilgenbauer, Stephan, Wierda, William G. and Seymour, John F. (2019). Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables. Blood, 134 (2). S. 111 - 123. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Roberts, Andrew W., Seymour, John F., Eichhorst, Barbara, Stilgenbauer, Stephan, Choi, Michael Y., Davids, Matthew S., Gerecitano, John F., Popovic, Relja, Chyla, Brenda, Zhu, Ming, Verdugo, Maria, Potluri, Jalaja, Lash, Leanne, Kim, Su Young and Hallek, Michael (2016). Pooled Multi-Trial Analysis of Venetoclax Efficacy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Rossi, Axel, Dupaty, Lea, Aillot, Ludovic, Zhang, Liang, Gallien, Celia, Hallek, Michael, Odenthal, Margarete, Adriouch, Sahil, Salvetti, Anna ORCID: 0000-0003-2007-8350 and Buening, Hildegard (2019). Vector uncoating limits adenoassociated viral vector-mediated transduction of human dendritic cells and vector immunogenicity. Sci Rep, 9. LONDON: NATURE PUBLISHING GROUP. ISSN 2045-2322

Rothe, Achim, Classen, Annika, Carney, Jonathan, Hallek, Michael, Mellinghoff, Sibylle C., Scheid, Christoph, Holtick, Udo and von Bergwelt-Baildon, Michael (2020). Bridging antifungal prophylaxis with 50 mg or 100 mg micafungin in allogeneic stem cell transplantation: A retrospective analysis. Eur. J. Haematol., 104 (4). S. 291 - 299. HOBOKEN: WILEY. ISSN 1600-0609

Rothe, Achim, Jachimowicz, Ron D., Borchmann, Sven, Madlener, Marie, Kessler, Joerg, Reiners, Katrin S., Sauer, Maike, Hansen, Hinrich P., Ullrich, Roland T., Chatterjee, Sampurna, Borchmann, Peter, Yazaki, Paul, Koslowsky, Thomas C., Engert, Andreas, Heukamp, Lukas C., Hallek, Michael and von Strandmann, Elke Pogge (2014). The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma. Int. J. Cancer, 134 (12). S. 2829 - 2841. HOBOKEN: WILEY. ISSN 1097-0215

Rubio, Marie T., Savani, Bipin N., Labopin, Myriam, Polge, Emmanuelle, Niederwieser, Dietger, Ganser, Arnold, Schwerdtfeger, Rainer, Ehninger, Gerhard, Finke, Juergen, Renate, Arnold, Craddock, Charles ORCID: 0000-0001-5041-6678, Kroeger, Nicolaus, Hallek, Michael, Jindra, Pavel, Mohty, Mohamad and Nagler, Arnon (2016). The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working party. J. Hematol. Oncol., 9. LONDON: BIOMED CENTRAL LTD. ISSN 1756-8722

Rusyn, Lisa, Reinartz, Sebastian, Nikiforov, Anastasia, Mikhael, Nelly, vom Stein, Alexander, Kohlhas, Viktoria, Bloehdorn, Johannes ORCID: 0000-0003-1433-9702, Stilgenbauer, Stephan, Lohneis, Philipp, Buettner, Reinhard, Robrecht, Sandra, Fischer, Kirsten, Pallasch, Christian, Hallek, Michael ORCID: 0000-0002-7425-4455 and Seeger-Nukpezah, Tamina (2022). The scaffold protein NEDD9 is necessary for leukemia-cell migration and disease progression in a mouse model of chronic lymphocytic leukemia. Leukemia, 36 (7). S. 1794 - 1806. LONDON: SPRINGERNATURE. ISSN 1476-5551

Sachanas, Sotirios, Pangalis, Gerassimos A., Fink, Anna-Maria, Bahlo, Jasmin, Fischer, Kirsten, Levidou, Georgia, Kyrtsonis, Marie-Christine, Bartzi, Vassiliki, Vassilakopoulos, Theodoros P., Kalpadakis, Christina, Koulieris, Efstathios, Moschogiannis, Maria, Yiakoumis, Xanthi, Tsirkinidis, Pantelis, Angelopoulou, Maria K., Eichhorst, Barbara and Hallek, Michael (2019). Small Lymphocytic Lymphoma: Analysis of Two Cohorts Including Patients in Clinical Trials of the German Chronic Lymphocytic Leukemia Study Group (GCLLSG) or in Real-Life Outside of Clinical Trials. Anticancer Res., 39 (5). S. 2591 - 2599. ATHENS: INT INST ANTICANCER RESEARCH. ISSN 1791-7530

Sallach, Jessica, Di Pasquale, Giovanni, Larcher, Fernando ORCID: 0000-0002-6771-3561, Niehoff, Nadine, Ruebsam, Matthias, Huber, Anke, Chiorini, Jay, Almarza, David, Eming, Sabine A., Ulus, Hikmet, Nishimura, Stephen, Hacker, Ulrich T., Hallek, Michael, Niessen, Carien M. and Buening, Hildegard (2014). Tropism-modified AAV Vectors Overcome Barriers to Successful Cutaneous Therapy. Mol. Ther., 22 (5). S. 929 - 940. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1525-0024

Salles, Gilles A., Boyd, Thomas E., Morschhauser, Franck, Wendtner, Clemens-Martin, Hallek, Michael, Eichhorst, Barbara F., Kozloff, Mark, Cartron, Guillaume, Li, Yan, Hilger, James, Mobasher, Mehrdad and Stilgenbauer, Stephan (2015). Updated Safety and Preliminary Efficacy Data from a Phase 1b Study Combining Venetoclax (GDC-0199, ABT-199) with Bendamustine/Rituximab in Patients with Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Samineni, Divya, Gibiansky, Leonid, Wang, Bei, Vadhavkar, Shweta, Rajwanshi, Richa, Tandon, Maneesh, Sinha, Arijit, Al-Sawaf, Othman, Fischer, Kirsten, Hallek, Michael ORCID: 0000-0002-7425-4455, Salem, Ahmed Hamed, Li, Chunze and Miles, Dale (2022). Pharmacokinetics and Exposure-Response Analysis of Venetoclax plus Obinutuzumab in Chronic Lymphocytic Leukemia: Phase 1b Study and Phase 3 CLL14 Trial. Adv. Ther., 39 (8). S. 3635 - 3654. NEW YORK: SPRINGER. ISSN 1865-8652

Santoro, Nicole, Labopin, Myriam, Giannotti, Federica, Ehninger, Gerard, Niederwieser, Dietger, Brecht, Arne, Stelljes, Matthias, Kroeger, Nicolaus, Einsele, Herman, Eder, Matthias, Hallek, Michael, Glass, Bertram, Finke, Juergen, Ciceri, Fabio, Mohty, Mohamad, Ruggeri, Annalisa and Nagler, Arnon (2018). Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT. J. Hematol. Oncol., 11. LONDON: BIOMED CENTRAL LTD. ISSN 1756-8722

Sascha, Dietrich, Pircher, Andreas ORCID: 0000-0002-7747-3012, Andrulis, Mindaugas, Ellert, Elena, Peyrade, Frederic, Wendtner, Clemens-Martin, Follows, George A., Dyer, Martin J. S., Elter, Thomas, Zeiser, Robert, Gaehler, Anita, Herrmann, Michael, Herold, Michael, Dearden, Claire, Glimm, Hanno, Hallek, Michael, Ho, Anthony D., Steurer, Michael and Zenz, Thorsten (2014). BRAF Inhibition in Hairy Cell Leukemia: Multicentre Experience of 21 Patients Treated with Vemurafenib. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Savani, Bipin N., Labopin, Myriam, Blaise, Didier, Niederwieser, Dietger, Ciceri, Fabio, Ganser, Arnold, Arnold, Renate, Afanasyev, Boris, Vigouroux, Stephane, Milpied, Noel ORCID: 0000-0002-5177-014X, Hallek, Michael, Cornelissen, Jan J., Schwerdtfeger, Rainer, Polge, Emmanuelle, Baron, Frederic, Esteve, Jordi, Gorin, Norbert C., Schmid, Christoph, Giebel, Sebastian ORCID: 0000-0002-4827-4401, Mohty, Mohamad and Nagler, Arnon (2016). Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT. Haematologica, 101 (2). S. 256 - 263. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Savani, Bipin N., Labopin, Myriam, Polge, Emmanuelle, Blaise, Didier, Niederwieser, Dietger, Ciceri, Fabio, Ganser, Arnold, Arnold, Renate, Afanasyev, Boris, Milpied, Noel, Hallek, Michael, Cornelissen, Jan, Schwerdtfeger, Rainer, Giebel, Sebastian, Mohty, Mohamad and Nagler, Arnon (2015). Influence of Stem Cell Source (Bone Marrow versus Peripheral Blood) on Outcome after Reduced-Intensity Conditioning Regimens for Acute Leukemia-a Report from the Acute Leukemia Working Party of the EBMT. Biol. Blood Marrow Transplant., 21 (2). S. S52 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1523-6536

Scheffold, Annika, Jebaraj, Billy Michael Chelliah, Jaramillo, Sonia, Tausch, Eugen, Steinbrecher, Daniela, Hahn, Michael, Boettcher, Sebastian, Ritgen, Matthias, Bunjes, Donald, Zeis, Matthias, Stadler, Michael, Uharek, Lutz, Scheid, Christoph, Hegenbart, Ute, Hallek, Michael, Kneba, Michael, Schmitz, Norbert, Doehner, Hartmut, Dreger, Peter and Stilgenbauer, Stephan (2017). Impact of telomere length on the outcome of allogeneic stem cell transplantation for poor-risk chronic lymphocytic leukaemia: results from the GCLLSG CLL3X trial. Br. J. Haematol., 179 (2). S. 342 - 347. HOBOKEN: WILEY. ISSN 1365-2141

Scheffold, Annika, Jebaraj, Billy Michael Chelliah, Tausch, Eugen, Boettcher, Sebastian, Ritgen, Matthias, Bunjes, Donald, Zeis, Matthias, Stadler, Michael, Uharek, Lutz, Scheid, Christof, Hegenbart, Ute, Hallek, Michael, Kneba, Michael, Schmitz, Norbert, Doehner, Hartmut, Dreger, Peter and Stilgenbauer, Stephan (2014). Telomere Lenght and Outcome of Allogeneic Stem Cell Transplantation for Poor Risk Chronic Lymphocytic Leukemia: Results from the GCLLSG CLL3X Trial. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Schilhabel, Anke, Walter, Peter Jonas, Cramer, Paula ORCID: 0000-0003-4046-9922, von Tresckow, Julia, Kohlscheen, Saskia, Szczepanowski, Monika ORCID: 0000-0001-5482-8880, Laqua, Anna, Fischer, Kirsten, Eichhorst, Barbara, Boettcher, Sebastian, Schneider, Christof, Tausch, Eugen, Brueggemann, Monika, Kneba, Michael, Hallek, Michael ORCID: 0000-0002-7425-4455 and Ritgen, Matthias (2022). CD20 Expression as a Possible Novel Prognostic Marker in CLL: Application of EuroFlow Standardization Technique and Normalization Procedures in Flow Cytometric Expression Analysis. Cancers, 14 (19). BASEL: MDPI. ISSN 2072-6694

Schloesser, Hans A., Drebber, Uta, Kloth, Michael, Thelen, Martin ORCID: 0000-0002-2785-9726, Rothschild, Sacha I., Haase, Simon, Garcia-Marquez, Maria, Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Berlth, Felix ORCID: 0000-0002-3780-0728, Urbanski, Alexander, Alakus, Hakan, Schauss, Astrid, Shimabukuro-Vornhagen, Alexander, Theurich, Sebastian ORCID: 0000-0001-5706-8258, Warnecke-Ebertz, Ute, Stippel, Dirk L., Zippelius, Alfred, Buettner, Reinhard, Hallek, Michael, Hoelscher, Arnulf H., Zander, Thomas, Moenig, Stefan P. and von Bergwelt-Baildon, Michael (2016). Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma. OncoImmunology, 5 (5). PHILADELPHIA: TAYLOR & FRANCIS INC. ISSN 2162-402X

Schmidt-Hellerau, Kirsten, Meyer-Schwickerath, Charlotte, Paul, Gregor ORCID: 0000-0002-1075-4362, Augustin, Max, Priesner, Vanessa, Rybniker, Jan, Suarez, Isabelle, Hallek, Michael, Burst, Volker, Kolibay, Felix, Fatkenheuer, Gerd, Lehmann, Clara and Jung, Norma (2021). Providing care in isolation while awaiting SARS-CoV-2 test results Considering differential diagnoses and avoiding anchoring bias. Medicine (Baltimore), 100 (30). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1536-5964

Schmoll, Hans-Joachim and Hallek, Michael (2011). Perspectives for ONKOLOGIE. Onkologie, 34 (12). S. 659 - 660. BASEL: KARGER. ISSN 0378-584X

Schnaiter, Andrea, Rossi, Marianna, Paschka, Peter, Cazzola, Mario, Doehner, Konstanze, Edelmann, Jennifer, Buehler, Andreas, Kless, Sabrina, Mertens, Daniel, Busch, Raymonde, Mack, Silja, Hallek, Michael, Doehner, Hartmut and Stilgenbauer, Stephan (2012). NOTCH1, SF3B1 and TP53 Mutations in Fludarabine-Refractory CLL Patients Treated with Alemtuzumab: Results From the CLL2H Trial of the Gcllsg. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Schrader, Alexandra, Popal, Wagma, Lilienthal, Nils, Crispatzu, Giuliano, Mayer, Petra, Jones, Dan, Hallek, Michael and Herling, Marco (2014). AKT-pathway Inhibition in Chronic Lymphocytic Leukemia Reveals Response Relationships Defined by TCL1. Curr. Cancer Drug Targets, 14 (8). S. 700 - 713. SHARJAH: BENTHAM SCIENCE PUBL LTD. ISSN 1873-5576

Schuldner, Maximiliane, Doersam, Bastian, Shatnyeva, Olga, Reiners, Katrin S., Kubarenko, Andriy, Hansen, Hinrich P., Finkernagel, Florian, Roth, Katrin, Theurich, Sebastian ORCID: 0000-0001-5706-8258, Nist, Andrea, Stiewe, Thorsten ORCID: 0000-0003-0134-7826, Paschen, Annette, Knittel, Gero, Reinhardt, Hans C., Mueller, Rolf, Hallek, Michael and von Strandmann, Elke Pogge (2019). Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53. Theranostics, 9 (21). S. 6047 - 6063. LAKE HAVEN: IVYSPRING INT PUBL. ISSN 1838-7640

Schwamb, Janine, Feldhaus, Valeska, Baumann, Michael, Patz, Michaela, Brodesser, Susanne, Brinker, Reinhild, Claasen, Julia, Pallasch, Christian P. ORCID: 0000-0001-5675-6905, Hallek, Michael, Wendtner, Clemens-Martin and Frenzel, Lukas P. (2012). B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides. Blood, 120 (19). S. 3978 - 3986. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Schwamb, Janine, Reinart, Nina, Vorholt, Daniela, Ulas, Thomas, Ristovska, Vangica, Braun, Christian J., Hemann, Michael T., Schultze, Joachim ORCID: 0000-0003-2812-9853, Hallek, Michael and Pallasch, Christian P. (2014). Phagocytic Function of Macrophages Is Impaired By Chronic Lymphocytic Leukemia and high-grade Lymphoma Progression and Can be Highly Effectively Restored for Chemo-Immunotherapy. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Schweighofer, Carmen D., Tuchscherer, Armin, Sperka, Sabine, Meyer, Thorsten, Rattel, Benno, Stein, Sandra, Ismail, Semra, Elter, Thomas, Staib, Peter, Reiser, Marcel and Hallek, Michael (2012). Clinical safety and pharmacological profile of the HLA-DR antibody 1D09C3 in patients with B cell chronic lymphocytic leukemia and lymphoma: results from a phase I study. Cancer Immunol. Immunother., 61 (12). S. 2367 - 2374. NEW YORK: SPRINGER. ISSN 0340-7004

Segura, Sonia Jaramillo, Agathangelidis, Andreas, Schneider, Christof, Bahlo, Jasmin, Robrecht, Sandra, Tausch, Eugen, Bloehdorn, Johannes, Hoechstetter, Manuela, Fischer, Kirsten, Eichhorst, Barbara, Goede, Valentin, Hallek, Michael, Doehner, Hartmut, Brandell, Richard Rosenquist, Ghia, Paolo, Stamatopoulos, Kostas and Stilgenbauer, Stephan (2020). Prognostic impact of common chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG). Leuk. Lymphoma, 61. S. 135 - 137. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Sehn, Laurie H., Hallek, Michael, Jurczak, Wojciech, Brown, Jennifer R., Barr, Paul M., Catalano, John, Coutre, Steven E., Furman, Richard R., Lamanna, Nicole, Loic, Ysebaert, Zelenetz, Andrew D., Sharman, Jeffrey P., Devos, Sven, Adewoye, Adeboye Henry, Kim, Yeonhee, Flinn, Ian W. and Salles, Gilles A. (2016). A Retrospective Analysis of Pneumocystis Jirovecii Pneumonia Infection in Patients Receiving Idelalisib in Clinical Trials. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Seidel, Danila ORCID: 0000-0003-4388-3117, Zander, Thomas, Heukamp, Lukas C., Peifer, Martin ORCID: 0000-0002-5243-5503, Bos, Marc, Fernandez-Cuesta, Lynnette ORCID: 0000-0002-0724-6703, Leenders, Frauke, Lu, Xin, Ansen, Sascha, Gardizi, Masyar, Nguyen, Chau, Berg, Johannes, Russell, Prudence, Wainer, Zoe, Schildhaus, Hans-Ulrich, Rogers, Toni-Maree, Solomon, Benjamin, Pao, William, Carter, Scott L., Getz, Gad, Hayes, D. Neil, Wilkerson, Matthew D., Thunnissen, Erik, Travis, William D., Perner, Sven, Wright, Gavin ORCID: 0000-0002-7000-9305, Brambilla, Elisabeth, Buettner, Reinhard, Wolf, Juergen, Thomas, Roman, Gabler, Franziska, Wilkening, Ines, Mueller, Christian, Dahmen, Ilona, Menon, Roopika, Koenig, Katharina, Albus, Kerstin, Merkelbach-Bruse, Sabine, Fassunke, Jana, Schmitz, Katja, Kuenstlinger, Helen, Kleine, Michaela, Binot, Elke, Querings, Silvia, Altmueller, Janine, Boessmann, Ingelore, Nuemberg, Peter, Schneider, Peter, Bogus, Magdalena, Buettner, Reinhard, Perner, Sven, Russell, Prudence, Thunnissen, Erik, Travis, William D., Brambilla, Elisabeth, Soltermann, Alex, Moch, Holger, Brustugun, Odd Terje, Solberg, Steinar, Lund-Iversen, Marius, Helland, Aslaug ORCID: 0000-0002-5520-0275, Muley, Thomas, Hoffmann, Hans, Schnabel, Philipp A., Chen, Yuan, Groen, Harry, Timens, Wim ORCID: 0000-0002-4146-6363, Sietsma, Hannie, Clement, Joachim H. ORCID: 0000-0002-6601-2456, Weder, Walter, Saenger, Joerg, Stoelben, Erich, Ludwig, Corinna, Engel-Riedel, Walburga, Smit, Egbert, Heideman, Danille A. M., Snijders, Peter J. F., Nogova, Lucia, Sos, Martin L., Mattonet, Christian, Toepelt, Karin, Scheffler, Matthias ORCID: 0000-0002-9031-1368, Goekkurt, Eray, Kappes, Rainer, Krueger, Stefan, Kambartel, Kato, Behringer, Dirk, Schulte, Wolfgang, Galetke, Wolfgang, Randerath, Winfried, Heldwein, Matthias, Schlesinger, Andreas, Serke, Monika, Hekmat, Khosro, Frank, Konrad F., Schnell, Roland, Reiser, Marcel, Huenerlituerkoglu, Ali-Nuri, Schmitz, Stephan, Meffert, Lisa, Ko, Yon-Dschun, Litt-Lampe, Markus, Gerigk, Ulrich, Fricke, Rainer, Besse, Benjamin ORCID: 0000-0001-5090-8189, Brambilla, Christian, Lantuejoul, Sylvie, Lorimier, Philippe, Moro-Sibilot, Denis, Cappuzzo, Federico, Ligorio, Claudia, Damiani, Stefania, Field, John K. ORCID: 0000-0003-3951-6365, Hyde, Russell, Validire, Pierre, Girard, Philippe, Muscarella, Lucia A., Fazio, Vito M., Hallek, Michael, Soria, Jean-Charles, Carter, Scott L., Getz, Gad, Hayes, D. Neil, Wilkerson, Matthew D., Achter, Viktor, Lang, Ulrich ORCID: 0000-0001-7166-0805, Seidel, Danila ORCID: 0000-0003-4388-3117, Zander, Thomas, Heukamp, Lukas C., Peifer, Martin ORCID: 0000-0002-5243-5503, Bos, Marc, Pao, William, Travis, William D., Brambilla, Elisabeth, Buettner, Reinhard, Wolf, Juergen and Thomas, Roman K. (2013). A Genomics-Based Classification of Human Lung Tumors. Sci. Transl. Med., 5 (209). WASHINGTON: AMER ASSOC ADVANCEMENT SCIENCE. ISSN 1946-6242

Seymour, John F., Davids, Matthew S., Roberts, Andrew W., Hallek, Michael, Wierda, William G., Hillmen, Peter, Gerecitano, John F., Cerri, Elisa, Potluri, Jalaja, Kim, Su Young, Busman, Todd, Verdugo, Maria, Humerickhouse, Rod A., Best, Andrea, Desai, Monali and Stilgenbauer, Stephan (2016). Safety Profile of Venetoclax Monotherapy in Patients with Chronic Lymphocytic Leukemia. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Shanafelt, Tait D., Parikh, Sameer A., Noseworthy, Peter A., Goede, Valentin, Chaffee, Kari G., Bahlo, Jasmin, Call, Timothy G., Schwager, Susan M., Ding, Wei, Eichhorst, Barbara, Fischer, Kirsten, Leis, Jose F., Chanan-Khan, Asher Alban, Hallek, Michael, Slager, Susan L. and Kay, Neil E. (2017). Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL). Leuk. Lymphoma, 58 (7). S. 1630 - 1640. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Sharman, Jeff P., Coutre, Steven E., Furman, Richard R., Cheson, Bruce D., Pagel, John M., Hillmen, Peter, Barrientos, Jacqueline C., Zelenetz, Andrew D., Kipps, Thomas J., Flinn, Ian W., Ghia, Paolo ORCID: 0000-0003-3750-7342, Eradat, Herbert, Ervin, Thomas, Lamanna, Nicole, Coiffier, Bertrand, Pettitt, Andrew R., Ma, Shuo, Tausch, Eugen, Cramer, Paula, Huang, Julie, Mitra, Siddhartha, Hallek, Michael, O'Brien, Susan M. and Stilgenbauer, Stephan (2019). Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia. J. Clin. Oncol., 37 (16). S. 1391 - 1405. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Sharman, Jeff P., Coutre, Steven E., Furman, Richard R., Cheson, Bruce D., Pagel, John M., Hillmen, Peter, Barrientos, Jacqueline C., Zelenetz, Andrew D., Kipps, Thomas J., Flinn, Ian W., Ghia, Paolo, Hallek, Michael, Coiffier, Bertrand, O'Brien, Susan, Tausch, Eugen, Kreuzer, Karl-Anton, Jiang, Wendy, Lazarov, Mirella, Li, Daniel, Jahn, Thomas M. and Stilgenbauer, Stephan (2014). Second Interim Analysis of a Phase 3 Study of Idelalisib (ZYDELIG (R)) Plus Rituximab (R) for Relapsed Chronic Lymphocytic Leukemia (CLL): Efficacy Analysis in Patient Subpopulations with Del(17p) and Other Adverse Prognostic Factors. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, Garcia-Marquez, Maria Alejandra ORCID: 0000-0002-5923-5942, Fischer, Rieke N., Iltgen-Breburda, Juliane, Fiedler, Anne, Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Rappl, Gunter ORCID: 0000-0003-0402-7940, Abken, Hinrich ORCID: 0000-0002-4302-3240, Lehmann, Clara ORCID: 0000-0002-7042-1578, Herling, Marco, Wolf, Dominik, Fätkenheuer, Gerd ORCID: 0000-0002-5054-1871, Rubbert-Roth, Andrea ORCID: 0000-0002-9016-2833, Hallek, Michael ORCID: 0000-0002-7425-4455, Theurich, Sebastian ORCID: 0000-0001-5706-8258 and von Bergwelt-Baildon, Michael (2017). Antigen-presenting human B cells are expanded in inflammatory conditions. J. Leukoc. Biol., 101 (2). S. 577 - 588. HOBOKEN: WILEY. ISSN 1938-3673

Shimabukuro-Vornhagen, Alexander, Marquez, Maria Alejandra Garcia, Fischer, Rieke N., Iltgen-Breburda, Juliane, Fiedler, Anne, Wennhold, Kerstin, Rappl, Gunter, Abken, Hinrich, Hartmann, Pia, Lehmann, Clara, Koslowsky, Thomas, Herling, Marco, Beutner, Dirk, Wolf, Dominik, Faetkenheuer, Gerd, Rubbert-Roth, Andrea, Hallek, Michael, Theurich, Sebastian and von Bergwelt-Baildon, Michael (2015). Human CD21(low) CD86(pos) B Cells Are Potent Antigen Presenting Cells, Which Are Expanded in Inflammatory Conditions. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, Schloesser, Hans A., Gryschok, Luise, Malcher, Joke, Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Garcia-Marquez, Maria, Herbold, Till, Neuhaus, Laura S., Becker, Hans J., Fiedler, Anne, Scherwitz, Pascal, Koslowsky, Thomas, Hake, Roland, Stippel, Dirk L., Hoelscher, Arnulf H., Eidt, Sebastian, Hallek, Michael, Theurich, Sebastian ORCID: 0000-0001-5706-8258 and von Bergwelt-Baildon, Michael S. (2014). Characterization of tumor-associated B-cell subsets in patients with colorectal cancer. Oncotarget, 5 (13). S. 4651 - 4665. ORCHARD PARK: IMPACT JOURNALS LLC. ISSN 1949-2553

Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, Zoghi, Shahram, Liebig, Tanja M., Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Chemitz, Jens, Draube, Andreas, Kochanek, Matthias, Blaschke, Florian, Pallasch, Christian, Holtick, Udo, Scheid, Christof, Theurich, Sebastian ORCID: 0000-0001-5706-8258, Hallek, Michael and von Bergwelt-Baildon, Michael S. (2014). Inhibition of Protein Geranylgeranylation Specifically Interferes with CD40-Dependent B Cell Activation, Resulting in a Reduced Capacity To Induce T Cell Immunity. J. Immunol., 193 (10). S. 5294 - 5306. BETHESDA: AMER ASSOC IMMUNOLOGISTS. ISSN 1550-6606

Simon, Florian, Giza, Adam, Robrecht, Sandra, Fink, Anna-Maria, Cramer, Paula ORCID: 0000-0003-4046-9922, von Tresckow, Julia, Fuerstenau, Moritz, Goede, Valentin, Tausch, Eugen, Schneider, Christof, Stilgenbauer, Stephan, Wendtner, Clemens-Martin, Eichhorst, Barbara, Fischer, Kirsten, Hallek, Michael ORCID: 0000-0002-7425-4455 and Al-Sawaf, Othman (2022). Pooled analysis of first-line treatment with targeted agents in patients with chronic lymphocytic leukemia aged 80 years and older. Leuk. Lymphoma, 63 (14). S. 3299 - 3307. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Simon, Steffen T., Pralong, Anne ORCID: 0000-0001-8201-2344, Hallek, Michael, Scheid, Christoph, Holtick, Udo and Herling, Marco (2021). What is known about palliative care in adult patients with allogeneic stem cell transplantation (allo-SCT)? Ann. Hematol., 100 (6). S. 1377 - 1390. NEW YORK: SPRINGER. ISSN 1432-0584

Soumerai, Jacob D., Ni, Ai ORCID: 0000-0003-3002-3556, Xing, Guan, Huang, Julie, Furman, Richard R., Jones, Jeffrey, Sharman, Jeffrey P., Hallek, Michael, Adewoye, Adeboye H., Dubowy, Ronald, Dreiling, Lyndah and Zelenetz, Andrew D. (2019). Evaluation of the CLL-IPI in relapsed and refractory chronic lymphocytic leukemia in idelalisib phase-3 trials. Leuk. Lymphoma, 60 (6). S. 1438 - 1447. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Soumerai, Jacob Drobnyk, Barrientos, Jacqueline Claudia, Hallek, Michael, Kipps, Thomas J., Jones, Jeffrey Alan, Stilgenbauer, Stephan, Xing, Guan, Yao, Nai-Shun, Ysebaert, Loic and Zelenetz, Andrew David (2016). An evaluation of the chronic lymphocytic leukemia (CLL) international prognostic index as a prognostic tool in patients with relapsed/refractory CLL in idelalisib phase 3 randomized studies. J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Steinbrecher, Daniela, Jebaraj, Billy Michael Chelliah, Schneider, Christof, Edelmann, Jennifer, Cymbalista, Florence, Leblond, Veronique, Delmer, Alain ORCID: 0000-0002-1430-2574, Ibach, Stefan, Tausch, Eugen, Scheffold, Annika, Bloehdorn, Johannes, Hallek, Michael, Dreger, Peter, Doehner, Hartmut and Stilgenbauer, Stephan (2018). Telomere length in poor-risk chronic lymphocytic leukemia: associations with disease characteristics and outcome. Leuk. Lymphoma, 59 (7). S. 1614 - 1624. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Stilgenbauer, Stephan, Busch, Raymonde, Schnaiter, Andrea, Paschka, Peter, Rossi, Marianna, Doehner, Konstanze, Zenz, Thorsten, Buehler, Andreas, Winkler, Dirk, Edelmann, Jennifer, Mertens, Daniel, Bullinger, Lars, Kless, Sabrina, Mack, Silja, Boettcher, Sebastian, Ritgen, Matthias, Kneba, Michael, Jaeger, Ulrich, Lichter, Peter, Patten, Nancy, Wenger, Michael K., Mendila, Myriam, Fingerle-Rowson, Gunter, Cazzola, Mario, Wendtner, Clemens, Fink, Anna Maria, Fischer, Kirsten, Hallek, Michael and Doehner, Hartmut (2012). Gene Mutations and Treatment Outcome in Chronic Lymphocytic Leukemia: Results From the CLL8 Trial. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Stilgenbauer, Stephan, Cymbalista, Florence, Leblond, Veronique, Delmer, Alain, Ibach, Stefan, Choquet, Sylvain, Dartigeas, Caroline, Cazin, Bruno, Tournilhac, Olivier, Pegourie, Brigitte, Seiler, Till M., Soekler, Martin, Zirlik, Katja, Alt, Juergen, Huber, Henriette, Bloehdorn, Johannes, Tausch, Eugen, Zenz, Thorsten, Hallek, Michael, Schetelig, Johannes, Dreger, Peter and Doehner, Hartmut (2014). Alemtuzumab Combined with Dexamethasone, Followed By Alemtuzumab Maintenance or Allo-SCT in ultra High-risk CLL: Final Results from the CLL2O Phase II Study. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Stilgenbauer, Stephan, Cymbalista, Florence, Leblond, Veronique, Delmer, Alain, Mack, Silja, Buehler, Andreas, Winkler, Dirk, Zenz, Thorsten, Busch, Raymonde, Ibach, Stefan, Choquet, Sylvain, Caroline, Dartigeas, Cazin, Bruno, Tournilhac, Olivier, Seiler, Till M., Zirlik, Katja, Alt, Juergen, Soekler, Martin, Schetelig, Johannes, Dreger, Peter, Hallek, Michael and Doehner, Hartmut (2012). Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Stilgenbauer, Stephan, Eichhorst, Barbara, Schetelig, Johannes, Coutre, Steven, Seymour, John F., Munir, Talha, Puvvada, Soham D., Wendtner, Clemens-Martin, Roberts, Andrew W., Jurczak, Wojciech ORCID: 0000-0003-1879-8084, Mulligan, Stephen P., Boettcher, Sebastian, Mobasher, Mehrdad, Zhu, Ming, Desai, Monali, Chyla, Brenda, Verdugo, Maria, Enschede, Sari Heitner, Cerri, Elisa, Humerickhouse, Rod, Gordon, Gary, Hallek, Michael and Wierda, William G. (2016). Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study. Lancet Oncol., 17 (6). S. 768 - 779. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-5488

Stilgenbauer, Stephan, Eichhorst, Barbara, Schetelig, Johannes, Hillmen, Peter, Seymour, John F., Coutre, Steven, Jurczak, Wojciech ORCID: 0000-0003-1879-8084, Mulligan, Stephen P., Schuh, Anna, Assouline, Sarit, Wendtner, Clemens-Martin, Roberts, Andrew W., Davids, Matthew S., Bloehdorn, Johannes, Munir, Talha, Boettcher, Sebastian, Zhou, Lang, Salem, Ahmed Hamed, Desai, Monali, Chyla, Brenda, Arzt, Jennifer, Kim, Su Young, Verdugo, Maria, Gordon, Gary, Hallek, Michael and Wierda, William G. (2018). Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial. J. Clin. Oncol., 36 (19). S. 1973 - 1984. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Stilgenbauer, Stephan, Eichhorst, Barbara F., Schetelig, Johannes, Coutre, Steven, Seymour, John F., Munir, Talha, Puvvada, Soham D., Wendtner, Clemens-Martin, Roberts, Andrew W., Jurczak, Wojciech, Mulligan, Stephen, Boettcher, Sebastian, Mobasher, Mehrdad, Zhu, Ming, Chyla, Brenda, Verdugo, Maria, Enschede, Sari Heitner, Cerri, Elisa, Humerickhouse, Rod A., Gordon, Gary, Hallek, Michael and Wierda, William (2015). Venetoclax (ABT-199/GDC-0199) Monotherapy Induces Deep Remissions, Including Complete Remission and Undetectable MRD, in Ultra-High Risk Relapsed/Refractory Chronic Lymphocytic Leukemia with 17p Deletion: Results of the Pivotal International Phase 2 Study. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Stilgenbauer, Stephan, Jones, Jeffrey A., Coutre, Steven, Mato, Anthony R., Hillmen, Peter, Tam, Constantine, Osterborg, Anders, Siddiqi, Tanya, Thirman, Michael J., Furman, Richard R., Ilhan, Osman, Keating, Michael, Call, Timothy G., Brown, Jennifer R., Li, Yunfeng, Eckert, Karl, Chang, Betty Y., James, Danelle F., Chu, Alvina D., Hallek, Michael and O'Brien, Susan (2015). Outcome of Ibrutinib Treatment by Baseline Genetic Features in Patients with Relapsed or Refractory CLL/SLL with del17p in the Resonate-17 Study. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Stilgenbauer, Stephan, Morschhauser, Franck, Wendtner, Clemens-Martin, Cartron, Guillaume, Hallek, Michael, Eichhorst, Barbara, Kozloff, Mark F., Giever, Thomas, Lozanski, Gerard, Jiang, Yanwen, Huang, Huang, Pignataro, Daniela Soriano, Schary, William, Humphrey, Kathryn, Mobasher, Mehrdad and Salles, Gilles (2018). Safety and Efficacy of Venetoclax (VEN) in Combination with Bendamustine (B) Plus Rituximab (R) or Obinutuzumab (G) in Patients (pts) with Previously Untreated Chronic Lymphocytic Leukemia (CLL): Results from a Phase Ib Study (GO28440). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Stilgenbauer, Stephan, Morschhauser, Franck, Wendtner, Clemens-Martin, Cartron, Guillaume, Hallek, Michael, Eichhorst, Barbara, Kozloff, Mark F., Giever, Thomas, Lozanski, Gerard, Jiang, Yanwen, Huang, Huang, Pignataro, Daniela Soriano, Schary, William, Humphrey, Kathryn, Mobasher, Mehrdad and Salles, Gilles (2021). Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase Ib study (GO28440). Haematologica, 106 (11). S. 2834 - 2845. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Stilgenbauer, Stephan, Morschhauser, Franck, Wendtner, Clemens-Martin, Cartron, Guillaume, Hallek, Michael, Eichhorst, Barbara F., Kozloff, Mark, Giever, Thomas A., Lozanski, Gerard, Punnoose, Elizabeth A., Wang, Jue, Hilger, James, Mobasher, Mehrdad and Salles, Gilles (2016). Phase Ib Study (GO28440) of Venetoclax with Bendamustine/Rituximab or Bendamustine/Obinutuzumab in Patients with Relapsed/ Refractory or Previously Untreated Chronic Lymphocytic Leukemia. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Stilgenbauer, Stephan, Schnaiter, Andrea, Paschka, Peter, Zenz, Thorsten, Rossi, Marianna ORCID: 0000-0003-1661-1511, Doehner, Konstanze, Buehler, Andreas, Boettcher, Sebastian, Ritgen, Matthias, Kneba, Michael, Winkler, Dirk, Tausch, Eugen, Hoth, Patrick, Edelmann, Jennifer, Mertens, Daniel ORCID: 0000-0003-0227-7188, Bullinger, Lars, Bergmann, Manuela, Kless, Sabrina, Mack, Silja, Jaeger, Ulrich, Patten, Nancy, Wu, Lin, Wenger, Michael K., Fingerle-Rowson, Guenter, Lichter, Peter, Cazzola, Mario, Wendtner, Clemens M., Fink, Anna M., Fischer, Kirsten, Busch, Raymonde, Hallek, Michael and Doehner, Hartmut (2014). Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial. Blood, 123 (21). S. 3247 - 3255. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Streckmann, Fiona, Balke, Maryam, Lehmann, Helmar C., Rustler, Vanessa, Koliamitra, Christina, Elter, Thomas, Hallek, Michael, Leitzmann, Michael, Steinmetz, Tilman, Heinen, Petra, Baumann, Freerk T. and Bloch, Wilhelm (2018). The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP. BMC Cancer, 18. LONDON: BIOMED CENTRAL LTD. ISSN 1471-2407

Strunk, Maximilian Alexander, Zopf, Eva M., Steck, Jule, Hamacher, Stefanie ORCID: 0000-0003-2158-9101, Hallek, Michael and Baumann, Freerk T. (2018). Effects of Kyusho Jitsu on Physical Activity-levels and Quality of Life in Breast Cancer Patients. In Vivo, 32 (4). S. 819 - 825. ATHENS: INT INST ANTICANCER RESEARCH. ISSN 1791-7549

Tahmaz, Volkan, Gehlsen, Uta ORCID: 0000-0001-9057-9199, Sauerbier, Laura, Holtick, Udo, Engel, Lisa, Radojska, Stela, Petrescu-Jipa, Viorica-Maria, Scheid, Christof, Hallek, Michael, Gathof, Birgit, Cursiefen, Claus and Steven, Philipp (2017). Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study. Br. J. Ophthalmol., 101 (3). S. 322 - 327. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2079

Tausch, Eugen, Schneider, Christof, Furstenau, Moritz, Robrecht, Sandra, Yosifov, Deyan Yordanov, Mertens, Daniel, Gregor, Michael, Thornton, Patrick, Staber, Philipp B., Tadmor, Tamar, Levin, Mark-David, Da Cunha-Bang, Caspar, Poulsen, Christian Bjorn, Illmer, Thomas, Schoettker, Bjoern, Janssens, Ann, Christiansen, Ilse, Noesslinger, Thomas, Baumann, Michael, Wendtner, Clemens-Martin, Eldering, Eric, Kreuzer, Karl-Anton, Ritgen, Matthias, Fink, Anna-Maria, Fischer, Kirsten, Kater, Arnon P., Niemann, Carsten Utoft, Hallek, Michael, Eichhorst, Barbara and Stilgenbauer, Stephan (2022). Genetic Markers and Front Line FCR/BR Vs. Rve, Gve and Give Treatment - Outcome Results from the CLL13/GAIA Trial. Blood, 140. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Tausch, Eugen, Schneider, Christof, Robrecht, Sandra, Zhang, Can, Dolnik, Anna, Bloehdorn, Johannes, Bahlo, Jasmin, Al-Sawaf, Othman, Ritgen, Matthias, Fink, Anna-Maria, Eichhorst, Barbara, Kreuzer, Karl-Anton, Tandon, Maneesh, Humphrey, Kathryn, Jiang, Yanwen, Schary, William, Bullinger, Lars, Mertens, Daniel, Lura, Michele Porro, Kneba, Michael, Doehner, Hartmut, Fischer, Kirsten, Hallek, Michael and Stilgenbauer, Stephan (2020). Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax. Blood, 135 (26). S. 2402 - 2413. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Teleanu, Veronica, Edelmann, Jennifer, Haferlach, Claudia, Ibach, Stefan, Tausch, Eugen, Bloehdorn, Johannes, Leblond, Veronique, Cymbalista, Florence, Delmer, Alain, Hallek, Michael, Doehner, Hartmut and Stilgenbauer, Stephan (2014). Genomic Mechanisms of 17p / TP53 Loss in Primary ultra High-risk and Refractory Chronic Lymphocytic Leukemia: Results from the CLL2O Trial. Blood, 124 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Theobald, Sebastian ORCID: 0000-0001-7042-8326, Simonis, Alexander ORCID: 0000-0003-2945-9897, Georgomanolis, Theodoros ORCID: 0000-0002-4066-9257, Kreer, Christoph ORCID: 0000-0002-9140-9850, Zehner, Matthias ORCID: 0000-0001-5745-0836, Eisfeld, Hannah S, Albert, Marie‐Christine, Chhen, Jason, Motameny, Susanne ORCID: 0000-0003-1186-1108, Erger, Florian ORCID: 0000-0002-2768-1702, Fischer, Julia ORCID: 0000-0001-6138-7454, Malin, Jakob J ORCID: 0000-0002-2989-0436, Gräb, Jessica, Winter, Sandra ORCID: 0000-0002-4930-2005, Pouikli, Andromachi ORCID: 0000-0003-1868-6875, David, Friederike ORCID: 0000-0001-9521-5669, Böll, Boris ORCID: 0000-0002-6432-0981, Koehler, Philipp ORCID: 0000-0002-7386-7495, Vanshylla, Kanika ORCID: 0000-0003-4552-9170, Gruell, Henning ORCID: 0000-0002-0725-7138, Suarez, Isabelle ORCID: 0000-0002-9863-9675, Hallek, Michael ORCID: 0000-0002-7425-4455, Fätkenheuer, Gerd ORCID: 0000-0002-5054-1871, Jung, Norma ORCID: 0000-0002-5740-0772, Cornely, Oliver A. ORCID: 0000-0001-9599-3137, Lehmann, Clara ORCID: 0000-0002-7042-1578, Tessarz, Peter ORCID: 0000-0002-6953-9835, Altmüller, Janine, Nürnberg, Peter ORCID: 0000-0002-7228-428X, Kashkar, Hamid ORCID: 0000-0003-2796-1429, Klein, Florian ORCID: 0000-0003-1376-1792, Koch, Manuel ORCID: 0000-0002-2962-7814 and Rybniker, Jan ORCID: 0000-0001-8351-2690 (2021). Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19. EMBO Molecular Medicine, 13 (8). e14150. Wiley. ISSN 1757-4676

Theobald, Sebastian J., Simonis, Alexander ORCID: 0000-0003-2945-9897, Georgomanolis, Theodoros ORCID: 0000-0002-4066-9257, Kreer, Christoph ORCID: 0000-0002-9140-9850, Zehner, Matthias, Eisfeld, Hannah S., Albert, Marie-Christine, Chhen, Jason, Motameny, Susanne, Erger, Florian ORCID: 0000-0002-2768-1702, Fischer, Julia ORCID: 0000-0001-6138-7454, Malin, Jakob J. ORCID: 0000-0002-2989-0436, Graeb, Jessica, Winter, Sandra, Pouikli, Andromachi ORCID: 0000-0003-1868-6875, David, Friederike ORCID: 0000-0001-9521-5669, Boell, Boris, Koehler, Philipp ORCID: 0000-0002-7386-7495, Vanshylla, Kanika ORCID: 0000-0003-4552-9170, Gruell, Henning, Suarez, Isabelle, Hallek, Michael, Faetkenheuer, Gerd, Jung, Norma, Cornely, Oliver A., Lehmann, Clara, Tessarz, Peter ORCID: 0000-0002-6953-9835, Altmueller, Janine, Nuernberg, Peter, Kashkar, Hamid, Klein, Florian, Koch, Manuel ORCID: 0000-0002-2962-7814 and Rybniker, Jan (2021). Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19. EMBO Mol. Med., 13 (8). HOBOKEN: WILEY. ISSN 1757-4684

Theobald, Sebastian J., Simonis, Alexander ORCID: 0000-0003-2945-9897, Mudler, Julie M., Goebel, Ulrike, Acton, Richard, Kohlhas, Viktoria, Albert, Marie-Christine, Hellmann, Anna-Maria, Malin, Jakob J. ORCID: 0000-0002-2989-0436, Winter, Sandra, Hallek, Michael ORCID: 0000-0002-7425-4455, Walczak, Henning, Koch, Manuel ORCID: 0000-0002-2962-7814 and Rybniker, Jan (2022). Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccination. EMBO Mol. Med., 14 (8). HOBOKEN: WILEY. ISSN 1757-4684

Theurich, Sebastian ORCID: 0000-0001-5706-8258, Fischmann, Hans, Chakupurakal, Geothy, Shimabukuro-Vomhagen, Alexander, Chemnitz, Jens M., Holtick, Udo, Rothe, Achim, Scheid, Christof, Hallek, Michael, Skoetz, Nicole ORCID: 0000-0003-4744-6192 and von Bergwelt-Baildon, Michael (2013). Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis-A systematic review and meta-analysis. Crit. Rev. Oncol./Hematol., 88 (1). S. 178 - 187. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-0461

Theurich, Sebastian, Malcher, Joke, Wennhold, Kerstin, Shimabukuro-Vornhagen, Alexander, Chemnitz, Jens M., Udo, Holtick, Krause, Anke, Kobe, Carsten, Kahraman, Deniz, Geothy, Chakupurakal, Engert, Andreas, Christof, Scheid, Hallek, Michael and von Bergwelt-Baildon, Michael (2012). CD30-Targeted Therapy with Brentuximab Vedotin Combined with Donor Lymphocyte Infusions Induce Sustained Clinical Remissions and Tumor Specific Immunity in a Series of Patients with Relapsed Hodgkin Lymphoma After Allogeneic Stem Cell Transplantation. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Theurich, Sebastian ORCID: 0000-0001-5706-8258, Schlaak, Max, Steguweit, Harold, Heukamp, Lukas C., Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Kurschat, Peter, Rabenhorst, Anja, Hartmann, Karin ORCID: 0000-0002-4595-8226, Schloesser, Hans, Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, Holtick, Udo, Hallek, Michael, Stadler, Rudolf and von Bergwelt-Baildon, Michael (2016). Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma. J. Clin. Oncol., 34 (12). S. E110 - 7. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Thijssen, Rachel ORCID: 0000-0002-4493-306X, ter Burg, Johanna, Garrick, Brett, van Bochove, Gregor G. W., Brown, Jennifer R., Fernandes, Stacey M., Sole Rodriguez, Maria, Michot, Jean-Marie ORCID: 0000-0003-3482-3331, Hallek, Michael, Eichhorst, Barbara, Reinhardt, Hans Christian, Bendell, Johanna, Derks, Ingrid A. M., van Kampen, Roel J. W., Hege, Kristen, Kersten, Marie Jose, Trowe, Torsten, Filvaroff, Ellen H., Eldering, Eric and Kater, Arnon P. (2016). Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia. Blood, 128 (4). S. 574 - 584. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Tiao, Grace, Improgo, M. Reina, Tausch, Eugen, Fernandes, Stacey M., Bahlo, Jasmin, Robrecht, Sandra, Fischer, Kirsten, Hallek, Michael, Stilgenbauer, Stephan, Kiezun, Adam, Getz, Gad and Brown, Jennifer R. (2017). Analysis of ITGB2 rare germ line variants in chronic lymphocytic leukemia. Blood, 130 (22). S. 2443 - 2445. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Bachurski, Daniel ORCID: 0000-0001-9168-9680, Liu, Shu, Surmann, Kristin, Babatz, Felix, Salazar, Manuela Gesell, Voelker, Uwe, Hallek, Michael, Herrlinger, Ulrich, Vorberg, Ina ORCID: 0000-0003-0583-4015, Coch, Christoph, Reiners, Katrin S. and Hartmann, Gunther (2021). Extracellular Vesicle Separation Techniques Impact Results from Human Blood Samples: Considerations for Diagnostic Applications. Int. J. Mol. Sci., 22 (17). BASEL: MDPI. ISSN 1422-0067

Tzaridis, Theophilos, Reiners, Katrin S., Weller, Johannes, Bachurski, Daniel ORCID: 0000-0001-9168-9680, Schaefer, Niklas, Schaub, Christina, Hallek, Michael, Scheffler, Bjoern, Glas, Martin, Herrlinger, Ulrich, Wild, Stefan, Coch, Christoph and Hartmann, Gunther (2020). Analysis of Serum miRNA in Glioblastoma Patients: CD44-Based Enrichment of Extracellular Vesicles Enhances Specificity for the Prognostic Signature. Int. J. Mol. Sci., 21 (19). BASEL: MDPI. ISSN 1422-0067

Tzaridis, Theophilos, Weller, Johannes, Bachurski, Daniel ORCID: 0000-0001-9168-9680, Schaefer, Niklas, Schaub, Christina, Hallek, Michael, Scheffler, Bjoern, Glas, Martin, Hartmann, Gunther, Herrlinger, Ulrich, Wild, Stefan, Coch, Christoph and Reiners, Katrin (2020). ANALYSIS OF SERUM MIRNA IN GLIOBLASTOMA PATIENTS: TARGETED ENRICHMENT OF EXTRACELLULAR VESICLES ENHANCES SPECIFICITY FOR PROGNOSTIC SIGNATURE. Neuro-Oncology, 22. S. 10 - 11. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Weller, Johannes, Bachurski, Daniel ORCID: 0000-0001-9168-9680, Shakeri, Farhad ORCID: 0000-0003-1161-1942, Schaub, Christina, Hau, Peter, Buness, Andreas, Schlegel, Uwe, Steinbach, Joachim-Peter, Seidel, Clemens, Goldbrunner, Roland, Schaefer, Niklas, Wechsler-Reya, Robert J., Hallek, Michael ORCID: 0000-0002-7425-4455, Scheffler, Bjoern, Glas, Martin, Haeberle, Lothar, Herrlinger, Ulrich, Coch, Christoph, Reiners, Katrin S. and Hartmann, Gunther (2023). A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression. Int. J. Cancer, 152 (2). S. 308 - 320. HOBOKEN: WILEY. ISSN 1097-0215

Uhrmacher, Sabrina, Schmidt, Christina, Erdfelder, Felix, Poll-Wolbeck, Simon Jonas, Gehrke, Iris, Hallek, Michael and Kreuzer, Karl-Anton (2011). Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL). Leuk. Res., 35 (10). S. 1360 - 1367. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 1873-5835

Vollbrecht, Claudia ORCID: 0000-0002-0861-001X, Mairinger, Fabian Dominik, Koitzsch, Ulrike, Peifer, Martin ORCID: 0000-0002-5243-5503, Koenig, Katharina, Heukamp, Lukas Carl, Crispatzu, Giuliano, Wilden, Laura, Kreuzer, Karl-Anton, Hallek, Michael, Odenthal, Margarete, Herling, Carmen Diana and Buettner, Reinhard (2015). Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation Sequencing. PLoS One, 10 (6). SAN FRANCISCO: PUBLIC LIBRARY SCIENCE. ISSN 1932-6203

Volz, Caroline, Breid, Sara, Selenz, Carolin, Zaplatina, Alina, Golfmann, Kristina, Meder, Lydia, Dietlein, Felix, Borchmann, Sven, Chatterjee, Sampurna, Siobal, Maike, Schoettle, Jakob, Florin, Alexandra, Koker, Mirjam, Nill, Marieke, Ozretic, Luka, Uhlenbrock, Niklas, Smith, Steven, Buettner, Reinhard, Miao, Hui, Wang, Bingcheng, Reinhardt, H. Christian, Rauh, Daniel, Hallek, Michael, Acker-Palmer, Amparo, Heukamp, Lukas C. and Ullrich, Roland T. (2020). Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLC. Cell Reports, 31 (4). CAMBRIDGE: CELL PRESS. ISSN 2211-1247

Vorholt, Daniela, Izquierdo-Alvarez, Elena, Sackey, Benedict, Schmitz, Jan, Nickel, Nadine, Blakemore, Stuart, Knittel, Gero, Reinhardt, Christian, Wendtner, Clemens-Martin, Bruns, Heiko, Hallek, Michael and Pallasch, Christian (2018). DNA Damage-Response Pathway in Lymphoma Determines Interactions with Macrophages By Altered PD-Li Expression and Fxosome Formation. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Vyas, Maulik ORCID: 0000-0003-2996-4682, Koehl, Ulrike ORCID: 0000-0002-8159-9160, Hallek, Michael and von Strandmann, Elke Pogge (2014). Natural ligands and antibody-based fusion proteins: harnessing the immune system against cancer. Trends Mol. Med, 20 (2). S. 72 - 83. OXFORD: ELSEVIER SCI LTD. ISSN 1471-499X

Vyas, Maulik ORCID: 0000-0003-2996-4682, Schneider, Ann-Charlott, Shatnyeva, Olga, Reiners, Katrin S., Tawadros, Samir, Kloess, Stephan, Koehl, Ulrike, Hallek, Michael, Hansen, Hinrich P. and von Strandmann, Elke Pogge (2016). Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activity in vitro and in vivo against chronic lymphocytic leukemia. OncoImmunology, 5 (9). PHILADELPHIA: TAYLOR & FRANCIS INC. ISSN 2162-402X

Weinhold, Max, Shimabukuro-Vornhagen, Alexander ORCID: 0000-0002-2351-7294, Franke, Axel, Theurich, Sebastian ORCID: 0000-0001-5706-8258, Wahl, Patrick, Hallek, Michael, Schmidt, Annette, Schinkoethe, Timo, Mester, Joachim, von Bergwelt-Baildon, Michael and Bloch, Wilhelm (2016). Physical exercise modulates the homeostasis of human regulatory T cells. J. Allergy Clin. Immunol., 137 (5). S. 1607 - 1614. NEW YORK: MOSBY-ELSEVIER. ISSN 1097-6825

Weiss, Jonathan, Sos, Martin L., Seidel, Danila, Peifer, Martin ORCID: 0000-0002-5243-5503, Zander, Thomas, Heuckmann, Johannes M., Ullrich, Roland T., Menon, Roopika, Maier, Sebastian, Soltermann, Alex, Moch, Holger, Wagener, Patrick, Fischer, Florian, Heynck, Stefanie, Koker, Mirjam, Schoettle, Jakob, Leenders, Frauke, Gabler, Franziska, Dabow, Ines, Querings, Silvia, Heukamp, Lukas C., Balke-Want, Hyatt, Ansen, Sascha, Rauh, Daniel ORCID: 0000-0002-1970-7642, Baessmann, Ingelore, Altmueller, Janine, Wainer, Zoe, Conron, Matthew, Wright, Gavin ORCID: 0000-0002-7000-9305, Russell, Prudence, Solomon, Ben, Brambilla, Elisabeth, Brambilla, Christian, Lorimier, Philippe, Sollberg, Steinar, Brustugun, Odd Terje, Engel-Riedel, Walburga, Ludwig, Corinna, Petersen, Iver, Saenger, Joerg, Clement, Joachim, Groen, Harry, Timens, Wim ORCID: 0000-0002-4146-6363, Sietsma, Hannie, Thunnissen, Erik ORCID: 0000-0001-5355-8508, Smit, Egbert, Heideman, Danielle, Cappuzzo, Federico, Ligorio, Claudia, Damiani, Stefania, Hallek, Michael, Beroukhim, Rameen, Pao, William, Klebl, Bert, Baumann, Matthias, Buettner, Reinhard, Ernestus, Karen, Stoelben, Erich, Wolf, Juergen, Nuernberg, Peter, Perner, Sven and Thomas, Roman K. (2010). Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer. Sci. Transl. Med., 2 (62). WASHINGTON: AMER ASSOC ADVANCEMENT SCIENCE. ISSN 1946-6242

Weisser, Martin, Yeh, Ru-Fang, Duchateau-Nguyen, Guillemette, Palermo, Giuseppe, Shi, Xiaoyan, Stinson, Susanna Y., Yu, Nancy, Dufour, Annika, Robak, Tadeusz, Salogub, Galina N., Dmoszynska, Anna, Solal-Celigny, Philippe, Warzocha, Krzysztof ORCID: 0000-0002-2396-3905, Loscertales, Javier, Catalano, John, Larratt, Loree, Rossiev, Viktor A., Bence-Bruckler, Isabelle, Geisler, Christian H., Montillo, Marco, Fischer, Kirsten, Fink, Anna-Maria, Hallek, Michael, Bloehdorn, Johannes, Busch, Raymonde, Benner, Axel, Doehner, Hartmut, Valente, Nancy, Wenger, Michael K., Stilgenbauer, Stephan and Dornan, David (2014). PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia. Blood, 124 (3). S. 420 - 426. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Wendtner, Clemens M., Hallek, Michael, Fraser, Graeme A. M., Michallet, Anne-Sophie, Hillmen, Peter, Durig, Jan, Kalaycio, Matt, Gribben, John G., Stilgenbauer, Stephan, Buhler, Andreas, Kipps, Thomas J., Purse, Brendan, Zhang, Jennie, De Bedout, Sabine, Mei, Jay and Chanan-Khan, Asher (2016). Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial*. Leuk. Lymphoma, 57 (6). S. 1291 - 1300. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Wendtner, Clemens-Martin, Byrd, John C., Eichhorst, Barbara, Foa, Robin, Hallek, Michael, Hillmen, Peter, Jager, Ulrich, Jurczak, Wojciech, Kelemen, Peter, Laribi, Kamel, Munir, Talha, Staber, Philipp B., Stilgenbauer, Stephan and Woyach, Jennifer Ann (2016). A phase II study of MOR208 plus idelalisib in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) previously treated with a Bruton's tyrosine kinase inhibitor (MIRACLE). J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Wennhold, Kerstin ORCID: 0000-0001-5539-7226, Thelen, Martin ORCID: 0000-0002-2785-9726, Schloesser, Hans Anton, Haustein, Natalie, Reuter, Sabrina, Garcia-Marquez, Maria, Lechner, Axel, Kobold, Sebastian, Rataj, Felicitas, Utermoehlen, Olaf, Chakupurakal, Geothy, Theurich, Sebastian ORCID: 0000-0001-5706-8258, Hallek, Michael, Abken, Hinrich, Shimabukuro-Vornhagen, Alexander and von Bergwelt-Baildon, Michael (2017). Using Antigen-Specific B Cells to Combine Antibody and T Cell-Based Cancer Immunotherapy. Cancer Immunol. Res., 5 (9). S. 730 - 744. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 2326-6074

Wierda, William, Chyla, Brenda, Eichhorst, Barbara, Schetelig, Johannes, Munir, Talha, Hillmen, Peter, Seymour, John F., Roberts, Andrew W., Coutre, Steven, Jurczak, Wojciech, Mulligan, Stephen P., Wendtner, Clemens-Martin, Davids, Matthew, Boettcher, Sebastian, Cerri, Elisa, Zhou, Lang, Popovic, Relja, Poteracki, Mia, Arzt, Jennifer, Kim, Su Young, Verdugo, Maria, Bhathena, Anahita, Stilgenbauer, Stephan and Hallek, Michael (2017). Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) with 17p Deletion: Outcome and Minimal Residual Disease (MRD) from the Full Population of the Pivotal M13-982 Trial. Clin. Lymphoma Myeloma Leuk., 17. S. S303 - 1. DALLAS: CIG MEDIA GROUP, LP. ISSN 2152-2669

Wolf, Christine, Garding, Angela, Filarsky, Katharina, Bahlo, Jasmin, Robrecht, Sandra, Becker, Natalia, Zucknick, Manuela ORCID: 0000-0003-1317-7422, Rouhi, Arefeh, Weigel, Anja, Claus, Rainer ORCID: 0000-0003-2617-8766, Weichenhan, Dieter, Eichhorst, Barbara, Fischer, Kirsten, Hallek, Michael, Kuchenbauer, Florian, Plass, Christoph, Doehner, Hartmut, Stilgenbauer, Stephan, Lichter, Peter and Mertens, Daniel ORCID: 0000-0003-0227-7188 (2018). NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinib. Int. J. Cancer, 142 (2). S. 322 - 334. HOBOKEN: WILEY. ISSN 1097-0215

Wolf, Juergen and Hallek, Michael ORCID: 0000-0002-7425-4455 (2022). Lung cancer. Innere Med., 63 (7). S. 691 - 694. Berlin: SPRINGER MEDIZIN. ISSN 2731-7099

Xochelli, Aliki, Baliakas, Panagiotis, Agathangelidis, Andreas, Hadzidimitriou, Anastasia, Sutton, Lesley-Ann, Minga, Eva, Tausch, Eugen, Yan, Xiao J., Shanafelt, Tait D., Plevova, Karla, Boudjogra, Myriam, Rossi, Davide, Davis, Zadie, Navarro, Alba, Sandberg, Yorick, Vojdeman, Fie Juhl, Scarfo, Lydia, Stavroyianni, Niki, Sudarikov, Andrey B., Veronese, Silvio, Tzenou, Tatiana, Karan-Djurasevic, Teodora, Catherwood, Mark, Kienle, Dirk, Chatzouli, Maria, Facco, Monica ORCID: 0000-0003-0100-5789, Bahlo, Jasmin, Pedersen, Lone Bredo, Mansouri, Larry, Smedby, Karin E., Chu, Charles C., Giudicelli, Veronique, Lefranc, Marie-Paule, Panagiotidis, Panagiotis, Juliusson, Gunnar, Anagnostopoulos, Achilles, Antic, Darko, Trentin, Livio, Montillo, Marco, Niemann, Carsten, Dohner, Hartmut ORCID: 0000-0003-2116-5536, Langerak, Anton W., Darzentas, Nikos, Pospisilova, Sarka, Hallek, Michael, Campo, Elias ORCID: 0000-0001-9850-9793, Chiorazzi, Nicholas, Oscier, David, Gaidano, Gianluca, Belessi, Chrysoula, Jelinek, Diane F., Stilgenbauer, Stephan, Davi, Frederic, Rosenquist, Richard, Ghia, Paolo and Stamatopoulos, Kostas (2015). CLL with Mutated IGHV4-34 Antigen Receptors Is Clinically Heterogeneous: Antigen Receptor Stereotypy Makes the Difference. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Xochelli, Aliki, Baliakas, Panagiotis, Kavakiotis, Ioannis, Agathangelidis, Andreas, Sutton, Lesley-Ann, Minga, Eva, Ntoufa, Stavroula, Tausch, Eugen, Yan, Xiao-Jie, Shanafelt, Tait, Plevova, Karla ORCID: 0000-0002-6148-8877, Boudjogra, Myriam, Rossi, Davide, Davis, Zadie, Navarro, Alba, Sandberg, Yorick, Vojdeman, Fie Juhl, Scarfo, Lydia, Stavroyianni, Niki, Sudarikov, Andrey ORCID: 0000-0001-9463-9187, Veronese, Silvio, Tzenou, Tatiana, Karan-Djurasevic, Teodora, Catherwood, Mark, Kienle, Dirk, Chatzouli, Maria, Facco, Monica ORCID: 0000-0003-0100-5789, Bahlo, Jasmin, Pott, Christiane, Pedersen, Lone Bredo, Mansouri, Larry, Smedby, Karin E., Chu, Charles C., Giudicelli, Veronique, Lefranc, Marie-Paule, Panagiotidis, Panagiotis, Juliusson, Gunnar, Anagnostopoulos, Achilles ORCID: 0000-0003-4384-9031, Vlahavas, Ioannis, Antic, Darko, Trentin, Livio, Montillo, Marco, Niemann, Carsten ORCID: 0000-0001-9880-5242, Doehner, Hartmut, Langerak, Anton W., Pospisilova, Sarka, Hallek, Michael, Campo, Elias ORCID: 0000-0001-9850-9793, Chiorazzi, Nicholas, Maglaveras, Nikos, Oscier, David, Gaidano, Gianluca, Jelinek, Diane F., Stilgenbauer, Stephan, Chouvarda, Ioanna ORCID: 0000-0001-8915-6658, Darzentas, Nikos, Belessi, Chrysoula, Davi, Frederic, Hadzidimitriou, Anastasia, Rosenquist, Richard, Ghia, Paolo ORCID: 0000-0003-3750-7342 and Stamatopoulos, Kostas (2017). Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes. Clin. Cancer Res., 23 (17). S. 5292 - 5302. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1557-3265

Zander, Thomas and Hallek, Michael ORCID: 0000-0002-7425-4455 (2022). What should specialist in internal medicine be aware of in patients treated with biologics? Infections and autoimmune phenomena. Internist, 63 (2). S. 165 - 171. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289

Zenz, Thorsten, Eichhorst, Barbara, Busch, Raymonde, Denzel, Tina, Haebe, Sonja, Winkler, Dirk, Buehler, Andreas, Edelmann, Jennifer, Bergmann, Manuela, Hopfinger, Georg ORCID: 0000-0002-8321-1342, Hensel, Manfred, Hallek, Michael, Doehner, Hartmut and Stilgenbauer, Stephan (2010). TP53 Mutation and Survival in Chronic Lymphocytic Leukemia. J. Clin. Oncol., 28 (29). S. 4473 - 4480. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Zimmer, Philipp, Baumann, Freerk T., Bloch, Wilhelm, Schenk, Alexander, Koliamitra, Christine, Jensen, Patrizia, Mierau, Andreas ORCID: 0000-0002-6305-3260, Huelsduenker, Thorben, Reinart, Nina, Hallek, Michael and Elter, Thomas (2014). Impact of exercise on pro inflammatory cytokine levels and epigenetic modulations of tumor-competitive lymphocytes in Non-Hodgkin-Lymphoma patients-randomized controlled trial. Eur. J. Haematol., 93 (6). S. 527 - 533. HOBOKEN: WILEY. ISSN 1600-0609

Zimmer, Philipp, Hillebrand, Philipp, Wolf, Florian, Joisten, Niklas ORCID: 0000-0002-9947-8746, Walzik, David, Hardt, Luca, Grossek, Anja, Hartig, Philipp, Kierdorf, Fiona, Belz, Maximilian, Tinschmann, Malina, Kiesl, David, Bloch, Wilhelm, Gross-Ophoff-Mueller, Carolin, Hallek, Michael, Boell, Boris, Oberste, Max and Elter, Thomas (2021). Impact of induction chemotherapy on objective and self-perceived cognitive performance in patients suffering from hematological disorders. Leuk. Lymphoma, 62 (10). S. 2526 - 2531. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Zimmer, Philipp, Mierau, Andreas ORCID: 0000-0002-6305-3260, Bloch, Wilhelm, Strueder, Heiko K., Huelsduenker, Thorben, Schenk, Alexander, Fiebig, Leonie, Baumann, Freek T., Hahn, Moritz, Reinart, Nina, Hallek, Michael and Elter, Thomas (2015). Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab and bendamustine. Leuk. Lymphoma, 56 (2). S. 347 - 353. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

van Gorkom, Gwendolyn, van Gelder, Michel, Eikema, Dirk-Jan, Blok, Henric-Jan, van Lint, M. T., Koc, Yener, Ciceri, Fabio, Beelen, Dietrich, Chevallier, Patrice, Selleslag, Dominik, Blaise, Didier, Foa, Roberto, Corradini, Paolo ORCID: 0000-0002-9186-1353, Castagna, Luca, Moreno, Carol, Solano, Carlos ORCID: 0000-0003-3702-0817, Mueller, Lutz Peter, Tischer, Johanna, Hilgendorf, Inken ORCID: 0000-0003-2038-9730, Hallek, Michael, Bittenbring, Joerg, Theobald, Matthias, Schetelig, Johannes and Kroeger, Nicolaus (2018). Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT. Bone Marrow Transplant., 53 (3). S. 255 - 264. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

van Gorkom, Gwendolyn, van Gelder, Michel, Ziagkos, Dimitris, Blok, Henric-Jan, van Lint, Maria Teresa, Koc, Yener, Ciceri, Fabio, Beelen, Dietrich W., Chevallier, Patrice, Selleslag, Dominik, Blaise, Didier, Foa, Roberto, Corradini, Paolo, Castagna, Luca, Moreno, Carol, Solano, Carlos ORCID: 0000-0003-3702-0817, Mueller, Lutz P., Tischer, Johanna, Hilgendorf, Inken ORCID: 0000-0003-2038-9730, Hallek, Michael, Bittenbring, Joerg Thomas, Theobald, Matthias, Schetelig, Johannes and Kroger, Nicolaus (2016). Outcomes of Mismatched Related Allogeneic Stem Cell Transplantation for Chronic Lymphocytic Leukemia: A Retrospective Study on Behalf of the Chronic Malignancies Working Party of the EBMT. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

von Tresckow, Bastian, Boell, Boris, Eichenauer, Dennis, Beschorner, Denissa, Knop, Stefan, Goebeler, Maria-Elisabeth, Chemnitz, Jens Marcus, Hallek, Michael, Engert, Andreas and Huebel, Kai (2014). Anti-epidermal growth factor receptor antibody cetuximab in refractory or relapsed multiple myeloma: a phase II prospective clinical trial. Leuk. Lymphoma, 55 (3). S. 695 - 698. LONDON: INFORMA HEALTHCARE. ISSN 1029-2403

von Tresckow, Julia, Cramer, Paula, Bahlo, Jasmin, Engelke, Anja, Langerbeins, Petra, Fink, Anna-Maria, Klaproth, Holger, Tausch, Eugen, Fischer, Kirsten, Wendtner, Clemens-Martin, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Boettcher, Sebastian, Eichhorst, Barbara and Hallek, Michael (2015). CLL2-BIG - a Novel Treatment Regimen of Bendamustine Followed By GA101 and Ibrutinib Followed By Ibrutinib and GA101 Maintenance in Patients with Chronic Lymphocytic Leukemia (CLL): Interim Results of a Phase II-Trial. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

von Tresckow, Julia, Cramer, Paula, Bahlo, Jasmin, Robrecht, Sandra, Engelke, Anja, Langerbeins, Petra, Fink, Anna-Maria, Illmer, Thomas, Klaproth, Holger, Estenfelder, Sven, Ritgen, Matthias, Fischer, Kirsten, Wendtner, Clemens-Martin, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Bottcher, Sebastian, Eichhorst, Barbara and Hallek, Michael (2016). CLL2-BIG - a Novel Treatment Regimen of Bendamustine Followed By GA101 and Ibrutinib Followed By Ibrutinib and GA101 Maintenance in Patients with Chronic Lymphocytic Leukemia (CLL): Results of a Phase II-Trial. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

von Tresckow, Julia, Cramer, Paula, Bahlo, Jasmin, Robrecht, Sandra, Langerbeins, Petra, Fink, Anna-Maria, Al-Sawaf, Othman, Illmer, Thomas, Klaproth, Holger, Estenfelder, Sven, Ritgen, Matthias, Fischer, Kirsten, Wendtner, Clemens-Martin, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Boettcher, Sebastian, Eichhorst, Barbara F. and Hallek, Michael (2019). CLL2-BIG: sequential treatment with bendamustine, ibrutinib and obinutuzumab (GA101) in chronic lymphocytic leukemia. Leukemia, 33 (5). S. 1161 - 1173. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551

von Tresckow, Julia ORCID: 0000-0001-5873-4603, Cramer, Paula ORCID: 0000-0003-4046-9922, Robrecht, Sandra, Langerbeins, Petra, Fink, Anna-Maria, Al-Sawaf, Othman, Fuerstenau, Moritz, Illmer, Thomas, Klaproth, Holger, Tausch, Eugen, Ritgen, Matthias, Fischer, Kirsten, Wendtner, Clemens-Martin, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Boettcher, Sebastian, Eichhorst, Barbara F. and Hallek, Michael ORCID: 0000-0002-7425-4455 (2022). Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial. Leukemia, 36 (8). S. 2125 - 2129. LONDON: SPRINGERNATURE. ISSN 1476-5551

von Tresckow, Julia, Eichhorst, Barbara, Bahlo, Jasmin and Hallek, Michael (2019). The Treatment of Chronic Lymphatic Leukemia. Dtsch. Arztebl. Int., 116 (4). S. 41 - 47. COLOGNE: DEUTSCHER AERZTE-VERLAG GMBH. ISSN 1866-0452

von Tresckow, Julia, Hallek, Michael and Eichhorst, Barbara (2018). Individualized Therapy of chronic lymphocytic Leukemia. Dtsch. Med. Wochenschr., 143 (18). S. 1318 - 1325. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-4413

This list was generated on Thu Apr 25 13:12:59 2024 CEST.

Export as	Atom RSS 1.0 RSS 2.0